[
    "This sample is a phase 3 trial testing the effectiveness of sodium enoxaparin and sodium enoxaparin clexane in preventing venous thromboembolism in patients undergoing abdominal surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial that aims to evaluate the effectiveness of two drug combinations, nimesulide + pantoprazole and naproxen + esomeprazole, in treating acute and chronic inflammation and dyspepsia. The eligibility criteria include being an adult aged 18 or older with osteo-articular injury requiring anti-inflammatory treatment for 14 days, while exclusion criteria include pregnancy, history of peptic ulcer or gastric surgery, recent use of certain medications, contraindications to NSAIDs or PPIs, and renal or hepatic impairment.",
    "This sample is a phase 3 clinical trial that aims to evaluate the effectiveness of hydration strategies using saline, sodium bicarbonate, and l-carnitine in patients with acute kidney injury and renal insufficiency, who are scheduled for a coronarography. The study has specific inclusion and exclusion criteria, and it excludes patients who are pregnant or breastfeeding, taking L-carnitine, have certain medical conditions, or are unable to participate in follow-up visits.",
    "This sample is a phase 3 clinical trial for psoriatic arthritis, testing the effectiveness of tofacitinib, adalimumab, and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with advanced unresectable hepatocellular carcinoma, testing the effectiveness of sorafenib, a drug used to treat liver cancer, based on specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and it is testing the effectiveness of two drugs, umeclidinium/vilanterol and tiotropium, in improving lung function and reducing symptoms. The eligibility criteria include being an outpatient, being 40 years or older, having a diagnosis of COPD, and having a smoking history of at least 10 pack-years.",
    "This sample is a phase 3 trial for pancreatic cancer patients with specific eligibility criteria, including tumor size and absence of metastasis, and the use of gemcitabine neoadjuvant and adjuvant drugs.",
    "This sample is a phase 3 trial for HIV infection, testing the effectiveness of monopi - boosted lopinavir or boosted darunavir and bi therapy (boosted lopinavir or boosted darunavir) + lamivudine as second line treatment for patients with specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with HER2-negative metastatic or locally advanced breast cancer, testing the effectiveness of niraparib and physician's choice drugs in patients with germline BRCA1 or BRCA2 mutations, who have received prior cytotoxic regimens and have adequate bone marrow, kidney, and liver function.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients, testing the drugs bdp/ff/gb, tiotropium, and bdp/ff + tiotropium, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of beclometasone/formoterol/glycopyrrolate and beclometasone/formoterol drugs in reducing exacerbations. The inclusion criteria include being aged \u2265 40 years, having a post-bronchodilator FEV1 < 50% of predicted normal value, and experiencing at least one exacerbation in the past 12 months. Exclusion criteria include pregnancy, asthma or history of allergic rhinitis, and clinically significant cardiovascular conditions.",
    "This phase 3 trial is investigating the efficacy of l-folinic acid, 5 fu, and oxaliplatin in treating non-resectable or recurrent/metastatic cholangiocarcinoma, gallbladder cancer, and ampullary cancer patients who have failed no more than one prior course of chemotherapy with clear evidence of disease progression.",
    "This sample is a phase 2/phase 3 trial for patients with heart failure, testing the effectiveness of anakinra (high dose and standard dose) and placebo in reducing symptoms and improving outcomes. The eligibility criteria include specific diagnostic criteria, left ventricular systolic dysfunction, age requirement, and C-reactive protein levels, while exclusion criteria include certain comorbidities, recent procedures, chronic use of certain medications, and pregnancy.",
    "This sample is a phase 3 trial for age-related macular degeneration, testing the drugs e10030, bevacizumab or aflibercept, and e10030 sham injection, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with hormone-resistant prostate cancer, testing the effectiveness of enzalutamide, abiraterone, and prednisone as treatment options, with specific eligibility criteria and required initial laboratory values.",
    "This sample is a phase 2/phase 3 trial for patients with acute myocardial infarction, testing the effectiveness of anakinra 100 mg and placebo in reducing symptoms, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of trastuzumab, doxorubicin, cyclophosphamide, paclitaxel, docetaxel, carboplatin, and neo-adjuvant chemotherapy in treating breast cancer patients with HER2-positive disease, who have no evidence of residual, locally recurrent, or metastatic disease after surgery and chemotherapy, and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for pancreatic neoplasms, testing the drugs nab-paclitaxel and gemcitabine, with eligibility criteria including confirmed resected ductal pancreatic adenocarcinoma, specific tumor staging, and acceptable hematology and blood chemistry levels.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of dolutegravir and protease inhibitor/ritonavir in HIV-infected patients who are currently on antiretroviral therapy and have viral suppression, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of various asthma medications, including flovent diskus and advair diskus, in individuals with asthma who have self-reported Black ancestry and meet specific eligibility criteria.",
    "This sample is a phase 3 trial for ovarian, fallopian tube, and peritoneal cancer patients who have received prior platinum-based treatment regimens and achieved a response, testing the efficacy of rucaparib compared to placebo as maintenance therapy.",
    "This sample is a phase 3 clinical trial for the treatment of central retinal vein occlusion using aflibercept and bevacizumab drugs, with specific eligibility criteria including visual acuity score, retinal thickness, and exclusion criteria such as prior treatments and ocular conditions.",
    "This sample is a phase 3 trial for the drug z-338 in patients with dyspepsia, specifically those with postprandial distress syndrome as defined by the Rome III Criteria, and excludes patients with certain conditions or who are taking specific medications.",
    "This sample is a phase 3 trial for patients with metastatic uveal melanoma, testing the efficacy of selumetinib, placebo, and dacarbazine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of idelalisib, chlorambucil, and obinutuzumab as potential treatments, with specific eligibility criteria for participation.",
    "This sample is a phase 3 clinical trial for chronic lymphocytic leukemia (CLL) patients, testing the effectiveness of the drugs idelalisib, bendamustine, rituximab, and placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for bipolar depression, testing the drugs placebo and sm-13496, with eligibility criteria including patients aged 18-74 with bipolar I disorder and exclusion criteria including recent hospitalization for a manic or mixed episode.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the effectiveness of adalimumab and placebo in patients with intestinal stenosis, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of non-biologic DMARDs, tocilizumab, and methotrexate in treating rheumatoid arthritis, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for the treatment of clostridium difficile infection, testing the effectiveness of drugs such as cadazolid and vancomycin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the effectiveness of paclitaxel in combination with other drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of ticagrelor 60 mg compared to a placebo in reducing the risk of cardiovascular events in patients with documented coronary artery occlusive disease or previous revascularization of a coronary artery.",
    "This sample is a phase 3 clinical trial for patients with acute ischaemic stroke or transient ischaemic attack, testing the effectiveness of ticagrelor and acetylsalicylic acid (ASA) as study medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, using the drugs asunaprevir and daclatasvir, with eligibility criteria including chronic HCV infection, intolerance to previous therapy, and specific laboratory values.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug qva149 compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is investigating the effectiveness of olaparib and physician's choice chemotherapy in treating patients with metastatic breast cancer who have a germline mutation in BRCA1 or BRCA2, and have received prior anthracycline and taxane therapy.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease and dementia patients, testing the drug EVP-6124, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with chronic lymphocytic leukemia (CLL) testing the effectiveness of bendamustine, venetoclax, and rituximab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the effectiveness of apomorphine hydrochloride compared to a placebo in controlling motor fluctuations that are not adequately controlled by levodopa treatment.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs placebo and idalopirdine, with specific inclusion and exclusion criteria for patients, such as having a knowledgeable caregiver and stable treatment with donepezil.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs placebo and idalopirdine, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for patients with HIV and acute hepatitis C genotype 1 infection, testing the efficacy of ribavirin and telaprevir in combination with atazanavir- or efavirenz- or raltegravir-based ART regimen in achieving a sustained virologic response.",
    "This sample is a phase 3 clinical trial for patients with pulmonary arterial hypertension (PAH) who have not responded to treatment with PDE-5 inhibitors. The trial will test the efficacy of riociguat (Adempas, Bay63-2521) in improving symptoms and exercise capacity in these patients.",
    "This sample is a phase 3 clinical trial for patients with non-squamous non-small cell lung cancer, testing the drugs atezolizumab and docetaxel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of myelodysplastic syndromes (MDS) using the drugs galunisertib and placebo, with specific eligibility criteria including confirmed MDS diagnosis, specific risk category, anemia with or without RBC transfusion dependence, and a performance status of \u22642 on the ECOG scale.",
    "This sample is a phase 3 trial for the treatment of moderate to severe ankylosing spondylitis (AS) using secukinumab and placebo secukinumab, with eligibility criteria including prior radiographic evidence of AS and inadequate response to NSAIDs.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of pl2200 aspirin capsules and enteric-coated aspirin caplets in reducing cardiovascular risk factors, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the drug tolvaptan, which aims to treat hyponatremia in pediatric patients who are resistant to standard therapy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with relapsed/refractory B-precursor acute lymphoblastic leukemia, testing the efficacy of blinatumomab in combination with standard of care chemotherapy as a treatment option. The eligibility criteria include specific disease characteristics, previous treatment history, and performance status, while exclusion criteria include certain medical conditions and recent treatments.",
    "This sample is a phase 3 clinical trial for the treatment of osteoporosis in postmenopausal women, comparing the drug denosumab with a placebo, and includes eligibility criteria such as age, BMD values, and additional risk factors.",
    "This sample is a phase 3 trial for the treatment of pneumonia using tedizolid phosphate and linezolid, targeting patients with ventilated nosocomial pneumonia caused by gram-positive bacteria, while excluding patients with community, viral, fungal or parasitic pneumonia, structural lung abnormalities, immunosuppression, previous antibiotics for more than 24 hours, and expected survival of less than 72 hours.",
    "This phase 3 trial is testing the effectiveness of a placebo in treating rheumatoid arthritis patients who are intolerant or inadequate responders to methotrexate, and have not received any non-biologic DMARDs for at least 2 weeks prior to the study.",
    "This sample is a phase 3 trial for the drug tolvaptan in the treatment of hyponatremia, with specific eligibility and ineligibility criteria outlined.",
    "This phase 3 clinical trial aims to investigate the effectiveness of metformin xr, saxagliptin, and saxagliptin-metformin xr in treating polycystic ovary syndrome (PCOS) with prediabetic hyperglycemia, as well as the eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of osteoarthritis of the knee using triamcinolone acetonide, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of levosimendan, a drug, in patients undergoing coronary artery bypass grafting, mitral valve surgery, or low cardiac output syndrome, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for diabetic gastroparesis, testing the effectiveness of metoclopramide nasal spray and placebo nasal spray in reducing symptoms, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for liver cancer patients who are ineligible for locoregional therapy, and it will test the effectiveness of the drug arq197 compared to a placebo in patients with c-Met high tumor samples.",
    "This phase 3 clinical trial is investigating the use of insulin degludec and insulin glargine in patients with type 2 diabetes who meet specific eligibility criteria, such as experiencing severe hypoglycemic episodes or having hypoglycemic symptom unawareness.",
    "This sample is a phase 2/phase 3 trial for the treatment of gastroparesis and diabetes mellitus using the drugs prucalopride and placebo, with eligibility criteria including age, clinical diagnosis, symptoms, gastric emptying, and exclusion criteria including cardiovascular, respiratory, renal, hepatic, gastrointestinal, hematological, neurological, psychiatric, or other diseases that may interfere with the study objectives or pose safety concerns.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer patients with Met-positive status and EGFR-activating mutation, testing the efficacy of erlotinib, onartuzumab, and placebo as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for triple negative breast cancer, testing the effectiveness of cyclophosphamide, placebo, doxorubicin, paclitaxel, carboplatin, and veliparib in combination with standard treatment. The eligibility criteria include histologically confirmed invasive breast cancer, negative BRCA germline mutation, triple-negative cancer, ECOG performance status of 0 to 1, and not being pregnant.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, using the drugs daclatasvir, sofosbuvir, and ribavirin, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis C virus (HCV) infection, testing the efficacy of daclatasvir and sofosbuvir drugs in treating HCV. The eligibility criteria include being HCV treatment-naive or treatment-experienced, having HCV RNA \u226510,000 IU/mL, and having HIV-1 infection. Exclusion criteria include HIV-2 infection, organ transplants, history of cancer, hepatocellular carcinoma, and decompensated liver disease.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, testing the drugs daclatasvir and sofosbuvir, with specific eligibility criteria including being HCV treatment-naive and having HCV genotype 3 infection.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of insulin degludec, insulin glargine, and insulin aspart in managing blood glucose levels, with specific eligibility criteria including experiencing severe hypo episodes, chronic renal failure, hypoglycemic symptom unawareness, and diabetes duration of more than 15 years.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of ertugliflozin and other drugs in combination with metformin or sitagliptin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial that aims to investigate the effects of ketamine and saline on individuals with suicidal ideation, major depressive disorder, and healthy participants, with specific inclusion and exclusion criteria outlined for each group.",
    "This sample is a phase 3 clinical trial for patients with polycythemia vera, testing the effectiveness of the drugs \"best available therapy\" and \"ruxolitinib\" in treating the disease, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of allopurinol, a drug used to lower uric acid levels, in individuals with pre-hypertension or stage I hypertension and high serum urate levels.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the effectiveness of vedolizumab and vedolizumab placebo in participants with small-intestinal, large-intestinal, or small-/large-intestinal Crohn's disease, who have failed previous treatments with corticosteroids, immunomodulators, and anti-tumor necrosis factor alpha (TNF\u03b1) antibodies.",
    "This sample is a phase 3 clinical trial for the treatment of ulcerative colitis using vedolizumab and vedolizumab placebo, with eligibility criteria including a diagnosis of total or left-sided ulcerative colitis and treatment failure with corticosteroids, immunomodulators, and tumor necrosis factor-alpha antagonists.",
    "This sample is a phase 3 clinical trial for patients with stage IV or recurrent non-small cell lung cancer, testing the effectiveness of gemcitabine, cisplatin, carboplatin, paclitaxel, and pemetrexed as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for acute lymphoblastic leukemia, testing the use of chemotherapy in patients aged 18-39 who are in their first complete remission, with specific eligibility criteria including hepatic and renal function, infection control, performance status, and ability to provide informed consent. Exclusion criteria include having an HLA-matched donor, high-risk ALL, pregnancy, and loss of ability to provide consent due to psychiatric or physical illness.",
    "This phase 3 trial aims to evaluate the efficacy of radium-223 dichloride, abiraterone, and prednisone/prednisolone in treating prostatic neoplasms, specifically in patients with bone metastases and no other visceral or brain metastasis, who have shown prostate cancer progression and have a performance status score of 0 or 1.",
    "This sample is a phase 2/phase 3 trial testing ticagrelor, prasugrel, and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic castration-resistant prostate cancer, testing the drugs taxotere and jevtana, with eligibility criteria including specific disease confirmation, hormone levels, disease progression, and organ function requirements.",
    "This sample is a phase 2/phase 3 clinical trial for the drug mirabegron and placebo in patients with urinary bladder, neurogenic disease. The eligibility criteria include having a diagnosis of suprasacral spinal cord injury or multiple sclerosis, stable bladder management, bothersome urinary symptoms, and ability to read and speak English. There are various exclusion criteria, including previous urologic surgery, cardiac disease, renal or liver dysfunction, history of cancer, interstitial cystitis, and active urinary tract infection.",
    "The sample is a phase 3 trial for type 1 diabetes, testing the effectiveness of metformin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of overactive bladder, urgency incontinence, and urinary bladder diseases using drugs such as solifenacin succinate and mirabegron, along with placebos, and includes specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar I depression in children and adolescents, using the drugs lurasidone and placebo, with specific eligibility criteria including age, diagnosis, symptom duration, and various health factors.",
    "This sample is a phase 3 clinical trial for patients with major depressive disorder, testing the drugs asc-01 and placebo. The inclusion criteria include patients with a diagnosis of major depressive disorder and a HAM-D 17 total score of 18 or more, while the exclusion criteria include pregnant or breastfeeding females, patients intolerant to all antidepressants, and patients with a history of electroconvulsive therapy or enrollment in another clinical trial within the past month.",
    "This sample is a phase 3 trial for rheumatoid arthritis patients who have an inadequate response to current non-biologic DMARD therapy or the first anti-TNF agent, and it aims to evaluate the effectiveness of tocilizumab, DMARDs, oral corticosteroids, and methotrexate as potential treatments.",
    "This sample is a phase 3 clinical trial testing the drugs cyclophosphamide, fludarabine phosphate, and ibrutinib for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma, with specific eligibility criteria including disease diagnosis, previous treatment history, and various health parameters.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs gantenerumab and placebo, with inclusion criteria including a clinical diagnosis of mild Alzheimer's disease, presence of amyloid pathology, and stable dosing of approved AD medications, and exclusion criteria including other forms of dementia, history of stroke or systemic autoimmune disorders, and certain medical conditions such as uncontrolled hypertension and impaired hepatic function.",
    "This sample is a phase 3 clinical trial for cystic fibrosis, testing the effectiveness of azithromycin, placebo, and tobramycin solution for inhalation in children aged 6 months to 18 years, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of brexpiprazole and aripiprazole in treating acute relapse of symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of semaglutide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic hepatitis B, testing the drugs telbivudine and placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes, testing the effectiveness of the insulin glargine/lixisenatide fixed ratio combination, insulin glargine, and lixisenatide in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for type 2 diabetes, testing the effectiveness of insulin glargine/lixisenatide and other drugs in participants who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of prostatic hyperplasia, testing the effectiveness of dutasteride and tamsulosin, with specific eligibility criteria for male participants aged 50 years and older.",
    "This sample is a phase 3 trial for a vaccine to prevent herpes zoster (shingles) in kidney transplant recipients, with the inclusion criteria including subjects who have received a renal transplant, are on maintenance immunosuppressive therapy, and have stable renal function, while the exclusion criteria include previous allograft loss due to recurrent primary kidney disease, history of chronic allograft injury, and use of certain immunosuppressive therapies.",
    "This sample is a phase 3 trial for type 2 diabetes mellitus, testing the drugs mk-1293, lantus\u2122, and prandial insulin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for the treatment of ADHD, testing the drug mg01ci (1400 mg) against a placebo, with eligibility criteria including a diagnosis of ADHD, moderate clinical severity, and fluency in English or Hebrew.",
    "This sample is a phase 2/phase 3 trial for involutional osteoporosis, testing the drugs ne-58095 ir, ne-58095 ir placebo, ne-58095 dr, and ne-58095 dr placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 trial for patients with pulmonary embolism, thromboembolism, thrombosis, venous thrombosis, or venous thromboembolism. The trial is testing the drugs bay 59-7939 and ASA, and the eligibility criteria include patients who have been treated for 6 to 12 months without interrupting anticoagulation for longer than 1 week.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus and diabetic nephropathy, testing the effectiveness of canagliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of fluticasone 44 mcg and fluticasone 220 mcg as controller therapy, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for patients with desmoid-type fibromatosis, testing the drug sorafenib tosylate, with specific eligibility criteria including confirmation of disease, prior treatments, exclusion of certain medications, and measurable disease.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of mometasone, tiotropium respimat, and placebo drugs, with specific eligibility criteria for participants, including a confirmed diagnosis of asthma, baseline FEV1\u226570% of predicted, and indications for chronic controller therapy. Exclusion criteria include chronic corticosteroid therapy, recent allergen immunotherapy, and certain medical conditions.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial skin and skin structure infections (ABSSSI) using drugs such as tedizolid and linezolid, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with myeloma and venous thromboembolism, testing the use of apixaban as a preventive treatment for venous thromboembolic events in combination with lenalidomide-dexamethasone therapy. The inclusion criteria include patients aged over 18 years, with myeloma in first-line treatment or relapse, and requiring prevention of venous thromboembolic events. The exclusion criteria include patients needing curative anticoagulant treatment, post-operative preventive treatment with an anticoagulant, and patients with active bleeding or high risk of bleeding.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin in combination with metformin hydrochloride as an add-on therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of ceftolozane/tazobactam and meropenem in treating healthcare-associated pneumonia and ventilator-associated pneumonia, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for HIV and HBV co-infected individuals, testing the drug e/c/f/taf, with specific eligibility criteria including absence of hepatocellular carcinoma or cirrhosis, certain viral markers, and CD4+ count, among others.",
    "This sample is a phase 3 trial for stroke patients, testing the efficacy of alteplase and aspirin as potential treatments, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 clinical trial for patients with atrial fibrillation, testing the effectiveness of edoxaban, warfarin, and enoxaparin as anticoagulant agents, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 3 clinical trial for the treatment of partial onset seizures, testing the effectiveness of pregabalin dose levels 1 and 2 compared to a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with hepatitis C virus and HIV, testing the effectiveness of ldv/sof and rbv drugs in combination therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of edoxaban, dalteparin, and low molecular weight heparin in treating venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and cancer patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with moderate to severe plaque type psoriasis, testing the effectiveness of drugs such as ain457, ustekinumab, and placebo secukinumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) that is ALK-positive. The study will evaluate the effectiveness of alectinib and crizotinib, two drugs, in treating advanced or recurrent NSCLC. The eligibility criteria include having a confirmed diagnosis of NSCLC, a life expectancy of at least 12 weeks, and a performance status of 0-2. Participants must also have no prior systemic treatment for NSCLC and meet certain renal and hematologic function requirements. Exclusion criteria include having a previous malignancy within the past 3 years, gastrointestinal or liver disease, and Grade 3 or higher toxicities due to prior therapy.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of daratumumab, lenalidomide, and dexamethasone as a treatment regimen. The eligibility criteria include having documented multiple myeloma, measurable disease, prior response to therapy, and a specific performance status score. Exclusion criteria include previous treatment with daratumumab or other anti-CD38 therapies, recent anti-myeloma treatment, refractoriness or intolerance to lenalidomide, recent stem cell transplantation, and certain history of malignancy.",
    "This sample is a phase 3 trial for patients with essential thrombocythemia, testing the drugs anagrelide retard and thromboreductin, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of mgn1703 treatment in combination with standard first-line chemotherapy, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug idalopirdine 60 mg, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for knee osteoarthritis, testing the effectiveness of chondroitin sulfate, celecoxib, and placebo drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug azeliragon against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with pulmonary arterial hypertension (PAH) and will test the effectiveness of the drug macitentan in improving symptoms and exercise capacity. The eligibility criteria include specific hemodynamic diagnosis, 6-minute walk distance, language fluency, and contraception requirements for women. Exclusion criteria include certain lung diseases, low hemoglobin levels, liver enzyme abnormalities, and concomitant use of certain medications.",
    "This sample is a phase 3 clinical trial for patients with inoperable perihilar cholangiocarcinoma, testing the effectiveness of photodynamic therapy-photofrin and chemotherapy regimen as treatment options, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the drug \"alks 5461\" for the treatment of major depressive disorder (MDD) in patients who have not responded adequately to current antidepressant treatment.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium + olodaterol compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug ruxolitinib in patients with primary myelofibrosis (mf), with specific eligibility criteria including age, disease diagnosis, risk factors, spleen size, blood counts, and previous treatment history.",
    "This phase 3 trial is testing the effectiveness of sodium zirconium cyclosilicate and placebo in treating hyperkalemia, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for impetigo, testing the effectiveness of ozenoxacin and placebo in patients with a clinical diagnosis of bullous or non-bullous impetigo, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of gwp42003-p and placebo control in treating epilepsy and Dravet syndrome in children aged 2 to 18 years who have not responded well to current antiepileptic drugs, while also considering various inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of incobotulinumtoxina and placebo in treating chronic troublesome sialorrhea associated with Parkinson's disease, post-stroke, and traumatic brain injury, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the drugs symbicort pmdi, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of chronic hepatitis C virus (HCV) infection using the drugs grazoprevir and elbasvir, along with placebos. The eligibility criteria include having documented chronic HCV GT 1 infection, evidence or no evidence of liver cirrhosis, and various HCV statuses. The exclusion criteria include decompensated liver disease, co-infection with hepatitis B virus or HIV, and history of malignancy within the last 5 years.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of dapagliflozin and dapagliflozin placebo in combination with injectable insulin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the efficacy of liraglutide compared to placebo in achieving glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of ertugliflozin and sitagliptin in combination with metformin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of lebrikizumab and montelukast in reducing symptoms and improving lung function, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for HIV patients in Rwanda, testing the effectiveness of rilpivirine/emtricitabine/tenofovir, a combination of antiretroviral drugs, in patients who have been on stable first-line antiretroviral therapy for at least twelve months. The eligibility criteria include specific laboratory values, negative TB symptom screen, and negative pregnancy test for women of reproductive potential.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of saxagliptin 5mg compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C virus using the drugs grazoprevir and elbasvir, with specific eligibility criteria for participants, including documented chronic HCV infection, absence or presence of cirrhosis, and exclusion criteria such as decompensated liver disease and co-infection with hepatitis B or HIV.",
    "This sample is a phase 3 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of drugs such as nivolumab, cetuximab, methotrexate, and docetaxel, with specific eligibility criteria for participation.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C using the drug grazoprevir/elbasvir, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, testing the efficacy of grazoprevir and elbasvir combination therapy compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial aims to evaluate the efficacy of grazoprevir + elbasvir and ribavirin in treating chronic hepatitis C infection in patients with documented HCV GT1, GT4, or GT6, with or without cirrhosis, who have previously received peginterferon/RBV treatment and meet other inclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug mepolizumab in patients with chronic obstructive pulmonary disease (COPD) who have a history of exacerbations and are on optimized standard of care therapy. The eligibility criteria include a diagnosis of COPD, specific lung function measurements, history of exacerbations, and concomitant COPD therapy. Exclusion criteria include asthma, recent respiratory infections, lung resection, unstable cardiac disease, and various other medical conditions.",
    "This sample is a phase 3 clinical trial for the drug mepolizumab in patients with chronic obstructive pulmonary disease (COPD). The trial aims to evaluate the efficacy and safety of mepolizumab compared to placebo in reducing exacerbations in COPD patients who have a history of moderate to severe exacerbations and are on triple therapy.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drugs fluticasone furoate/vilanterol and vilanterol. The eligibility criteria include being an outpatient, having a clinical history of COPD, and experiencing symptoms of COPD.",
    "This sample is a phase 3 trial for HIV-infected individuals, testing the efficacy of the drug combination abc/dtg/3tc fdc compared to ongoing cart regimen, with eligibility criteria including being on current antiretroviral therapy for at least 6 months and having achieved plasma HIV-1 RNA level <50 c/mL within 6 months of starting initial therapy.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of drugs such as apf530, ondansetron, fosaprepitant, and dexamethasone, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with squamous non-small cell lung cancer, testing the effectiveness of carboplatin, veliparib, paclitaxel, and placebo to veliparib in treating the disease, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with non CF idiopathic or post-infectious bronchiectasis, testing the effectiveness of ciprofloxacin (bayq3939) dry powder for inhalation and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of irritable bowel syndrome with diarrhea, testing the efficacy of ibodutant 10 mg compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with HR+, HER2- breast cancer, testing the efficacy of abemaciclib and fulvestrant compared to a placebo, with specific eligibility criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy of alirocumab, a lipid-modifying therapy, in participants with hypercholesterolemia who are not adequately controlled with statin therapy.",
    "This sample is a phase 3 trial for the treatment of influenza in patients who meet specific clinical and laboratory criteria, with the drugs celecoxib, oseltamivir, and placebo being tested.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs rbp-7000, placebo, and risperidone, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2/phase 3 trial for patients with coronary artery disease, testing the efficacy of ticagrelor and placebo in reducing major adverse cardiovascular events, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is investigating the use of rivaroxaban and placebo in patients with various diseases including heart failure, respiratory insufficiency, stroke acute, infectious diseases, and rheumatic diseases, who meet specific inclusion criteria related to venous thromboembolism risk.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drugs simeprevir and sofosbuvir, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drugs simeprevir and sofosbuvir, with specific eligibility criteria for participants.",
    "This sample is a phase 2/phase 3 trial for the treatment of chronic hepatitis C using the drugs grazoprevir, elbasvir, and mk-5172a, with specific eligibility criteria including documented chronic HCV infection, clinical evidence of hepatic cirrhosis, and no evidence of co-infection with hepatitis B or HIV.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the drugs etanercept and chs-0214 in combination with methotrexate (MTX) for patients with active disease. The inclusion criteria include a diagnosis of rheumatoid arthritis for at least 6 months, specific joint and blood test criteria, and being on a stable dose of MTX. The exclusion criteria include the use of certain medications, abnormal lab values, active lung disease, and significant comorbid conditions. Pregnant or nursing women are also excluded.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of olanzapine, chemotherapy, and antiemetic treatment in patients with hematopoietic/lymphoid cancer, nausea and vomiting, and unspecified adult solid tumor, who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for pancreatic cancer, testing the drugs ruxolitinib, placebo, and capecitabine, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of dermatitis, atopic using an2728 topical ointment, 2% and a matching vehicle control, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of dermatitis, atopic using an2728 topical ointment, 2% and a matching vehicle control, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of irritable bowel syndrome with diarrhea, using the drugs ibodutant 10 mg and placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes, testing the drugs chiglitazar and placebo, with eligibility criteria including meeting the WHO Diagnostic Criteria for Type 2 Diabetes, specific HbA1c levels, age range, BMI range, and willingness to be assigned to any treatment arm.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of FTC/TDF and f/taf as antiretroviral regimens, with specific eligibility criteria including plasma HIV-1 RNA levels, renal function, liver function, and contraception methods for females.",
    "This sample is a phase 3 clinical trial for the drug plecanatide, which is being tested for the treatment of chronic idiopathic constipation. The study includes eligibility criteria for participants and exclusion criteria for those who do not meet certain requirements.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drugs daclatasvir, asunaprevir, and dcv 3daa, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for colorectal cancer, testing the use of acetylsalicylic acid (ASA) as a preventive treatment, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes and dyslipidemia, testing the effectiveness of gemigliptin and/or rosuvastatin in treating the conditions. The inclusion criteria include adults aged 19 and above, while the exclusion criteria include patients with type 1 diabetes, gestational diabetes, and certain heart conditions.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of albuterol mdpi, placebo, and proair hfa inhaler in children aged 4-11 years, who have a documented diagnosis of asthma and meet specific eligibility criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of dalbavancin, a drug used to treat acute bacterial skin and skin structure infections caused by Gram-positive bacteria, in participants with abscess, wound infection, surgical site infection, or cellulitis.",
    "This sample is a phase 3 clinical trial for dry eye disease, testing the effectiveness of omega-3 supplements and placebo in patients with specific eligibility criteria, including signs of dry eye, OSDI score, symptoms duration, and use of artificial tears.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of semaglutide and insulin glargine in combination with metformin or metformin and SU as stable diabetes treatment. The inclusion criteria include being insulin-na\u00efve, having an HbA1c level between 7.0 - 10.0%, and being 18 years or older. Exclusion criteria include pregnancy, certain medical conditions, recent use of glucose-lowering agents other than insulin, and history of pancreatitis or thyroid carcinoma.",
    "This sample is a phase 3 clinical trial for patients with chronic myelogenous leukemia (CML) testing the effectiveness of bosutinib and imatinib drugs, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with HER2-positive breast cancer, testing the effectiveness of carboplatin, docetaxel, pertuzumab, trastuzumab, and trastuzumab emtansine in neoadjuvant therapy before mastectomy or breast-conserving surgery.",
    "This phase 3 trial is testing the effectiveness of reformulated raltegravir, raltegravir, truvada\u2122, and placebos in treating HIV infection in individuals who are HIV-1 positive and naive to antiretroviral therapy, while also meeting various inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for children with type 2 diabetes mellitus, testing the effectiveness of insulin detemir and insulin nph in controlling blood sugar levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of insulin peglispro and insulin glargine in combination with stable doses of basal insulin, metformin, thiazolidinediones, sodium glucose co-transporter 2 inhibitors, or dipeptidyl peptidase inhibitors, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis vulgaris, testing the efficacy of various drugs including leo 90100 aerosol foam, aerosol foam vehicle, calcipotriol bdp gel, and gel vehicle, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with cardiorenal syndrome, testing the drugs levosimendan and dobutamine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with carotid stenosis who are resistant to clopidogrel, testing the efficacy of ticlopidine + ginko biloba and clopidogrel as alternative antiplatelet therapies for carotid stent implantation.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the efficacy of the drugs patritumab and erlotinib compared to a placebo, with eligibility criteria including age, disease stage, prior treatment, and genetic testing for EGFR genotype.",
    "This sample is a phase 2/phase 3 trial that aims to evaluate the effectiveness of polymyxin b and polymyxin b + doripenem in treating monomicrobial XDR-GNB bacteremia, ventilator-associated pneumonia, and healthcare-associated pneumonia. The eligibility criteria include specific disease conditions, exclusion criteria, and renal impairment.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis using the drugs etanercept and chs-0214, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial is investigating the effectiveness of inhaled mannitol compared to a placebo in patients with cystic fibrosis, and the eligibility criteria include having a confirmed diagnosis of cystic fibrosis, being at least 18 years old, and having a FEV1 between 40% and 90% predicted.",
    "This sample is a phase 3 trial for the treatment of hyperlipidemia, testing the drugs bococizumab and atorvastatin, with inclusion criteria including statin intolerance and specific lipid levels, and exclusion criteria including pregnancy, recent cardiovascular events, adverse events with statin use, and poorly controlled hypertension.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) who are currently hospitalized for potential infectious acute exacerbation. The trial aims to evaluate the effectiveness of azithromycin compared to a placebo in reducing exacerbations. The inclusion criteria include an established diagnosis of COPD, a smoking history of at least 10 pack-years, and a history of at least one exacerbation in the past year. The exclusion criteria include certain medical conditions, medications, and pregnancy.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of daratumumab, velcade (bortezomib), and dexamethasone as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of ads-5102, a drug, in treating dyskinesia, levodopa induced dyskinesia (lid), and Parkinson's disease, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for gastric cancer, testing the drugs rilotumumab, placebo, cisplatin, and capecitabine, with specific eligibility criteria for patients with unresectable locally advanced or metastatic gastric or GEJ adenocarcinoma.",
    "This sample is a phase 3 trial testing the drug letermovir and placebo for the prevention of CMV infection or disease in patients undergoing hematopoietic stem cell transplant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for post-menopausal women with metastatic breast cancer, testing the efficacy of fulvestrant, anastrozole, everolimus, and placebo in combination with anastrozole or everolimus. The eligibility criteria include specific disease characteristics, prior treatment history, and various health parameters.",
    "This sample is a phase 3 trial for the drug lubiprostone, which is being tested for the treatment of functional constipation. The inclusion criteria include completing a previous placebo-controlled study and abstaining from medication that affects gastrointestinal motility, while the exclusion criteria include having untreated faecal impaction or significant changes in medical status.",
    "This sample is a phase 3 trial for the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD) using benralizumab and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for gout, testing the efficacy of drugs such as febuxostat ir, febuxostat xr, colchicine, naproxen, and lansoprazole, with eligibility criteria including a history of gout, serum urate level \u22658.0 mg/dL, and at least one gout flare within the past 12 months.",
    "This sample is a phase 3 clinical trial for insomnia, testing the effectiveness of amitriptyline, zolpidem, and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the drug ataluren (ptc124\u00ae) and placebo in patients with cystic fibrosis, with specific inclusion and exclusion criteria, including age, weight, genetic mutation, lung function, and laboratory values.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the efficacy of various drugs including albuterol/salbutamol and beclomethasone dipropionate, with specific eligibility criteria such as FEV1 range and stable asthma diagnosis.",
    "This sample is a phase 2/phase 3 trial investigating the use of acetyl-l-carnitine and placebo in patients with carpal tunnel syndrome and compression neuropathy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the drug ALKS 5461, which aims to treat major depressive disorder (MDD). The study includes inclusion and exclusion criteria, such as the requirement to use contraception, the exclusion of pregnant or breastfeeding individuals, and the exclusion of those with a history of drug abuse or other primary Axis-I disorders.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of various drugs including fs mdpi, fp mdpi, placebo mdpi, and albuterol/salmeterol hfa mdi, with eligibility criteria including specific lung function measurements, stable asthma diagnosis, and ability to perform spirometry and peak expiratory flow.",
    "This phase 3 clinical trial is testing the effectiveness of pembrolizumab, paclitaxel, carboplatin, pemetrexed, cisplatin, and gemcitabine in treating non-small cell lung carcinoma patients who lack EGFR-sensitizing mutation and/or ALK translocation and have not received prior systemic chemotherapy treatment for their metastatic NSCLC.",
    "This sample is a phase 3 trial for patients with overactive bladder, testing the drug darifenacin, and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the drug elagolix in the treatment of endometriosis, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of basal cell carcinoma (BCC) using the drugs bf-200 ala and methyl-aminolevulinate, with specific eligibility criteria for patients and exclusion criteria for participation.",
    "This sample is a phase 2/phase 3 trial testing the drugs eculizumab and placebo in patients with delayed graft function after kidney transplant, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of losmapimod, a drug used for acute coronary syndrome, in combination with standard therapy, compared to placebo, in patients with NSTEMI or STEMI who meet specific inclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drugs dlbs1033 and placebo on subjects with diabetes and peripheral arterial disease, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of pain associated with fibromyalgia. The drugs being tested are ds-5565, pregabalin, placebo tablet, and placebo capsule. The eligibility criteria include meeting specific diagnostic criteria for fibromyalgia, having a certain level of pain, and not having certain medical conditions or medication use.",
    "This sample is a phase 3 trial testing the effectiveness of ulipristal acetate (upa) compared to a placebo in premenopausal women with leiomyoma and uterine hemorrhage, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of ulipristal acetate (upa) compared to placebo in pre-menopausal women with leiomyoma and uterine hemorrhage, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with colorectal neoplasms, testing the efficacy of nintedanib (bibf 1120) compared to placebo, with eligibility criteria including age, confirmed adenocarcinoma, measurable lesions, and previous progression on standard therapies.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of rituxan and mabthera drugs in patients who have had an inadequate response to previous anti-TNF treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with asthma, testing the effectiveness of different drug combinations (budesonide/formoterol, terbutaline) in comparison to placebos, with specific eligibility criteria including age, duration of asthma diagnosis, treatment guidelines, lung function requirements, and exclusion criteria such as history of life-threatening asthma, recent changes in treatment, and smoking history.",
    "This sample is a phase 3 clinical trial for the treatment of rheumatoid arthritis using methotrexate as the drug, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for patients with locally advanced or metastatic NSCLC who have experienced disease progression after 1st line EGFR TKI treatment. The study aims to evaluate the efficacy of chemotherapy and cross-over to osimertinib in these patients.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension who are unresponsive to Fimasartan 60mg monotherapy, and it will test the effectiveness of fimasartan and amlodipine in reducing blood pressure.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of dulaglutide, placebo, insulin glargine, and metformin in combination with basal insulin glargine once daily with or without metformin for at least 3 months prior to screening, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and it is testing the effectiveness of the drug umec/vi compared to a placebo in improving lung function and reducing symptoms. The eligibility criteria include being 40 years or older, having a history of COPD, and being a current or former smoker with a certain pack-year history.",
    "This sample is a phase 3 clinical trial for patients with stage IV non-small cell lung cancer (NSCLC) who have detectable mutations in codons 12 or 13 of the KRAS oncogene. The study aims to evaluate the efficacy of abemaciclib and erlotinib as a second-line therapy for patients who have progressed after platinum-based chemotherapy and an immune checkpoint inhibitor.",
    "This sample is a phase 3 clinical trial for patients with intermittent claudication, testing the effectiveness of omega-3 fatty acids in improving symptoms and walking ability. The inclusion criteria include age \u2265 18, newly diagnosed intermittent claudication, and a low ankle brachial index, while exclusion criteria include heart failure, recent myocardial infarction, and pregnancy.",
    "This phase 3 trial aims to evaluate the efficacy of amantadine hcl er and placebo in reducing levodopa induced dyskinesia in patients with Parkinson's disease, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 3 trial for the drug benralizumab in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria, and multiple arms including a placebo arm.",
    "This phase 3 trial is investigating the efficacy of high dose alks 5461, low dose alks 5461, and placebo in treating major depressive disorder, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the drugs alks 5461 and placebo, with inclusion criteria including a BMI of 18.0 to 40.0 kg/m2, a primary diagnosis of MDD, and no more than 2 inadequate responses to antidepressant therapy. Exclusion criteria include current primary Axis-I disorder other than MDD, recent use of opioid agonists or antagonists, and a history of intolerance or allergy to buprenorphine or opioid antagonists.",
    "This sample is a phase 3 trial for epilepsy patients with seizure clusters, testing the drug usl261, and the eligibility criteria include having a documented history of seizure clusters, being on a stable regimen of AEDs, and weighing between 40 kg and 125 kg.",
    "This sample is a phase 3 trial investigating the use of ropivacaine and saline for postoperative pain, postoperative nausea and vomiting, and quality of life in female patients undergoing mastectomy followed by bilateral immediate tissue expander breast reconstruction. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for patients with follicular lymphoma, testing the effectiveness of cyclophosphamide, vincristine, and prednisone as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 3 trial for the drug sodium zirconium cyclosilicate, which aims to treat hyperkalemia by enrolling eligible subjects who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial conducted by Kala Pharmaceuticals, Inc. to study the efficacy of kpi-121 0.25% and kpi-121 1.0% in treating ocular infections, irritations, and inflammations in patients undergoing routine cataract surgery, with specific inclusion and exclusion criteria provided.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drugs fluticasone furoate, vilanterol, and umeclidinium bromide, with eligibility criteria including age, gender, smoking history, COPD diagnosis, severity of symptoms and disease, and history of exacerbations.",
    "This phase 3 trial is investigating the effectiveness of various drugs, including dabigatran etexilate and warfarin, in patients with atrial fibrillation and undergoing percutaneous coronary intervention, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients diagnosed with scleroderma and experiencing symptoms of Raynaud's syndrome, testing the effectiveness of onabotulinumtoxin A and sterile saline solution in treating the condition.",
    "This sample is a phase 3 trial for Waldenstr\u00f6m's macroglobulinemia, testing the effectiveness of ibrutinib, placebo, and rituximab as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug roflumilast in combination with standard of care COPD treatment. The eligibility criteria include having a history of COPD, specific lung function measurements, and being a former or current smoker with a certain smoking history.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of lixisenatide and insulin glargine in controlling HbA1c levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the effectiveness of isradipine and placebo in early-stage patients who are not currently receiving dopaminergic therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for hypertension, testing the efficacy of amlodipine besylate and celecoxib in reducing blood pressure in adults aged 40 to 75 with newly diagnosed hypertension.",
    "This sample is a phase 3 clinical trial for type 2 diabetes, testing the drugs chiglitazar and sitagliptin, with inclusion criteria including meeting WHO diagnostic criteria, specific HbA1c levels, age and BMI ranges, and willingness to be assigned to any treatment arm, while exclusion criteria include type 1 diabetes, previous antidiabetic drug treatment, certain medical conditions, and participation in other clinical trials in the past 3 months.",
    "This sample is a phase 3 trial for the treatment of Dravet Syndrome, a rare form of epilepsy, using clobazam and placebo drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial testing the drug roxadustat versus placebo in patients with anemia due to chronic kidney disease, with specific eligibility criteria including age, eGFR levels, hemoglobin values, and various exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of anemia in patients with end-stage renal disease, using the drugs roxadustat and epoetin alfa, with specific eligibility criteria including age, dialysis treatment, hemoglobin levels, and various exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with persistent asthma, testing the efficacy of various drugs including fp mdpi, fs mdpi, flovent hfa, advair diskus, and albuterol/salbutamol hfa, with eligibility criteria including specific lung function measurements and stable asthma diagnosis.",
    "This phase 3 trial aims to investigate the effectiveness of colchicine, a drug used to treat various diseases, in reducing post-operative atrial fibrillation in patients undergoing coronary artery bypass surgery and/or aortic valve surgery.",
    "This sample is a phase 3 trial for HIV-infected, ART-na\u00efve adults with plasma HIV-1 RNA>=1000 copies/mL and CD4+ cell count >= 50 cells/mm^3. The study aims to compare the efficacy and safety of two drugs, dtg 50 mg and efv 600 mg, in combination with TB treatment for subjects with new diagnosis of pulmonary, pleural, or Lymph node TB.",
    "This phase 3 trial is testing the combination of bbi608 and paclitaxel as a treatment for advanced gastric or gastroesophageal junction cancer that has failed previous treatment, with specific eligibility criteria including disease confirmation, treatment history, imaging investigations, performance status, age, contraception, laboratory evaluations, and accessibility for treatment and follow-up.",
    "This sample is a phase 3 clinical trial for the treatment of Prader-Willi Syndrome and obesity, using the drugs zgn-440 for injectable suspension and zgn-440 placebo for injectable suspension. The eligibility criteria include a confirmed genetic diagnosis of Prader-Willi Syndrome, age between 12-65, and specific BMI ranges.",
    "This sample is a phase 3 clinical trial for the treatment of Clostridium difficile-associated diarrhea (CDAD) using the drugs opt-80 and vancomycin, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial aims to evaluate the effectiveness of sublingual buprenorphine tablets, buprenorphine implant, placebo implants, and sublingual placebo tablets in treating opioid dependence in subjects who meet specific inclusion criteria, such as being clinically stable on sublingual buprenorphine treatment for at least 6 months and having no positive urine toxicology results for illicit opioids in the last 90 days.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma who have undergone autologous stem cell transplant, testing the efficacy of ixazomib citrate compared to placebo as post-transplant consolidation therapy.",
    "This sample is a phase 3 trial for patients with psoriatic arthritis, testing the effectiveness of golimumab and placebo drugs in treating the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with biliary tract cancer, testing the effectiveness of gemcitabine/cisplatin and gemcitabine/cisplatin/s-1 as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of empagliflozin low dose and empagliflozin high dose compared to placebo in patients with type 2 diabetes mellitus and hypertension, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of olaparib, a PARP inhibitor, in treating patients with germline BRCA1/2 mutations and metastatic adenocarcinoma of the pancreas, who have not shown disease progression on initial chemotherapy treatment.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and aims to evaluate the efficacy and safety of umeclidinium bromide compared to a placebo in Asian patients. The eligibility criteria include being 40 years or older, having a history of COPD, and meeting certain lung function and dyspnea requirements.",
    "This sample is a phase 3 clinical trial for osteoporosis in men, testing the effectiveness of a placebo drug on subjects aged 55 to 90 years with low bone mineral density and a history of fragility fractures, while excluding those with severe metabolic bone diseases or recent treatment affecting bone metabolism.",
    "This sample is a phase 3 clinical trial for ankylosing spondylitis, testing the effectiveness of golimumab and placebo in participants who have had an inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs) and have symptoms of active disease.",
    "This sample is a phase 3 trial for the drug clobazam in patients with Dravet Syndrome, a rare form of epilepsy, and the inclusion criteria include a diagnosis of Dravet Syndrome, specific seizure types, abnormal EEG, and stable dose of clobazam for at least 3 months.",
    "This sample is a phase 3 trial testing the effectiveness of atorvastatin and evolocumab in treating primary hyperlipidemia and mixed dyslipidemia, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the drug brexpiprazole in patients with schizophrenia with impulsivity, and it includes eligibility criteria such as age, diagnostic criteria, medication history, and exclusion criteria such as other psychiatric disorders and suicidal ideation.",
    "This sample is a phase 3 clinical trial for multiple myeloma, testing the effectiveness of drugs such as velcade, melphalan, prednisone, daratumumab iv, dexamethasone, and daratumumab sc, in patients who are not eligible for high-dose chemotherapy with stem cell transplantation. The eligibility criteria include specific diagnostic criteria, performance status, and laboratory criteria, while exclusion criteria include certain medical conditions and prior treatments.",
    "This sample is a phase 2/phase 3 trial for the treatment of tardive dyskinesia using the drugs sd-809 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of brexpiprazole combined with adt compared to a placebo combined with adt in male and female subjects aged 18-65 with major depressive disorder. The study aims to assess the response to treatment in subjects with a current depressive episode lasting at least 8 weeks, while excluding those with a history of Neuroleptic Malignant Syndrome or Serotonin Syndrome, inadequate response to more than 3 antidepressant treatments, or current Axis I diagnoses of Delirium, dementia, amnestic or other cognitive disorder, Schizophrenia, schizoaffective disorder, or other psychotic disorder, Bipolar I or II disorder.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drugs bortezomib-melphalan and melphalan, with eligibility criteria including confirmation of diagnosis and eligibility for high-dose therapy with autologous stem cell transplantation.",
    "This phase 3 clinical trial aims to evaluate the efficacy of darolutamide (nubeqa, bay1841788) compared to placebo in patients with castration-resistant prostate cancer (CRPC) who have non-metastatic prostate cancer and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic myeloid leukemia, testing the effectiveness of nilotinib (tasigna \u00ae) and pegylated interferon alfa 2a (pegasys\u00ae) as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hepatitis C virus infection, testing the drugs sof/vel and rbv, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drugs sof/vel and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drugs sof/vel, sof, and rbv, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for psoriasis, testing the drugs ustekinumab and guselkumab, along with placebos, on patients who meet specific inclusion criteria such as having a diagnosis of plaque-type psoriasis and certain severity indices, while excluding patients with certain medical conditions or previous use of the drugs being tested.",
    "This sample is a phase 2/phase 3 trial for the treatment of chronic Japanese HCV genotype 1 with the drugs grazoprevir and elbasvir, along with placebos, and includes eligibility criteria such as being treatment-na\u00efve or intolerant/non-responder to prior anti-HCV interferon-based treatment without DAA therapy, and excluding patients with decompensated liver disease, hepatitis B or HIV coinfection, recent malignancy, cirrhosis with hepatocellular carcinoma, drug/alcohol abuse, pregnancy/breastfeeding, and certain medical/surgical conditions.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the drug rbp-7000. The inclusion criteria include a diagnosis of schizophrenia, a PANSS score <=70, and being otherwise healthy. Exclusion criteria include taking certain medications, having hepatic disorders, a history of drug-induced leukopenia, and other medical conditions.",
    "This sample is a phase 3 clinical trial for hypertension, testing the efficacy of azilsartan medoxomil, a drug used to treat high blood pressure, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with follicular lymphoma, testing the effectiveness of duvelisib, placebo, and rituximab as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C in patients with compensated cirrhosis or severe renal impairment, using the drugs ombitasvir/paritaprevir/ritonavir, dasabuvir, and ribavirin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of psoriasis, testing the drugs guselkumab and adalimumab, with specific eligibility criteria including a diagnosis of plaque-type psoriasis, certain severity scores, and exclusion criteria such as previous use of guselkumab or adalimumab, and various medical conditions.",
    "This sample is a phase 3 trial for the treatment of psoriasis, testing the drugs guselkumab and adalimumab, with specific eligibility criteria including a diagnosis of plaque-type psoriasis, certain severity scores, and exclusion criteria such as previous use of guselkumab or adalimumab, and various medical conditions.",
    "This sample is a phase 3 clinical trial for Japanese subjects with type 2 diabetes mellitus, testing the efficacy of semaglutide and a DPP-4 inhibitor in combination with diet and exercise therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of ocular hypertension and open-angle glaucoma, using timolol maleate ophthalmic solution 0.5% bid and ar-13324 ophthalmic solution 0.02%, with specific eligibility criteria for subjects to be included in the study.",
    "This sample is a phase 3 clinical trial for the treatment of ocular hypertension and open-angle glaucoma, using drugs such as ar-13324 ophthalmic solution 0.02% and timolol maleate ophthalmic solution 0.5%, with specific eligibility criteria for subjects to be included or excluded from the study.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as umeclidinium and tiotropium in improving lung function and reducing symptoms. The eligibility criteria include age, smoking history, severity of disease, and exclusion criteria such as pregnancy, asthma, and other respiratory disorders.",
    "This sample is a phase 2/phase 3 trial for patients with HER2-positive breast cancer who have progressed on or are intolerant to pertuzumab and ado-trastuzumab emtansine, and have previously been treated with trastuzumab. The study will test the efficacy of mm-302, gemcitabine, capecitabine, vinorelbine, and trastuzumab as potential treatments.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drugs lenalidomide and dexamethasone, with eligibility criteria including age, disease criteria, and laboratory values.",
    "In this phase 3 trial, the focus is on peripheral neuropathy, with lidocaine and placebo being tested as potential treatments, and the eligibility criteria include exclusion of patients with underlying heart disease or arrhythmia, allergies to lidocaine or other specified drugs, history of epilepsy or lidocaine use, underlying psychiatric disease, history of drug abuse, and pregnancy or nursing.",
    "This phase 3 trial is testing the efficacy of ALKS 5461, a drug, versus placebo in patients with major depressive disorder who have had no more than 2 inadequate responses to antidepressant therapy, and meet other inclusion criteria.",
    "This phase 3 trial is testing the effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir, and ribavirin in treating chronic hepatitis C and decompensated cirrhosis caused by hepatitis C virus, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C infection and compensated cirrhosis, testing the effectiveness of ombitasvir/paritaprevir/ritonavir and dasabuvir drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the effectiveness of fampridine, a drug used to improve walking impairment in patients with MS, compared to a placebo. The trial has specific inclusion and exclusion criteria, such as a diagnosis of MS, a certain disability score, and no history of HIV or hepatitis.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer patients, testing the effectiveness of carboplatin, paclitaxel, and pemetrexed in combination with pembrolizumab, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drug teneligliptin/canagliflozin, and includes eligibility criteria such as age, HbA1c levels, and exclusion criteria such as type I diabetes and serious diabetic complications.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drugs sof/vel, sof, and rbv, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of budesonide/formoterol and budesonide in treating asthma, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for menopausal women, testing the effectiveness of oral estradiol and oral progesterone in treating menopause symptoms, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of Lennox Gastaut Syndrome (LGS) and epilepsy, testing the drug gwp42003-p against a placebo control, with eligibility criteria including a documented history of LGS, a history of slow spike-and-wave pattern in an EEG, and a minimum of 2 drop seizures each week during the baseline period.",
    "This sample is a phase 3 clinical trial for the treatment of Lennox-Gastaut syndrome and epilepsy, testing the effectiveness of the drug \"gwp42003-p\" compared to a placebo, with specific eligibility criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of the drug gwp42003-p compared to a placebo control in treating epilepsy and Dravet syndrome, with specific eligibility criteria for participants including age range, previous treatment history, and exclusion criteria such as medical conditions, cannabis use, and hypersensitivity to cannabinoids.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) testing the effectiveness of the drug PRC-063 at various doses compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of ertugliflozin, sitagliptin, and glimepiride as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for homozygous familial hypercholesterolemia (HoFH) patients, testing the efficacy of rosuvastatin 20mg compared to placebo in reducing LDL cholesterol levels, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for HIV infections, testing the efficacy of the drugs dtg, lpv/rtv, and two nrtis in subjects who have experienced virologic failure to their first-line treatment regimen. The study includes eligibility criteria such as age, HIV-1 infection status, and prior exposure to certain drugs, while excluding subjects with specific conditions or treatments.",
    "This sample is a phase 3 trial for patients with type 1 diabetes, testing the effectiveness of Mylan's insulin glargine and Lantus\u00ae in controlling blood sugar levels, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of Mylan's insulin glargine and Lantus\u00ae in achieving glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with Type 2 Diabetes Mellitus (T2DM) who are currently being treated with basal insulin glargine and metformin or sulfonylurea. The study aims to evaluate the efficacy of exenatide in combination with these treatments.",
    "This sample is a phase 3 trial for patients with diabetes mellitus, testing the drugs exantide with dapagliflozin, exentide, and dapagliflozin, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for the treatment of growth hormone disorders, specifically adult growth hormone deficiency, using drugs such as somapacitan, somatropin, and placebo, with eligibility criteria including age range, previous exposure to growth hormone treatments, and specific diagnostic tests for confirming growth hormone deficiency.",
    "This sample is a phase 3 clinical trial for patients with colorectal neoplasms and peritoneal neoplasms, testing the effectiveness of standard adjuvant systemic chemotherapy in combination with HIPEC (hyperthermic intraperitoneal chemotherapy). The inclusion criteria include age between 18 and 75 years, intention to start routine adjuvant systemic therapy, and adequate clinical condition for HIPEC. The exclusion criteria include postoperative complications, liver and/or lung metastases, and hypersensitivity to certain medications.",
    "This sample is a phase 3 clinical trial for patients with non-small-cell lung carcinoma who have failed first-line platinum-based chemotherapy, and it involves the drugs docetaxel, placebo, and nintedanib. The eligibility criteria include age, histological confirmation of adenocarcinoma of the lung, and exclusion of patients with certain prior treatments or mutations.",
    "This sample is a phase 3 clinical trial for advanced and metastatic renal cell carcinoma, testing the drug sunitinib, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial aims to evaluate the efficacy of leuprolide mesylate, an androgen ablation therapy, in males with histologically confirmed carcinoma of the prostate, who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for children with venous thromboembolism, testing the drugs rivaroxaban and standard of care, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for stroke patients, testing the efficacy of various drugs including optional asa as comedication, placebo to asa, placebo to optional asa as comedication, placebo to dabigatran etexilate, asa 100 mg, and dabigatran etexilate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 clinical trial for the treatment of diarrhea predominant irritable bowel syndrome (IBS-D) using the drugs ranolazine and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the efficacy of rifaximin eir compared to placebo, with specific eligibility criteria including disease severity and previous surgeries.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the effectiveness of rifaximin eir compared to a placebo, with specific eligibility criteria including disease severity and previous surgeries.",
    "This sample is a phase 3 clinical trial for the treatment of chronic lymphocytic leukemia (CLL) using chlorambucil, venetoclax, and obinutuzumab, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for pregnant women with untreated HIV infection in late pregnancy, testing the efficacy of dolutegravir 50mg od in combination with standard of care drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma, testing the efficacy of three drugs (mgr001, advair, and placebo) on subjects with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hormone receptor-positive, HER2-negative breast cancer, testing the efficacy of abemaciclib, anastrozole, letrozole, and placebo in postmenopausal patients with locoregionally recurrent or metastatic disease. The eligibility criteria include having measurable or nonmeasurable bone-only disease, a performance status \u22641, adequate organ function, and having discontinued previous localized radiotherapy. Exclusion criteria include CNS metastasis, prior endocrine therapy or chemotherapy for breast cancer, prior treatment with everolimus or any CDK4/6 inhibitor, initiation of bisphosphonates or RANK-L targeted agents within 7 days prior to randomization, and participation in incompatible medical research or recent major surgery.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C genotype 4 infection, using the drugs 2 daa and rbv, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of protease inhibitor and isentress\u00ae (raltegravir) in HIV-1 infected patients who have been on a stable antiretroviral regimen for at least 6 months and have had at least 2 consecutive viral load measurements between 50 and 500 copies/milliliter over the last 9 months.",
    "This sample is a phase 3 trial for the treatment of glaucoma and ocular hypertension, testing the effectiveness of bimatoprost sr, timolol 0.5%, and timolol vehicle (placebo) in lowering intraocular pressure (IOP) in patients with these conditions. The eligibility criteria include a diagnosis of open-angle glaucoma or ocular hypertension in both eyes requiring IOP-lowering treatment, with exclusion criteria such as previous enrollment in another Allergan Bimatoprost SR Study and history of glaucoma surgery.",
    "This sample is a phase 3 clinical trial for the treatment of osteoarthritis of the knee, testing the effectiveness of duloxetine and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for a therapeutic hepatitis B vaccine treatment arm, targeting patients with chronic hepatitis B. The eligibility criteria include age, specific HBV markers, previous treatment history, and exclusion criteria such as liver conditions, other viral infections, and substance abuse history.",
    "This sample is a phase 3 clinical trial for patients with portal vein thrombosis, testing the efficacy of the drug NPB-06 compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of glaucoma and ocular hypertension, testing the effectiveness of bimatoprost sustained-release, timolol, and timolol vehicle (placebo) drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, specifically genotype 4, using the drugs simeprevir and sofosbuvir. The eligibility criteria include having confirmed HCV with a viral load above 10,000 IU/mL, being treatment naive or experienced, and having documentation of a liver biopsy or fibroscan.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer who have undergone radical resection and are eligible for adjuvant chemotherapy with mFOLOFX6 or XELOX, aiming to assess the neurotoxicity caused by the drugs gm1 and placebo.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, testing the drugs grazoprevir/elbasvir and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of grazoprevir + elbasvir and placebo in treating hepatitis C patients with sickle cell anemia, thalassemia, or hemophilia/von Willebrand disease, who may or may not have cirrhosis, are HIV coinfected or not infected, and meet certain contraception requirements.",
    "This sample is a phase 3 clinical trial for patients with head and neck squamous cell cancer, testing the effectiveness of methotrexate and docetaxel in combination with pembrolizumab, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of multiple myeloma using daratumumab, lenalidomide, dexamethasone, and daratumumab sc, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of vulvovaginal atrophy, menopause, dyspareunia, and painful intercourse using estradiol and placebo drugs, with specific eligibility criteria for postmenopausal females between the ages of 40 and 75 years, and various exclusion criteria including the use of certain medications, history of medical diseases, and abnormal test results.",
    "This phase 3 trial is testing the effectiveness of utd1 injection plus capecitabine and capecitabine alone in patients with advanced, metastatic breast cancer who have previously been treated with \u22644 chemotherapeutic regimes, including an anthracyclin antibiotics and a taxane, and have no abnormal function for major internal organs or heart diseases.",
    "This sample is a phase 2/phase 3 clinical trial for the treatment of keratoconjunctivitis sicca and dry eye disease using the drugs otx-101 0.05%, otx-101 0.09%, and vehicle, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for subjects with type 2 diabetes, testing the efficacy of semaglutide and sitagliptin in combination with oral antidiabetic drugs or diet and exercise therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the drug curcumin, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy of the drug \"hld200\" compared to a placebo in children aged 6-12 years with a previous diagnosis of attention deficit hyperactivity disorder (ADHD). The study will assess the eligibility criteria, including confirmation of ADHD diagnosis, ability to swallow treatment capsules, availability for the entire study period, and provision of informed consent. Exclusion criteria include the presence of significant medical conditions, comorbid psychiatric diagnoses, severe asthma, severe allergic reactions to MPH, history of seizures or eating disorders, and abnormal clinical laboratory values. The study also excludes participants with positive history for hepatitis B, hepatitis C, HIV, illicit drug use, or use of medications that may confound the results. Additionally, participants should not have used prescription medications (except ADHD medications) within 7 days or over-the-counter medications (except birth control) within 3 days prior to enrollment. The study excludes those who have participated in another clinical trial with an investigational drug within the past 30 days and individuals with current suicidal ideation or history of suicidality.",
    "This study aims to investigate the effectiveness of vitamin D supplementation in newly diagnosed or already diagnosed patients with primary restless legs syndrome (RLS) and vitamin D deficiency, excluding patients with secondary RLS or other mimicking disorders, and those receiving medications that can trigger RLS.",
    "This sample is a phase 3 clinical trial for patients with urothelial cancer, testing the effectiveness of paclitaxel, vinflunine, and docetaxel as second-line chemotherapy options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and it includes eligibility criteria, such as age, gender, smoking history, disease severity, and other medical conditions. The trial involves testing various drugs, including umec/vi, tiotropium, indacaterol, and albuterol/salbutamol metered dose inhaler (MDI), to evaluate their effectiveness in treating COPD.",
    "This sample is a phase 3 clinical trial for atopic dermatitis, testing the effectiveness of dupilumab compared to a placebo, with specific eligibility criteria including chronic AD for at least 3 years and inadequate response to topical AD medication.",
    "This sample is a phase 3 trial for HIV infection, testing the efficacy of dolutegravir and lamivudine in maintaining viral suppression in patients with HIV-1 RNA <50 copies/mL on a three-drug antiretroviral regimen.",
    "This sample is a phase 3 clinical trial for patients with chronic lymphocytic leukemia and small-cell lymphoma, testing the effectiveness of ibrutinib, obinutuzumab, and chlorambucil in treating the diseases based on specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of rheumatoid arthritis using the drug baricitinib, with eligibility criteria including a diagnosis of adult-onset RA, active joint inflammation, and regular use of methotrexate.",
    "This sample is a phase 3 clinical trial that aims to test the effectiveness of loperamide and placebo in patients with rectal cancer, ulcerative colitis, or short bowel syndrome who have undergone recent surgery or have a permanent ileostomy. The eligibility criteria include having a signed consent form and excluding patients with complications associated with surgery, non-radical surgery, chemotherapy, poor compliance, or other serious illnesses.",
    "This sample is a phase 3 clinical trial for patients with unresectable advanced or recurrent gastric cancer, testing the drugs ono-4538 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for type 1 diabetes mellitus, testing the drugs dapagliflozin and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with human immunodeficiency virus type 1 (HIV-1), testing the efficacy of a combination of drugs including d/c/f/taf, boosted protease inhibitor (bpi), and ftc/tdf, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of vortioxetine and escitalopram as a switch treatment for patients who have had inadequate response to SSRI/SNRI monotherapy.",
    "This sample is a phase 3 clinical trial for subjects with type 2 diabetes mellitus, testing the efficacy of saxagliptin and metformin in reducing HbA1c levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for participants with type 1 diabetes mellitus, testing the effectiveness of sar342434, Humalog, and insulin glargine hoe901 in reducing HbA1c levels, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial aims to evaluate the efficacy of tenofovir + lamivudine + raltegravir and tenofovir + lamivudine + efavirenz in treating HIV-1 infection in patients with confirmed or probable active tuberculosis, while considering various inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of tardive dyskinesia using the drugs nbi-98854 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of ads-5102 in treating levodopa-induced dyskinesia (lid) and Parkinson's disease (pd) patients, who have been on a stable regimen of antiparkinson's medications for at least 30 days prior to screening.",
    "This sample is a phase 3 trial for HIV-1 patients, testing the effectiveness of doravirine, darunavir, ritonavir, and truvada\u2122 or epzicom\u2122/kivexa\u2122 in combination as antiretroviral therapy, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for the drug dasotraline in the treatment of adult attention deficit hyperactivity disorder (ADHD), with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of the drugs sun-101 and spiriva\u00ae in improving lung function, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the efficacy of tedizolid phosphate, aztreonam, and metronidazole in treating skin diseases, specifically infectious and bacterial skin diseases, in participants aged 12 to <18 years, with inclusion criteria including adequate venous access, onset of local symptoms within 7 days before the study, and suspected or documented Gram-positive infection, while exclusion criteria include uncomplicated minor skin infections, known bacteremia, recent history of opportunistic infections, hypersensitivity to study drugs, and use of certain medications.",
    "This sample is a phase 3 trial for essential hypertension, testing the drugs tak-536tch tablet, tak-536ccb tablet, and hctz 12.5 mg tablet, with eligibility criteria including specific blood pressure ranges and exclusion criteria such as secondary hypertension and cardiovascular diseases.",
    "This sample is a phase 3 clinical trial for the treatment of dermatitis, atopic using the drug dupilumab, with eligibility criteria including a minimum duration of chronic AD, specific severity scores, and inadequate response to topical medications.",
    "This sample is a phase 3 clinical trial for patients with chronic atopic dermatitis, testing the effectiveness of the drug dupilumab compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with advanced metastatic breast cancer, testing the efficacy of the drugs lee011, tamoxifen, letrozole, anastrozole, and goserelin, along with a placebo, in combination with eligibility criteria for patient selection.",
    "This sample is a phase 2/phase 3 clinical trial for the drug Aramchol, which aims to treat patients with fatty liver disease (steatohepatitis) who also have type II diabetes or pre-diabetes. The study includes eligibility criteria such as age, BMI, liver biopsy results, liver fat concentration, and normal liver function. It also lists exclusion criteria, including other liver diseases, liver cirrhosis, alcohol or drug abuse, and various medical conditions.",
    "This sample is a phase 3 trial for major depressive disorder, testing the efficacy of vortioxetine, placebo, and SSRI drugs in patients who have achieved either partial or full remission of MDD, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for major depressive disorder, testing the efficacy of vortioxetine, paroxetine, and placebo in patients aged 18-65 who are employed full or part-time, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the efficacy of a placebo and standard of care drugs in reducing exacerbations, with eligibility criteria including age, prior treatment with high-dose inhaled corticosteroids, persistent airflow obstruction, and a history of two or more exacerbations requiring systemic corticosteroids.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of tofacitinib in combination with methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with relapsed ovarian cancer and BRCA mutation, testing the effectiveness of olaparib and single agent chemotherapy as treatment options. The eligibility criteria include having received at least 2 prior platinum-based lines of chemotherapy and having normal organ and bone marrow function.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drugs iti-007 and placebo, with inclusion criteria including male or female subjects aged 18-60 with a clinical diagnosis of schizophrenia experiencing an acute exacerbation of psychosis, and exclusion criteria including subjects unable to provide informed consent, pregnant or breastfeeding females, and subjects judged medically inappropriate for study participation.",
    "This sample is a phase 3 clinical trial for dry eye disease, testing the effectiveness of lifitegrast and placebo as potential treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of saxagliptin, dapagliflozin, and sitagliptin compared to placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for mild cognitive impairment due to Alzheimer's disease, testing the efficacy of pioglitazone compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of lenalidomide, placebo, rituximab, cyclophosphamide, doxorubicin, prednisone, and vincristine in treating newly diagnosed diffuse large B-cell lymphoma patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of the drug dsp-5423p in various doses, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for cutaneous melanoma patients with locally advanced metastases, testing the efficacy of pv-10 and dacarbazine, temozolomide, or talimogene laherparepvec as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of alirocumab, a lipid-modifying therapy, in participants with hypercholesterolemia and established coronary heart disease who are not adequately controlled with a maximally tolerated daily dose of statin.",
    "This sample is a phase 2/phase 3 trial for hypertrophic cardiomyopathy, testing the drugs eleclazine and placebo, with key inclusion criteria including a diagnosis of hypertrophic cardiomyopathy, exertional symptoms, and screening peak VO2 below 80% of predicted.",
    "This sample is a phase 3 clinical trial for patients with chronic sinusitis and nasal polyposis, testing the effectiveness of the drugs \"s8 sinus implant\" and \"mometasone furoate nasal spray\" in improving symptoms and reducing the need for repeat endoscopic sinus surgery. The eligibility criteria include confirmed diagnosis of chronic sinusitis, previous ethmoidectomy, specific symptoms and endoscopic evidence, while exclusion criteria include certain grades of polyposis or adhesions, immune deficiency, concurrent conditions, and allergies to corticosteroids or mometasone furoate.",
    "This sample is a phase 3 clinical trial for the treatment of chronic idiopathic constipation, testing the effectiveness of the drug linaclotide compared to a matching placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of tardive dyskinesia using the drugs sd-809 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with polycythemia vera, testing the drug ruxolitinib. The inclusion criteria include confirmed diagnosis of PV, palpable spleen, resistance or intolerance to hydroxyurea, and ECOG performance status of 0, 1, or 2. The exclusion criteria include inadequate liver or renal function, active malignancy within the past 5 years (except for certain cases), and pregnancy or nursing for women.",
    "This sample is a phase 3 clinical trial for patients undergoing elective surgery for open repair of an aortic abdominal aneurysm, testing the effectiveness of patient-controlled analgesia with chlorhydrate of morphine and acetaminophen as post-operative pain management, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of sarilumab sar153191 (regn88) and methotrexate in treating rheumatoid arthritis, with specific eligibility criteria including a diagnosis of RA, certain joint and inflammation markers, and exclusion criteria such as age restrictions and prior treatment with certain drugs.",
    "This sample is a phase 3 clinical trial for mild to moderate Alzheimer's disease, testing the efficacy of sodium oligo-mannurarate and placebo drugs, with eligibility criteria including age, education level, memory impairment, diagnostic criteria, and stable caregivers.",
    "This sample is a phase 3 trial for multiple sclerosis, testing the drugs ozanimod, interferon beta-1a, and their respective placebos, with inclusion criteria of a diagnosis of multiple sclerosis and an EDSS score between 0 and 5.0 at baseline, and exclusion criteria of primary progressive multiple sclerosis.",
    "This sample is a phase 3 trial for patients with progressive metastatic prostate cancer, testing the effectiveness of enzalutamide and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the effectiveness of sar342434, Humalog, and insulin glargine hoe901 in managing the disease. The eligibility criteria include being diagnosed with T2DM for at least 12 months, being treated with insulin glargine and Humalog, and having a signed informed consent.",
    "This sample is a phase 3 clinical trial for locally advanced or metastatic EGFR sensitising mutation positive non-small cell lung cancer, testing the efficacy of various drugs including azd9291, erlotinib, and gefitinib, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of olodaterol and tiotropium drugs in reducing COPD exacerbations, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/liraglutide in combination with metformin and pioglitazone, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with acute nonspecific low back pain, testing the effectiveness of nonivamide + nicoboxil (finalgon cream) compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for individuals with long QT syndrome type 3, testing the efficacy of eleclazine and eleclazine placebo in patients with an established diagnosis of LQT3 and a mean QTc interval \u2265 480 msec at screening.",
    "This sample is a phase 3 clinical trial for previously treated Chronic Lymphocytic Leukemia (CLL) patients with high-risk cytogenetic features, testing the combination of ublituximab and ibrutinib as a potential treatment option.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of various drugs including fluticasone furoate/vilanterol and fluticasone propionate/salmeterol, with specific eligibility criteria for subjects to participate in the study.",
    "This sample is a phase 3 clinical trial for bladder cancer, testing the efficacy of atezolizumab, docetaxel, paclitaxel, and vinflunine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for diabetes, specifically type 2 diabetes mellitus, testing the efficacy of semaglutide compared to a placebo, with eligibility criteria including stable diabetes treatment with basal insulin and/or metformin, and HbA1c levels between 7.0 - 10.0 percent.",
    "This sample is a phase 3 trial for the treatment of rheumatoid arthritis (RA) using the drugs peficitinib, placebo, and methotrexate, with specific eligibility criteria including disease duration, previous drug usage, joint assessments, laboratory values, and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of brolucizumab ophthalmic solution and aflibercept ophthalmic solution in treating neovascular age-related macular degeneration and choroidal neovascularization, with specific eligibility criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of various inhalation drugs, including budesonide/formoterol easyhaler and symbicort turbuhaler, in treating asthma patients who meet specific inclusion criteria, such as having a diagnosis of asthma for at least 6 months and stable asthma on the same regular treatment for at least 4 weeks before the study.",
    "This sample is a phase 3 trial for the treatment of rheumatoid arthritis, testing the efficacy of peficitinib compared to placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for stroke patients with recent ischemic stroke, where the drugs being tested are rivaroxaban (Xarelto) and acetylsalicylic acid (Aspirin), and the eligibility criteria include absence of certain conditions and exclusion of severely disabling stroke and low estimated glomerular filtration rate.",
    "This sample is a phase 3 clinical trial for patients with metastatic gastric adenocarcinoma or gastroesophageal junction adenocarcinoma, testing the effectiveness of ramucirumab, capecitabine, cisplatin, placebo, and fluorouracil as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for fruquintinib and placebo in patients with colorectal cancer who have failed standard treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of irritable bowel syndrome with constipation (IBS-C) using the drugs linaclotide and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the drug cannabidiol oral solution in patients with treatment-resistant seizure disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for diabetic peripheral neuropathic pain, testing the drugs ds-5565 and placebo, with inclusion criteria including type 1 or type 2 diabetes mellitus and a pain scale of \u2265 40 mm, and exclusion criteria including HbA1c > 10.0%.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C using the drugs daclatasvir, sofosbuvir, and ribavirin, with specific eligibility criteria including genotype 3 chronic HCV, advanced fibrosis or compensated cirrhosis, and HCV RNA viral load \u2265 10,000 IU/mL.",
    "This sample is a phase 3 clinical trial for patients with esophageal neoplasms, testing the drugs s1, s-1, and irinotecan, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for the treatment of seasonal allergic rhinitis using desloratadine 5 mg and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the effectiveness of insulin glargine (hoe901 - u300), insulin glargine (hoe901 - u100), and background therapy in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with multiple myeloma, testing the eligibility for long-term lenalidomide maintenance therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for gastric cancer, testing the drugs tas-118 plus oxaliplatin and s-1 plus cisplatin, with key inclusion criteria including patients diagnosed with gastric cancer, no prior treatment, negative or unknown HER2 testing, and ECOG performance status of 0 or 1. Key exclusion criteria include unmanageable diarrhea, current peripheral sensory neuropathy or paresthesia, and being pregnant or lactating.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the efficacy of the drug syr-472 compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is investigating the effectiveness of aspirin and ticagrelor in patients with peripheral artery disease and type 2 diabetes, who have previously undergone peripheral artery intervention, and have specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of respiratory syncytial virus infections in preterm infants, using suptavumab and a placebo, with specific eligibility criteria including age, gestational age, and exclusion criteria such as previous use of palivizumab or other RSV prophylaxis.",
    "This sample is a phase 3 clinical trial for patients with heterozygous familial hypercholesterolemia, testing the effectiveness of alirocumab and placebo in combination with LDL apheresis therapy.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug mt-4666, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for heart failure patients who have been treated with oral furosemide and have certain eligibility criteria, such as NT-proBNP > 300 pg/mL or BNP > 100 pg/mL, and excludes patients with acute decompensated heart failure or recent hospitalization for heart failure, among other exclusion criteria.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of sarilumab, adalimumab, and placebos as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of hypoactive sexual desire disorder (HSDD) using the drug bremelanotide, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of osteoarthritis of the knee using the drug duloxetine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients who experience delayed emesis after receiving certain chemotherapy regimens, and it aims to evaluate the effectiveness of aprepitant and mirtazapine in preventing chemotherapy-induced nausea and vomiting.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the drugs tvp-1012 and placebo, with eligibility criteria including a diagnosis of Parkinson's disease, specific signs and scores, and exclusion criteria such as previous medication use and certain medical conditions.",
    "This sample is a phase 2/phase 3 clinical trial for Parkinson's disease, testing the drugs tvp-1012 1mg, tvp-1012 0.5mg, and placebo, with eligibility criteria including a diagnosis of Parkinson's disease, specific disease stage, and stable dose regimens of levodopa combination drugs and other concomitant medications.",
    "This sample is a phase 3 clinical trial for the treatment of hypoactive sexual desire disorder (HSDD) using the drugs bremelanotide and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of fluoruracil, oxaliplatin, irinotecan, and bevacizumab as chemotherapy drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with open-angle glaucoma or ocular hypertension, testing the effectiveness of a combination eye drop medication (brinzolamide and brimonidine) compared to individual eye drop medications, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for postmenopausal women with locally advanced or metastatic estrogen receptor positive breast cancer, testing the efficacy of taselisib, fulvestrant, and placebo as treatment options, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of multiple drugs, including gff mdi (pt003), ff mdi (pt005), gp mdi (pt001), and placebo mdi, in treating chronic obstructive pulmonary disease (COPD) patients who meet specific inclusion criteria such as having an established clinical history of COPD and a forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio of <0.70.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of gemigliptin ls15-0444, vildagliptin, and metformin in controlling blood sugar levels. The eligibility criteria include patients who are inadequately controlled with metformin or on a stable dose of metformin for a certain period of time.",
    "This sample is a phase 3 trial for the treatment of mycobacterium infections, specifically nontuberculous mycobacterium (MAC). The drug being tested is liposomal amikacin for inhalation (LAI), and the eligibility criteria include having a positive MAC culture, evidence of lung infection on chest CT, and willingness to adhere to the treatment regimen.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using a combination of drugs including triple ff/umec/vi and budesonide/formoterol. The study includes eligibility criteria such as age, gender, COPD diagnosis, smoking history, severity of symptoms, and existing COPD maintenance treatment. Exclusion criteria include pregnancy, asthma, other respiratory disorders, lung resection, risk factors for pneumonia, and unstable or life-threatening cardiac disease.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the efficacy of drugs such as ftc/rpv/taf and efv/ftc/tdf in patients who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the efficacy of the drug combination FTC/RPV/TDF FDC, with specific eligibility criteria including plasma HIV-1 RNA levels, hepatic transaminases, total bilirubin, hematologic function, renal function, and exclusion criteria such as hepatitis B or C infection, decompensated cirrhosis, pregnancy, active infections, and prior therapy that would make the individual unsuitable for the study.",
    "This sample is a phase 3 clinical trial testing the drug AV2 and a placebo in sexually-active women with uterine cervical dysplasia and papillomavirus infections, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for cystic fibrosis patients who are homozygous for the F508del CFTR mutation, testing the efficacy of vx-661 plus ivacaftor combination and ivacaftor in improving lung function and disease stability.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of SUN-101 and placebo nebulizers in improving lung function, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of acute myeloid leukemia (AML) in adults who are not candidates for intensive remission induction chemotherapy, and it will test the efficacy of the drugs sgi-110 (guadecitabine) and treatment choice.",
    "This sample is a phase 3 clinical trial for narcolepsy, testing the drugs jzp-110 and placebo oral tablet, with eligibility criteria including a diagnosis of narcolepsy, specific age range, and consent to use contraception.",
    "This phase 3 trial is testing the effectiveness of ixekizumab, a drug used to treat psoriatic arthritis, in patients who have not responded well to tumor necrosis factor inhibitors, and have been treated with conventional disease-modifying antirheumatic drugs.",
    "This study is testing the effectiveness of nabilone, a drug used to treat agitation, in patients with Alzheimer's disease who are in the moderate-to-severe stage of dementia. The study includes patients who meet specific inclusion criteria, such as being \u226555 years old and having clinically significant agitation.",
    "This sample is a phase 3 clinical trial for the treatment of moderate to severe glabellar lines using a placebo drug, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of canagliflozin, teneligliptin, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for boys with Duchenne muscular dystrophy, testing the drugs eplerenone and spironolactone to improve cardiac function, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for infertility, testing the effectiveness of intrauterine injection of uhcg and placebo in patients with a history of one fresh embryo transfer failure and primary infertility, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis who have inadequate response to MTX, testing the efficacy of drugs Enbrel and Lbec0101, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for osteoarthritis of the knee, testing the effectiveness of the drugs fx006, placebo, and tca ir 40, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial testing the effectiveness of suboxone, rbp-6000, and placebo in treating opioid dependence and opioid-related disorders, with specific eligibility criteria for participants.",
    "This phase 3 clinical trial is investigating the efficacy of cisplatin, carboplatin, and 5-fu in treating recurrent or metastatic head and neck cancer, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of hepatitis C, using the drugs sofosbuvir, ribavirin, and grazoprevir/elbasvir, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for individuals with chronic HIV-1 infection who have failed their current antiretroviral regimen, and it aims to evaluate the effectiveness of the drug bms-663068 in combination with other antiretrovirals in forming a viable new regimen.",
    "This sample is a phase 3 clinical trial for melanoma patients, testing the efficacy of a placebo drug. The eligibility criteria include having completely resected Stage III melanoma, availability of tumor tissue for PD-L1 evaluation, and an ECOG performance status of 0 or 1. Exclusion criteria include mucosal or ocular melanoma, history of pneumonitis or interstitial lung disease, and prior treatment with certain immunotherapy agents.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe, chronic non-neuropathic low back pain, testing the effectiveness of nktr-181 bid tablets compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for acute ischemic stroke, testing the drugs placebo and dlbs1033, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial aims to evaluate the effectiveness of lofexidine, a drug used for opioid withdrawal, in patients seeking treatment for partial or total withdrawal from opioids, with specific inclusion and exclusion criteria outlined in the study.",
    "This sample is a phase 3 clinical trial for alcohol dependence, testing the effectiveness of nalmefene hydrochloride and placebo in Japanese patients with high drinking risk levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of bevacizumab, paclitaxel, and carboplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of methicillin-resistant staphylococcus aureus (MRSA) infection using the drug beta-lactam, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for non-small-cell lung carcinoma, testing the effectiveness of atezolizumab, bevacizumab, carboplatin, and paclitaxel in participants with no prior treatment for stage IV non-squamous NSCLC, who have measurable disease and meet certain eligibility criteria.",
    "This sample is a phase 3 clinical trial for non-squamous non-small cell lung carcinoma, testing the effectiveness of atezolizumab, carboplatin, nab-paclitaxel, and pemetrexed as treatment options, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The study will evaluate the efficacy of drugs such as medi4736 and tremelimumab, along with standard of care, in treating the disease. The eligibility criteria include age, confirmed PD-L1 status, performance status, and previous treatment history.",
    "This phase 3 trial is testing the effectiveness of pembrolizumab and paclitaxel in treating patients with gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed on or after prior first-line therapy containing platinum/fluoropyrimidine doublet, and have confirmed metastatic or locally advanced, unresectable disease.",
    "This sample is a phase 2/phase 3 trial for the treatment of chronic hepatitis C using the drugs ravidasvir hydrochloride, sofosbuvir, and ribavirin, with specific eligibility criteria including age, HCV genotype, BMI, and previous treatment history.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the efficacy of sarilumab, sulfasalazine, leflunomide, bucillamine, tacrolimus, and mizoribine as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for psoriatic arthritis, testing the effectiveness of etanercept and methotrexate compared to placebos, with specific eligibility criteria including a diagnosis of psoriatic arthritis, tender and swollen joints, and no prior use of biologics or methotrexate.",
    "This sample is a phase 3 clinical trial for the drug everolimus in female patients with metastatic or recurrent ER-positive breast cancer who have resistance to aromatase inhibitor therapy.",
    "This sample is a phase 3 clinical trial testing the drugs omadacycline and linezolid for the treatment of bacterial infections and skin structures and soft tissue infections, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for alcohol dependence, testing the drug nalmefene hydrochloride, with inclusion criteria requiring completion of a previous study and signed informed consent, and exclusion criteria including unstable illness and abnormal ECG.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of dapagliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of cetuximab, cisplatin/carboplatin, and 5-fluorouracil as treatment options. The eligibility criteria include confirmed diagnosis of SCCHN, presence of measurable lesions, and an ECOG performance status of 0 or 1.",
    "This sample is a phase 3 clinical trial for the treatment of epidermolysis bullosa, a rare genetic skin disorder, using sd-101-6.0 cream and placebo cream. The study includes specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for type 1 diabetes mellitus, testing the drugs placebo and sotagliflozin, with inclusion criteria including being 18 years or older, having a diagnosis of T1D for at least 1 year, and using insulin or insulin analog delivery methods.",
    "This sample is a phase 3 clinical trial for the treatment of irritable bowel syndrome characterized by constipation. The drugs being tested are plecanatide and placebo, and the eligibility criteria include age, diagnosis of IBS-C, and exclusion criteria such as refusal to sign informed consent, pregnancy, and use of certain medications.",
    "This sample is a phase 3 clinical trial for the treatment of erosive esophagitis, testing the drugs vonoprazan and lansoprazole against their respective placebos, with eligibility criteria including confirmation of erosive esophagitis through endoscopy and exclusion criteria such as a history of hypersensitivity to the drugs or certain medical conditions.",
    "This sample is a phase 3 clinical trial for melanoma patients, testing the drugs ipilimumab and nivolumab, with eligibility criteria including age, previous treatment, and stage of melanoma.",
    "This sample is a phase 2/phase 3 clinical trial for patients with non-small cell lung cancer, testing the efficacy of anlotinib versus placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of vortioxetine compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of lumacaftor and ivacaftor drugs in treating cystic fibrosis and advanced lung disease in participants who are homozygous for the F508del-CFTR mutation and have a percent predicted FEV1 <40.",
    "This sample is a phase 3 trial for cystic fibrosis patients who are heterozygous for F508del-CFTR and a second allele with a CFTR mutation predicted to have residual function, and it will test the efficacy of vx-661/ivacaftor, ivacaftor, and their placebos in improving lung function and disease stability.",
    "This sample is a phase 3 clinical trial for the treatment of high-risk first relapse B-precursor acute lymphoblastic leukemia (ALL) using a combination of drugs including blinatumomab, dexamethasone, vincristine, daunorubicin, methotrexate, ifosfamide, peg-asparaginase, and erwinia-asparaginase. The eligibility criteria include age restrictions, absence of CNS involvement, and specific laboratory values.",
    "This sample is a phase 3 clinical trial for participants with non-small-cell lung carcinoma who have experienced disease progression. The trial will test the efficacy of avelumab and docetaxel drugs in treating the disease, and participants must meet specific eligibility criteria to be included in the trial.",
    "This sample is a phase 3 clinical trial for the treatment of neovascular glaucoma using aflibercept (Eylea, Bay 86-5321) and sham injection, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of doravirine, tenofovir, and lamivudine in combination with different baseline regimens, with specific eligibility criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of galcanezumab, a CGRP antibody, in treating episodic cluster headache, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glargine (u300) in controlling blood sugar levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for the treatment of complex regional pain syndrome type I using neridronic acid and placebo, with eligibility criteria including a diagnosis of CRPS type I, baseline pain intensity score, and stable treatment for at least 1 month.",
    "This sample is a phase 3 trial for contraception using levonorgestrel (bay98-7196) as the drug, with inclusion criteria including healthy females requesting contraception and willing to use the IVR, and exclusion criteria including pregnancy or lactation, diseases or conditions that can compromise the function of the body systems, and major surgery scheduled during the study period.",
    "This phase 3 trial aims to evaluate the efficacy of doravirine, tenofovir, and lamivudine in treating human immunodeficiency virus (HIV) patients who have not received antiretroviral therapy (ART), with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the efficacy of clopidogrel, a blood-thinning medication, in combination with standard treatment for locally advanced or metastatic pancreatic cancer patients who have not received previous chemotherapy.",
    "This sample is a phase 3 clinical trial for the treatment of dry eye disease using the drugs ebi-005 and placebo, with key inclusion criteria being a history of dry eye disease and willingness to follow study instructions, and key exclusion criteria including ocular conditions that could confound study assessments and recent intraocular surgery.",
    "This sample is a phase 3 clinical trial for the drug nbi-98854, targeting tardive dyskinesia, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial is testing the effectiveness of ustekinumab, a drug used to treat inflammatory bowel diseases, in patients with moderately to severely active ulcerative colitis who have failed previous biologic therapy.",
    "This phase 3 trial is investigating the effectiveness of atezolizumab, carboplatin, cisplatin, gemcitabine, and pemetrexed in treating non-squamous and squamous non-small cell lung cancer patients who have not received prior treatment for stage IV disease, have a tumor PD-L1 expression, and meet other eligibility criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs atezolizumab, carboplatin, cisplatin, and gemcitabine, with specific eligibility criteria for patients to be included or excluded from the trial.",
    "This sample is a phase 3 clinical trial for metastatic non-small cell lung cancer patients with an activating EGFR mutation, testing the efficacy of ramucirumab, placebo, erlotinib, gefitinib, and osimertinib as first-line treatments. The eligibility criteria include confirmed diagnosis of stage IV NSCLC, provision of tissue samples, and a life expectancy of at least 3 months. Exclusion criteria include T790M EGFR mutation, leptomeningeal carcinomatosis, and ongoing treatment with certain medications.",
    "This sample is a phase 3 trial for cystic fibrosis patients who are heterozygous for F508del-CFTR mutation and a second CFTR allele with a gating defect that is clinically demonstrated to be ivacaftor responsive. The study will test the efficacy of ivacaftor and tezacaftor/ivacaftor in improving lung function (FEV1) in these patients.",
    "This sample is a phase 3 clinical trial for patients with relapsed or refractory multiple myeloma, testing the effectiveness of carfilzomib and dexamethasone as treatment options. The eligibility criteria include prior exposure to immunomodulatory agents and proteasome inhibitors, as well as specific disease measurements and organ function requirements.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of dapagliflozin 10 mg compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with glioblastoma multiforme or anaplastic astrocytoma, testing the drugs toca fc, lomustine, and temozolomide, with eligibility criteria including prior treatment, measurable disease, and laboratory values.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of dupilumab, placebo, inhaled corticosteroid therapy, albuterol/salbutamol, and levalbuterol/levosalbutamol in combination with medium to high dose ICS and a second controller for at least 3 months, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 1 diabetes mellitus, testing the efficacy of empagliflozin and placebo in combination with insulin therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Friedreich's ataxia, testing the efficacy of interferon \u03b3-1b and placebo in subjects between the ages of 10 and 25 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for treatment-resistant depression, testing the effectiveness of esketamine and other oral antidepressants in participants who have had non-response to previous treatments, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of esketamine, duloxetine, escitalopram, sertraline, and venlafaxine extended release in treating treatment-resistant depression in participants who have had non-response to oral antidepressant treatments, and meet specific inclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with Type 2 diabetes mellitus (T2DM) and inadequate glycemic control, testing the effectiveness of saxagliptin, dapagliflozin, and glimepiride in combination with metformin. The inclusion criteria include specific age requirements, negative pregnancy test for women of childbearing potential, and agreement to use contraception during the study. Exclusion criteria include type 1 diabetes, history of diabetic ketoacidosis, cardiovascular/vascular diseases, renal and hepatic diseases, pancreatitis, hematological and oncological conditions, contraindications to the therapy being studied, and use of weight loss programs or chronic systemic corticosteroid therapy.",
    "This phase 3 clinical trial is investigating the effectiveness of insulin degludec/liraglutide, insulin glargine, and insulin aspart in combination with metformin for the treatment of type 2 diabetes in patients with a stable daily dose of IGlar and metformin, and a BMI below or equal to 40 kg/m^2.",
    "This sample is a phase 3 clinical trial for patients with renal cell carcinoma, testing the effectiveness of atezolizumab, bevacizumab, and sunitinib as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the drug sotagliflozin in patients with type 1 diabetes mellitus, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 3 clinical trial for patients with unresectable epithelial ovarian, fallopian tube, or primary peritoneal cancer, testing the effectiveness of lurbinectedin, pegylated liposomal doxorubicin, and topotecan as treatment options for platinum-resistant disease. The inclusion criteria include age \u2265 18 years, confirmed diagnosis of the specified cancers, evaluable disease, and no more than three prior chemotherapy regimens, among others. Exclusion criteria include certain concomitant diseases/conditions and prior treatment with specific drugs.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) who are refractory to or have relapsed after first-line therapy. The trial aims to evaluate the efficacy of multiple drugs including gilteritinib, lodac, azacitidine, mec, and flag-ida in treating AML patients with FLT3 mutation. The eligibility criteria include specific disease diagnosis, FLT3 mutation status, performance status, laboratory test results, and contraception requirements. Exclusion criteria include certain types of leukemia, prior treatment with specific drugs, and various medical conditions.",
    "This sample is a phase 3 trial for the treatment of depressive disorder, treatment-resistant, using drugs such as esketamine, duloxetine, escitalopram, sertraline, and venlafaxine extended release. The eligibility criteria include being 65 years or older, meeting the diagnostic criteria for major depressive disorder, having a certain level of depressive symptoms, and having nonresponse to previous oral antidepressant treatments.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes and coronary artery disease, testing the effectiveness of icosapent ethyl in reducing triglyceride levels and improving cardiovascular health.",
    "This sample is a phase 3 clinical trial for patients with advanced breast cancer, testing the efficacy of ribociclib and fulvestrant in comparison to a ribociclib placebo, with specific eligibility criteria including hormone receptor status, disease stage, and prior treatment history.",
    "This sample is a phase 3 clinical trial for HIV infections, testing the effectiveness of the drugs dtg 50 mg, rpv 25 mg, and car in participants who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for multiple sclerosis (MS) patients, testing the effectiveness of ponesimod and teriflunomide drugs in reducing disease activity. The eligibility criteria include age, MS diagnosis, disease activity, and ambulatory status, while exclusion criteria include significant medical conditions, pregnancy, and contraindications to MRI.",
    "This sample is a phase 3 clinical trial for triple negative breast cancer, testing the efficacy of atezolizumab, nab-paclitaxel, and placebo as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with urothelial carcinoma, testing the effectiveness of the drugs ramucirumab, docetaxel, and placebo in participants who have had disease progression while on a platinum-containing regimen in the first-line setting or within 14 months after completing the first-line platinum regimen.",
    "This sample is a phase 3 clinical trial for patients with diabetes and foot ulcers, testing the effectiveness of gentamicin collagen sponge as a treatment for moderate to severe infections, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with unresectable melanoma, testing the drugs cobimetinib and vemurafenib, with eligibility criteria including histological diagnosis, measurable disease, and adequate organ function.",
    "This sample is a phase 2/phase 3 trial for attention deficit hyperactivity disorder (ADHD) using the drugs dasotraline and placebo comparator, with eligibility criteria including a diagnosis of ADHD, specific ADHD symptom scores, age range, and various health requirements.",
    "This sample is a phase 3 clinical trial for HIV infections, testing the effectiveness of the drugs dtg 50 mg, rpv 25 mg, and car in participants who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for antiretroviral treatment-naive individuals with human immunodeficiency virus type 1, testing the efficacy of darunavir/cobicistat/emtricitabine/tenofovir alafenamide fdc, drv/cobi fdc, ftc/tdf fdc, d/c/f/taf fdc - matching placebo, ftc/tdf fdc matching placebo, and drv/cobi fdc matching placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of brolucizumab ophthalmic solution and aflibercept ophthalmic solution in treating neovascular age-related macular degeneration and choroidal neovascularization, with specific eligibility criteria for participants.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of sildenafil and placebo in patients with pulmonary hypertension and diseases of the mitral valve, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for hepatocellular carcinoma (HCC) testing the efficacy of ramucirumab and placebo in participants with specific eligibility criteria, including a diagnosis of HCC, prior treatment with sorafenib, and specific liver function and tumor characteristics.",
    "This sample is a phase 3 clinical trial for fibromyalgia and related diseases, testing the effectiveness of tnx-102 sl tablet and placebo sl tablet in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This phase 3 trial is investigating the use of inhaled nitric oxide as a potential treatment for pulmonary arterial hypertension (PAH) in patients who have been on continuous prostacyclin analog (PGI) therapy for at least 1 year and are eligible for weaning off parenteral PGI therapy.",
    "This sample is a phase 3 clinical trial for patients with metastatic pancreatic adenocarcinoma, testing the effectiveness of a combination treatment with ibrutinib, gemcitabine, and nab-paclitaxel, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is testing the efficacy of ustekinumab and golimumab, along with a placebo, in treating axial spondyloarthritis, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with postmenopausal estrogen-receptor positive breast cancer, testing the efficacy of fulvestrant and alpelisib (with a placebo) in combination with endocrine therapy, with specific eligibility criteria including prior treatment history and disease progression.",
    "This sample is a phase 3 trial for prostate cancer patients with progressive metastatic disease, testing the drugs galeterone and enzalutamide, and the eligibility criteria include detectable AR-V7 from circulating tumors and ECOG performance status 0 or 1.",
    "This sample is a phase 2/phase 3 trial for patients with recurrent non-small cell lung carcinoma or stage IV non-small cell lung cancer, testing the drug afatinib dimaleate, and includes eligibility criteria such as the presence of specific EGFR mutations, availability of tissue and blood samples, and exclusion of prior systemic anticancer therapy.",
    "This sample is a phase 3 clinical trial for the treatment of chronic cluster headache, testing the effectiveness of galcanezumab 300 mg compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for acute migraine, testing the efficacy of lasmiditan 100 mg, lasmiditan 200 mg, and placebo, with inclusion criteria including participants with migraine fulfilling IHS diagnostic criteria, history of disabling migraine, MIDAS score \u226511, and history of 3-8 migraine attacks per month, while exclusion criteria include pregnancy, history of seizures or certain medical conditions, and use of certain medications.",
    "This sample is a phase 2/phase 3 trial for the treatment of hepatitis C using the drugs ABT-493 and ABT-530, with eligibility criteria including prior treatment with an ABT-493 and/or ABT-530 containing regimen and completion of the post-treatment period of an eligible prior study.",
    "This phase 3 trial is investigating the effectiveness of enzalutamide, nsaa, and lhrha or surgical castration in men with metastatic prostate cancer, and the eligibility criteria include having metastatic adenocarcinoma of the prostate, adequate bone marrow and liver function, and a performance status of 0-2.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of various drugs including fluticasone furoate, vilanterol, fluticasone propionate, salmeterol, budesonide, and formoterol fumarate, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2/phase 3 trial for patients with chronic hepatitis C, testing the efficacy of abt-493, abt-530, and ribavirin in treating the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with active systemic lupus erythematosus, testing the effectiveness of a placebo drug in combination with standard care medications, such as prednisone and other immunosuppressants, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with active systemic lupus erythematosus, testing the effectiveness of a placebo drug in combination with standard care medications such as prednisone, azathioprine, antimalarials, mycophenolate mofetil, methotrexate, and mizoribine, based on specific eligibility criteria including ACR classification criteria and SLEDAI-2K scores.",
    "This sample is a phase 3 trial for patients with foot ulcers and infections, testing the effectiveness of gentamicin collagen sponge as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for osteoarthritis in the knee and hip, testing the drugs regn475 and placebo, with eligibility criteria including a clinical diagnosis of OA, inadequate pain relief, and willingness to discontinue certain medications.",
    "This sample is a phase 2/phase 3 trial for patients with soft tissue sarcoma, testing the efficacy of anlotinib and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using the drug oradur\u00ae and placebo, with specific inclusion and exclusion criteria for subjects aged 6 to 18 years old.",
    "This sample is a phase 3 trial for the treatment of advanced soft tissue sarcoma using a combination of olaratumab, doxorubicin, and placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial aims to evaluate the efficacy of imipenem+cilastatin/relebactam, colistimethate sodium (cms), imipenem+cilastatin, and placebo to cms in treating bacterial infections caused by Gram-negative bacteria with imipenem resistance and susceptibility to imipenem/relebactam and colistin. The study includes patients with hospitalization requiring IV antibiotic therapy for new, persistent, or progressing bacterial infections involving specific infection types.",
    "This sample is a phase 2/phase 3 trial testing the use of ketamine in adults undergoing gastric bypass or sleeve gastrectomy, with specific inclusion and exclusion criteria, and the study aims to evaluate its effects on pain and postoperative depression.",
    "This phase 3 clinical trial is testing the effectiveness of the drug reslizumab compared to a placebo in participants with asthma who have required an inhaled corticosteroid and an additional asthma controller medication, and have a history of asthma exacerbation.",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes mellitus, testing the drug ASP1941 against a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for systemic sclerosis, testing the effectiveness of tocilizumab and placebo in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This phase 3 clinical trial is investigating the effectiveness of various drug combinations, such as paclitaxel + carboplatin and gemcitabine + cisplatin, in treating non-small-cell lung carcinoma (NSCLC) patients who do not have sensitizing EGFR mutation or ALK rearrangement, and have not received prior chemotherapy or any other systemic therapy for recurrent/metastatic NSCLC. The study also includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with idiopathic Parkinson's disease, testing the efficacy of the drugs tozadenant and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of various drugs including linagliptin and empagliflozin, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of morphine sulfate compared to placebo in reducing dyspnea in patients with chronic obstructive pulmonary disease (COPD) who are already on stable COPD medications and have a certain level of breathlessness.",
    "This sample is a phase 3 clinical trial for the drug erenumab and placebo in patients with a history of migraine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) using the drugs td-4208 and placebo, with inclusion criteria of subjects being 40 years or older and exclusion criteria of pregnant or breastfeeding females.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the drug dapagliflozin, and includes eligibility criteria such as specific insulin use, C-peptide levels, and HbA1c range.",
    "This phase 3 clinical trial is testing the drug sorafenib for the treatment of hepatocellular carcinoma, hepatoma, and liver cell carcinoma, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for plaque psoriasis, testing the efficacy of idp-118 lotion and idp-118 vehicle lotion as topical treatments, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for plaque psoriasis, testing the efficacy of idp-118 lotion and idp-118 vehicle lotion as topical treatments, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for macular degeneration, testing the drugs abicipar pegol and ranibizumab, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial aims to evaluate the effectiveness of cl-108, a combination drug containing hydrocodone, acetaminophen, and promethazine, in reducing pain, nausea, and vomiting in patients with conditions such as bunion surgery, moderate to severe pain, and a risk of opioid-induced nausea and vomiting.",
    "This sample is a phase 3 trial for macular degeneration, testing the drugs abicipar pegol and ranibizumab, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using the drug shp465 and a placebo, with eligibility criteria including age, diagnosis of ADHD, and willingness to comply with study requirements.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease experiencing \"off\" episodes, testing the efficacy of apl-130277 and placebo in reducing \"off\" time duration and improving symptoms.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs iti-007, risperidone, and placebo, with inclusion criteria including male or female subjects aged 18-60 with a clinical diagnosis of schizophrenia experiencing an acute exacerbation of psychosis, and exclusion criteria including subjects unable to provide informed consent, pregnant or breastfeeding females, and subjects judged medically inappropriate for study participation.",
    "This phase 3 trial is testing the efficacy of f/taf, abc/3tc, and a placebo in HIV-1 infected individuals who have been on an antiretroviral regimen containing ABC/3TC FDC for at least 6 months, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the drug selexipag in patients with pulmonary arterial hypertension (PAH), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drugs ldv/sof and rbv, with specific eligibility criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of various drugs, including exparel, femoral nerve block bupivacaine, toradol, and morphine sulfate, in managing pain for patients undergoing primary, unilateral, Total Knee Replacement. The study is being conducted at the New England Baptist Hospital in Boston, Massachusetts.",
    "This sample is a phase 3 clinical trial for patients with chronic plaque-type psoriasis, testing the effectiveness of fumaric acid as a systemic therapy. The inclusion criteria include specific scores for PASI, BSA, and DLQI, as well as a documented inadequate response to topical treatment. The exclusion criteria include previous systemic treatment for psoriasis, ongoing use of prohibited treatments, and various medical conditions.",
    "This sample is a phase 2/phase 3 trial for acute myeloid leukemia and hematopoietic stem cell transplantation, testing the drug sorafenib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug tecovirimat, testing its effectiveness in treating smallpox, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for HIV patients with resistance to antiretroviral medications, testing the efficacy of an optimized background regimen (OBR) drug called ibalizumab. The study aims to determine if ibalizumab can effectively treat HIV-1 infection in patients with specific eligibility criteria and exclude those with certain conditions or allergies.",
    "This sample is a phase 3 clinical trial for chronic lymphocytic leukemia, testing the drugs acalabrutinib, obinutuzumab, and chlorambucil, with specific eligibility criteria for age, performance status, diagnosis, and laboratory parameters.",
    "This sample is a phase 3 trial for the treatment of super-refractory status epilepticus, testing the drugs sage-547 and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for ovarian cancer patients who have completed first-line platinum-taxane chemotherapy and received prior bevacizumab treatment. The trial aims to evaluate the efficacy of olaparib compared to placebo in patients with germline BRCA 1 or 2 deleterious mutation.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs aducanumab and placebo, with specific eligibility criteria including cognitive impairment, positive amyloid PET scan, and stable drug doses.",
    "This sample is a phase 3 clinical trial for type 2 diabetes mellitus, testing the drugs pex168(100\u00b5g), pex168(200\u00b5g), and placebo, with eligibility criteria including confirmed diagnosis, age range, BMI range, and specific HbA1c levels.",
    "This sample is a phase 3 clinical trial for type 2 diabetes mellitus, testing the drugs pex168, metformin, and placebo, with eligibility criteria including confirmed diagnosis, age range, BMI range, and previous metformin monotherapy.",
    "This phase 3 trial is testing the effectiveness of self-injectable epinephrine, albuterol/salbutamol, loratadine, olopatadine, and mometasone furoate monohydrate in treating ragweed pollen-induced allergic rhinitis/rhinoconjunctivitis in children aged 4 to 17 years.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drug sof/vel, with key inclusion criteria including HCV RNA \u2265 10^4 IU/mL, HCV genotype 1-6, cirrhosis determination, HIV-1 infection, and use of contraception, and key exclusion criteria including clinically-significant illness, hepatic decompensation, hepatocellular carcinoma, and use of prohibited concomitant medications.",
    "This sample is a phase 3 clinical trial for patients with small cell lung cancer (SCLC) who have recurrence or progression after first-line chemotherapy or chemoradiation therapy. The trial is testing the effectiveness of the drugs nivolumab, topotecan, and amrubicin in treating SCLC.",
    "This phase 3 trial is investigating the efficacy of chidamide, exemestane, and placebo in postmenopausal women with hormone receptor-positive breast cancer who have experienced disease progression or recurrence after endocrine therapy, with specific eligibility criteria outlined.",
    "This sample is a phase 2/phase 3 trial for HIV patients with limited treatment options, testing the efficacy of the drugs pro 140, placebo, and an optimized background regimen, with eligibility criteria including specific laboratory values and willingness to remain on treatment without changes.",
    "This sample is a phase 3 clinical trial for the drug erenumab and placebo in patients with migraines, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for asthma, testing the effectiveness of drugs such as montelukast and albuterol/salbutamol in children aged 5-11 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for epilepsy patients, testing the effectiveness of different doses of eslicarbazepine acetate (esl) as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs aducanumab and placebo, with specific eligibility criteria including cognitive impairment, positive amyloid PET scan, and stable drug doses.",
    "This sample is a phase 3 clinical trial for overactive bladder, testing the drugs thvd-201 and detrusitol 2mg tablet, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with neurotoxicity, testing the effectiveness of placebo, gm, and oxaliplatin-based chemotherapy drugs, with specific eligibility criteria including normal organic function, diagnosis of GI cancer, and chronic neurotoxicity grade of 2 or more.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drugs ldv/sof and rbv, with specific eligibility criteria including HCV genotype 4, treatment-naive or prior participation in the study, and defined laboratory values.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of drugs qva149, umeclidinium/vilanterol, and placebos in improving lung function and quality of life.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of drugs qva149, umeclidinium/vilanterol, and placebos in improving lung function and quality of life. The inclusion criteria include age, smoking history, COPD diagnosis, lung function measurements, and symptom severity, while exclusion criteria include recent respiratory tract infection, concomitant pulmonary disease, asthma history, lung cancer, certain cardiovascular conditions, and contraindications for specific medications.",
    "This sample is a phase 3 trial for patients with advanced heart failure, testing the prophylactic treatment with wilfactin, with specific inclusion and exclusion criteria related to VWF functional defects and previous treatment with Wilfactin.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis using the drugs chs-1420 and adalimumab, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for prostate cancer patients with metastatic disease, testing the effectiveness of apalutamide, placebo, and androgen deprivation therapy (adt) in combination with prior treatments for localized prostate cancer. The eligibility criteria include specific diagnosis and disease progression requirements, as well as restrictions on prior treatments and exclusion criteria such as brain metastases and certain prior malignancies.",
    "This sample is a phase 2/phase 3 trial for HIV-1 infection, testing the drugs vm-1500, efavirenz, and antiretroviral therapy (art), with eligibility criteria including confirmed HIV-1 infection, clinically stable HIV infection, indications for ART, specific laboratory parameters, and exclusion criteria such as primary HIV-1 resistance to ART and history of antiretroviral therapy.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of various doses of empagliflozin and linagliptin combination drugs compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease, hyperphosphatemia, iron deficiency anemia, and renal insufficiency, testing the effectiveness of ferric citrate in reducing serum phosphate levels, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for a drug called plecanatide, which is being tested for the treatment of irritable bowel syndrome characterized by constipation (IBS-C). The study includes adult patients between the ages of 18 and 85 with a diagnosis of IBS-C based on ROME III diagnostic criteria. The inclusion and exclusion criteria are listed, including restrictions on BMI, pregnancy, lactation, and the use of certain medications.",
    "This sample is a phase 3 clinical trial for the treatment of hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) using a combination of drugs including imipenem, relebactam, cilastatin, piperacillin, tazobactam, and linezolid, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using the drugs hld200 methylphenidate hydrochloride (mph) capsules and placebo, with eligibility criteria including a diagnosis of ADHD, specific ADHD symptom scores, and prior experience or response to MPH treatment.",
    "This sample is a phase 3 clinical trial for the treatment of depressive disorder, treatment-resistant, using drugs such as esketamine, duloxetine, escitalopram, sertraline, and venlafaxine extended release. The eligibility criteria include meeting the DSM-5 diagnostic criteria for major depressive disorder, having a certain level of depressive symptoms, and having nonresponse to previous oral antidepressant treatments.",
    "This sample is a phase 3 clinical trial for patients with gastric adenocarcinoma, testing the efficacy of cisplatin, 5-fu, capecitabine, and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis C genotype 1b, testing the effectiveness of daclatasvir and asunaprevir as HCV direct acting antiviral agents, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug tirasemtiv in patients with amyotrophic lateral sclerosis (ALS), with specific inclusion and exclusion criteria, and requirements for contraception and riluzole use.",
    "This sample is a phase 3 trial for treatment-resistant depression, testing the effectiveness of multiple oral antidepressant drugs, including esketamine, duloxetine, escitalopram, sertraline, and venlafaxine extended release, in participants who have not responded to previous treatments. The eligibility criteria include meeting the DSM-5 diagnostic criteria for major depressive disorder, having a MADRS total score of >=22, and having nonresponse to >=2 oral antidepressant treatments. Participants with certain psychiatric disorders, substance or alcohol use disorder, or cognitive impairment are excluded from the study.",
    "This sample is a phase 3 clinical trial for the treatment of ulcerative colitis using vedolizumab and adalimumab, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the efficacy of faster-acting insulin aspart, insulin aspart, and insulin degludec in maintaining glycemic control, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 clinical trial is investigating the effectiveness of insulin degludec/liraglutide and insulin glargine in treating type 2 diabetes mellitus, with specific eligibility criteria including HbA1c levels, body mass index, and prior insulin treatment.",
    "This phase 3 clinical trial aims to evaluate the efficacy of reslizumab, a non-oral corticosteroid asthma medication, in patients with asthma and elevated blood eosinophils who are dependent on oral corticosteroids.",
    "This sample is a phase 3 clinical trial for asthma, testing the effectiveness of fluticasone furoate and salbutamol as treatments, with specific eligibility criteria for children aged 5 to less than 12 years.",
    "This phase 3 trial is investigating the effectiveness of axs-02 (oral zoledronate) compared to placebo in treating complex regional pain syndrome (CRPS-1) patients, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis C infection and early stage hepatocellular carcinoma (HCC), testing the efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir, ombitasvir/paritaprevir/ritonavir, and ribavirin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the drugs abatacept and methotrexate, with specific eligibility criteria including a recent diagnosis of RA, elevated CRP or ESR levels, joint inflammation, and positive ACPA antibodies.",
    "This sample is a phase 3 clinical trial for lupus erythematosus, systemic, testing the drugs ipp-201101 and placebo, with eligibility criteria including a positive test result for ANA or anti-dsDNA Ab, fulfillment of ACR Classification Revised Criteria, and specific medication usage requirements.",
    "This sample is a phase 2/phase 3 trial testing the drugs selepressin and placebo on patients with septic shock, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) using the drugs td-4208 and placebo, with inclusion criteria of subjects being 40 years or older and exclusion criteria of pregnant or breastfeeding females.",
    "This sample is a phase 3 trial for patients with persistent asthma, testing the effectiveness of beclomethasone dipropionate and albuterol/salbutamol as compared to a placebo, with eligibility criteria including stable asthma diagnosis, ability to perform spirometry, and willingness to use birth control if applicable.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis using the drugs ixekizumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of cystic fibrosis, testing the drugs vx-809, placebo, and vx-770, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis using idp-122 lotion and idp-122 vehicle lotion, with specific eligibility criteria including the body surface area affected by psoriasis and the exclusion of certain areas for calculation.",
    "This sample is a phase 3 clinical trial for plaque psoriasis, testing the efficacy of idp-122 lotion and idp-122 vehicle lotion as topical treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of vaginal atrophy, menopause, and dyspareunia in females aged 45-70 years, using the drug Vagifem, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for cystic fibrosis patients who are heterozygous for the F508del-CFTR mutation and have a second CFTR mutation that is not likely to respond to VX-661 and/or ivacaftor therapy. The study will test the efficacy of vx-661 plus ivacaftor combination, ivacaftor, and placebos in improving lung function (FEV1) in these patients.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of pro-netupitant/palonosetron, netupitant/palonosetron, and dexamethasone as antiemetic drugs for patients receiving highly emetogenic reference chemotherapies.",
    "This phase 3 trial is investigating the efficacy of td-4208 and tiotropium in treating chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria for subjects participating in the study.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using methylphenidate hydrochloride (mph) capsules and placebo as drugs, with eligibility criteria including a diagnosis of ADHD, specific baseline scores, and general good health.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease, testing the effectiveness of lower dose and higher dose sodium bicarbonate compared to a placebo, with eligibility criteria including specific serum bicarbonate levels, eGFR range, blood pressure, weight, age, and ability to provide consent and follow the treatment regimen.",
    "This sample is a phase 3 trial for smoking cessation, testing the effectiveness of nicotine patch and nicotine in helping smokers quit, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, specifically for patients with relapsing-remitting multiple sclerosis. The drug being tested is dimethyl fumarate, and the eligibility criteria include having a confirmed diagnosis of RRMS and not having a history of certain infections or prior treatment with specific medications.",
    "This sample is a phase 2/phase 3 trial for the treatment of familial partial lipodystrophy, using the drugs volanesorsen and placebo, with eligibility criteria including a clinical diagnosis of FPL, type 2 diabetes mellitus, hypertriglyceridemia, and fatty liver.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of dupilumab, placebo, and various other drugs in treating severe asthma in adult and adolescent participants who meet specific eligibility criteria, including a well-documented regular prescribed treatment of maintenance corticosteroids and a forced expiratory volume in 1 second (FEV1) below certain thresholds.",
    "This sample is a phase 3 trial for participants with type 1 diabetes mellitus and high levels of sugar in the blood, testing the effectiveness of the drug sotagliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of bacterial pneumonia and community-acquired infections, using the drugs omadacycline and moxifloxacin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin, dapagliflozin, and metformin in combination with a sulfonylurea, compared to matching placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with clear-cell metastatic renal cell carcinoma, testing the effectiveness of sunitinib or pazopanib drugs in combination with various eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for the treatment of cystic fibrosis using the drug lum/iva, with specific inclusion and exclusion criteria for subjects participating in the study.",
    "This phase 3 trial aims to evaluate the effectiveness of the drug \"gwp42003-p\" compared to a placebo in treating seizures in patients with tuberous sclerosis complex (TSC) and epilepsy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with inoperable, locally advanced, or metastatic gastric adenocarcinoma, testing the efficacy of andecaliximab, placebo, leucovorin, 5-fluorouracil, and oxaliplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes mellitus, chronic kidney disease, and albuminuria, testing the efficacy of dapagliflozin, saxagliptin, and matching placebos in combination with ACE inhibitors or ARBs.",
    "This sample is a phase 2/phase 3 trial for the treatment of secondary hyperparathyroidism in patients with stable chronic renal disease treated with hemodialysis, using the drugs khk7580 and krn1493, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of secondary hyperparathyroidism in patients with stable chronic renal disease treated with peritoneal dialysis, using the drug khk7580, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of the drug donepezil in patients with specific inclusion criteria such as dementia, probable Alzheimer's disease, and specific scores on the MMSE and GDS/CDR scales.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of saxagliptin, dapagliflozin, glargine insulin, and metformin in combination with metformin and/or sulfonylurea, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for dry eye syndromes, testing the effectiveness of carboxymethylcellulose based eye drops and carboxymethylcellulose sodium 0.5% in improving visual acuity and reducing the need for artificial tears. The inclusion criteria include previous use of artificial tears and a visual acuity of at least 20/32, while the exclusion criteria include recent use of contact lenses, herpes keratitis, and certain eye surgeries.",
    "This sample study is a phase 2/phase 3 trial investigating the use of EPA (eicosapentaenoic acid) at different doses for the treatment of major depressive disorder in overweight individuals with inflammation, and it includes specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 clinical trial for participants with asthma, testing the effectiveness of multiple drugs including indacaterol acetate/mometasone furoate, mometasone furoate, and salmeterol xinafoate/fluticasone propionate, based on specific eligibility criteria such as ACQ-7 score, FEV1, and bronchodilator reversibility.",
    "This sample is a phase 3 clinical trial for the drug dimethyl fumarate in patients with relapsing-remitting multiple sclerosis. The eligibility criteria include the ability to provide informed consent, completion of a previous clinical study with the same drug, and exclusion of subjects who cannot tolerate the treatment.",
    "This phase 3 trial is investigating the efficacy of capecitabine, eribulin, gemcitabine, and vinorelbine in treating metastatic triple negative breast cancer patients who have previously received anthracycline and/or taxane treatment, and have documented disease progression on or after the most recent therapy.",
    "This sample is a phase 3 clinical trial testing the drug rivaroxaban versus placebo in patients with various solid malignancies, who have a Khorana thromboembolic risk score of 2 or higher, and are planning to initiate systemic cancer therapy within 1 week of receiving the first dose of the study drug.",
    "This sample is a phase 3 trial for transcatheter aortic valve replacement (TAVR) in patients who have undergone successful TAVR with any approved device, and it aims to evaluate the safety and efficacy of different anticoagulant and antiplatelet regimens, including rivaroxaban, acetylsalicylic acid, clopidogrel, and vitamin K antagonist. The study has specific inclusion and exclusion criteria, and it excludes patients with certain medical conditions or ongoing treatments.",
    "This sample is a phase 3 trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of palonosetron and dexamethasone as a combination therapy for patients with solid tumor malignancy who are naive to cytotoxic chemotherapy.",
    "This sample is a phase 3 clinical trial for patients with open-angle glaucoma or ocular hypertension, testing the effectiveness of ar-13324 ophthalmic solution 0.02% and timolol maleate ophthalmic solution 0.5% bid in reducing intraocular pressure, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of open-angle glaucoma and ocular hypertension, testing the effectiveness of three drugs: pg324 ophthalmic solution 0.02%/0.005%, netarsudil (ar-13324) ophthalmic solution 0.02%, and latanoprost ophthalmic solution 0.005%. The eligibility criteria include age, diagnosis, intraocular pressure, visual acuity, and exclusion criteria such as ocular diseases, previous surgeries, and systemic diseases.",
    "This sample is a phase 3 clinical trial for the drug ALD403 and placebo in patients with migraine disorders, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of human regular U-500 insulin (CSII) and human regular U-500 insulin (MDI) in combination with other antihyperglycemic agents, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis, testing the drugs ixekizumab and ustekinumab against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial testing the drug doxycycline for patients with vascular diseases, cardiovascular diseases, and acute myocardial infarction, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of binge eating disorder, with the drugs dasotraline and placebo being tested, and includes eligibility criteria such as age, diagnosis of BED, negative alcohol and drug tests, and the use of effective birth control.",
    "This sample is a phase 3 trial for patients with acute myocardial infarction, testing the effectiveness of bivalirudin and heparin as drugs for percutaneous coronary intervention (PPCI), with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 trial for the drug tofacitinib in patients with rheumatoid arthritis, with eligibility criteria including age, ability to provide informed consent, negative pregnancy test, use of contraception, and disease activity score, while exclusion criteria include certain medical conditions, history of certain diseases, use of certain medications, and pregnancy or breastfeeding.",
    "This sample is a phase 3 clinical trial for patients with anorexia nervosa, testing the effectiveness of denosumab subcutaneous injections compared to placebo injections in improving bone mineral density, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drug teneligliptin, with inclusion criteria of adults aged \u2265 19 years old and HbA1c levels between 7% and 11% at screening and run-in visit.",
    "This sample is a phase 2/phase 3 trial for patients with early-stage breast carcinoma or her-2 positive breast cancer, testing the drugs docetaxel + trastuzumab sc + pertuzumab and trastuzumab emtansin, with specific eligibility criteria including tumor and blood samples availability, adequate organ functions, and no other uncontrolled medical or psychiatric disorders.",
    "This sample is a phase 3 clinical trial for patients with unresectable advanced or recurrent esophageal cancer, testing the effectiveness of nivolumab and docetaxel/paclitaxel as potential treatments. The eligibility criteria include age, confirmed diagnosis, previous treatment history, performance status, and life expectancy.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial skin and skin structure infections (ABSSSI) using sodium fusidate and linezolid, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with asthma, testing the effectiveness of various drugs (qvm149, qmf149, salmeterol/fluticasone) in reducing symptoms and improving lung function, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with advanced hepatocellular carcinoma, testing the drugs nivolumab and sorafenib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drugs pomalidomide and dexamethasone, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of ipragliflozin and sitagliptin in combination with diet/exercise therapy and sitagliptin monotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin, placebo, and ipragliflozin in combination with diet/exercise therapy and ipragliflozin monotherapy, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is investigating the effectiveness of cisplatin, carboplatin, pemetrexed, dexamethasone 4 mg, and saline solution in treating non-small-cell lung carcinoma patients who have not received prior systemic treatment for their advanced/metastatic NSCLC and meet specific eligibility criteria.",
    "This sample is a phase 2/phase 3 trial for patients with congestive heart failure, testing the effectiveness of furosemide injection solution and furosemide injection solution, usp in treating decompensated heart failure symptoms. The inclusion criteria include having a history of treated heart failure, being able to understand and comply with study procedures, and being over 18 years old. The exclusion criteria include presenting with symptoms that may require hospitalization, being on experimental medication or participating in another cardiovascular research study, and having conditions that may interfere with study participation.",
    "This sample is a phase 3 clinical trial for the drug dimethyl fumarate in patients with relapsing-remitting multiple sclerosis (RRMS), with specific inclusion and exclusion criteria based on disease diagnosis, EDSS score, relapse history, and MRI findings.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of two drug combinations (chf 5993 + ultibro matched placebo and ultibro + chf 5993 matched placebo) in improving symptoms and lung function. The eligibility criteria include age, smoking history, lung function measurements, and previous exacerbations. Various exclusion criteria are also listed, such as pregnancy, asthma diagnosis, recent use of certain medications, and other respiratory disorders.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drugs lenalidomide and dexamethasone, and includes eligibility criteria such as confirmed diagnosis, age restrictions, performance status, and contraception requirements.",
    "This sample is a phase 3 clinical trial for patients with platinum resistant/refractory ovarian cancer, testing the drug pld. The eligibility criteria include histologically confirmed cancer, platinum resistant/refractory disease, and measurable disease. Exclusion criteria include non-epithelial tumors, prior therapy with certain antibodies, and severe gastrointestinal conditions.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the efficacy of empagliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hepatitis C infection using the drugs ombitasvir/paritaprevir/ritonavir and dasabuvir, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for participants with hypercholesterolemia, testing the effectiveness of alirocumab, placebo, atorvastatin, and non-statin lipid-modifying therapy in reducing LDL-C levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glargine (u300) in achieving glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial that aims to evaluate the effectiveness of apixaban and dalteparin in treating various thrombosis-related diseases, such as cerebral vein thrombosis, deep vein thrombosis, and pulmonary embolism, in patients with active cancer. The study also includes specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug rvt-101 against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients with HER2-positive tumors, testing the efficacy of fec chemotherapy, docetaxel, pertuzumab, placebo, and trastuzumab in combination with standard treatment. The eligibility criteria include specific tumor size, stage, HER2 status, hormone receptor status, and cardiac health.",
    "This sample is a phase 3 clinical trial for patients with diabetes mellitus type 2, coronary artery disease, and cardiovascular diseases, testing the drugs rvx000222, placebo (for rvx000222), atorvastatin, and rosuvastatin, with eligibility criteria including CAD events, prior MI, documented diagnosis of T2DM, and HDL-C levels.",
    "This sample is a phase 2/phase 3 trial for medullary thyroid carcinoma, testing the efficacy of anlotinib and placebo drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of 0.9% saline solution, oral betamethasone placebo, adrenaline, and oral betamethasone in treating acute bronchiolitis in infants aged 6 weeks to 12 months, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients with specific EGFR mutations, testing the efficacy of naquotinib mesilate, erlotinib, and gefitinib as treatment options, with detailed inclusion and exclusion criteria provided.",
    "This sample is a phase 3 clinical trial for patients with asthma, testing the effectiveness of mepolizumab and placebo as additional controller medications, with specific eligibility criteria including a diagnosis of asthma, certain medication requirements, and a history of exacerbations.",
    "This sample is a phase 3 clinical trial for metastatic breast cancer patients, testing the efficacy of oraxol and IV paclitaxel drugs, with eligibility criteria including signed informed consent, histologically-confirmed breast cancer, and adequate hematological, liver, and renal function.",
    "This sample is a phase 3 trial for HIV patients currently on dolutegravir + abacavir + lamivudine treatment, with specific eligibility criteria, and aims to assess the efficacy of dolutegravir in maintaining viral load suppression.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the drugs ged-0301 and placebo, with inclusion criteria including active Crohn's disease and previous failure or intolerance to certain medications.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of dulaglutide, placebo, sglt2 inhibitor, and metformin in combination, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2/phase 3 clinical trial for the treatment of dry eye syndrome using the drugs rgn-259 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of systemic scleroderma using the drugs nintedanib and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial testing the drug grazoprevir/elbasvir for the treatment of acute hepatitis C and human immunodeficiency virus (HIV) in patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drugs ldv/sof and rbv, with specific eligibility criteria including HCV RNA levels, genotype, prior treatment history, and cirrhosis status.",
    "This sample is a phase 3 clinical trial for bipolar depression, testing the drug iti-007 (lumateperone) against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the drugs e/c/f/taf and b/f/taf, with eligibility criteria including stable antiretroviral regimen, low HIV-1 RNA concentrations, and CD4+ T cell count above 200 cells/\u03bcL.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the efficacy of a combination of drugs including ritonavir, atazanavir, darunavir, cobicistat, and various other drugs, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of drugs such as abc/dtg/3tc and b/f/taf, with specific eligibility criteria including stable HIV-1 RNA levels and no documented resistance to certain medications.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, focusing on patients with HCV genotype 1 infection who are treatment-na\u00efve or treatment-experienced. The study will evaluate the efficacy of the drug abt-493/abt-530 in non-cirrhotic patients, with additional inclusion criteria for HCV GT1/HIV-1 co-infected patients.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) that is ALK-positive. The trial aims to evaluate the efficacy of alectinib, docetaxel, and pemetrexed as treatment options for advanced or recurrent NSCLC. The eligibility criteria include prior systemic therapy, measurable disease, and an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. Participants with previous malignancies within the past 3 years or who have received previous ALK inhibitors other than crizotinib are excluded from the study.",
    "This sample is a phase 3 clinical trial for the treatment of migraine with or without aura using lasmiditan, with inclusion criteria such as fulfilling the International Headache Society diagnostic criteria, having a history of disabling migraine, and a Migraine Disability Association score of at least 11, while exclusion criteria include pregnancy, hypersensitivity to lasmiditan, history of seizures or vestibular disorders, and significant renal or hepatic impairment.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the effectiveness of various drugs including accordion pill\u2122 carbidopa/levodopa and sinemet\u00ae, as well as placebos, on patients who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for Japanese subjects with type 2 diabetes, testing the effectiveness of insulin degludec/liraglutide, insulin degludec, and liraglutide in controlling HbA1c levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hepatitis C, testing the drugs sof/vel/vox and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, testing the drugs sof/vel/vox and sof/vel, with specific eligibility criteria including HCV RNA levels, treatment history, and contraception use.",
    "This phase 3 clinical trial aims to evaluate the efficacy of semaglutide, sitagliptin, and placebo in treating type 2 diabetes mellitus (T2DM) patients with HbA1c levels between 7.0-10.5%. The study includes patients diagnosed with T2DM for at least 90 days, who are on a stable daily dose of metformin alone or in combination with SU. Various inclusion and exclusion criteria are specified, including restrictions on pregnancy, history of pancreatitis, recent cardiovascular events, renal impairment, and malignant neoplasms.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of drugs such as abc/dtg/3tc and b/f/taf, with specific inclusion and exclusion criteria, including being antiretroviral treatment na\u00efve and having a plasma HIV-1 RNA level of at least 500 copies/mL.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the efficacy of drugs such as dtg, f/taf, and b/f/taf, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of vedolizumab, a drug used to treat Crohn's disease, compared to a placebo, in patients with moderately to severely active Crohn's disease who have not responded to other treatments.",
    "This phase 3 trial is testing the effectiveness of vedolizumab, a drug used to treat ulcerative colitis, compared to a placebo, in patients who have not responded well to other treatments and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs nivolumab and docetaxel, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for individuals with chronic genotype 1 or 2 hepatitis C virus infection and hepatitis B virus coinfection, testing the drug ldv/sof, with specific eligibility criteria including weight, cirrhosis determination, screening laboratory values, and contraception use.",
    "This sample is a phase 3 clinical trial testing the effectiveness of galcanezumab, a drug used to treat episodic migraine, compared to a placebo, in patients with a history of migraine headaches. The eligibility criteria include having a diagnosis of episodic migraine, a specific frequency of migraine headache days, and exclusion criteria such as not being enrolled in another clinical trial involving an investigational product or having a known hypersensitivity to galcanezumab.",
    "This sample is a phase 3 clinical trial for the treatment of migraine, testing the effectiveness of galcanezumab compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for chronic migraine, testing the effectiveness of galcanezumab compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of various drugs including e/c/f/taf, tdf, ftc, ftc/tdf, and 3tc, with eligibility criteria including documented plasma HIV-1 RNA levels < 50 copies/mL, adequate renal function, and absence of resistance to TDF or FTC.",
    "This sample is a phase 3 clinical trial for patients with diffuse large B cell lymphoma, testing the effectiveness of rituximab, doxorubicin, vincristine, cyclophosphamide, and prednisone as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for brain cancer (glioblastoma) patients with MGMT unmethylated type tumors, testing the drugs nivolumab and temozolomide, and includes specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 3 clinical trial for constipation predominant irritable bowel syndrome, testing the effectiveness of the drug tenapanor compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of fremanezumab, a drug used for migraine treatment, compared to a placebo, in patients aged 18 to 70 with a history of migraine. The eligibility criteria include specific age range, migraine diagnosis, weight range, and e-diary compliance. Various exclusion criteria are also listed, such as significant medical conditions, psychiatric issues, infections, and recent participation in other clinical studies.",
    "This sample is a phase 2/phase 3 trial for primary open angle glaucoma and ocular hypertension, testing the efficacy of placebo ophthalmic solution, de-117 ophthalmic solution low and high, and latanoprost ophthalmic solution 0.005% as potential treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with unresectable, recurrent, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, testing the efficacy of avelumab, irinotecan, and paclitaxel as third-line treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with metastatic renal cell carcinoma (RCC) who have failed prior systemic regimens. The study aims to evaluate the efficacy of tivozanib hydrochloride and sorafenib in treating RCC patients who have not previously received these drugs. The eligibility criteria include age, histological confirmation of clear cell RCC, measurable disease, Eastern Cooperative Oncology Group (ECOG) performance status, and life expectancy. Exclusion criteria include prior treatment with sorafenib or tivozanib, more than 3 prior regimens for metastatic RCC, and certain medical conditions.",
    "This sample is a phase 3 trial for rheumatoid arthritis (RA) patients who have been on methotrexate therapy, testing the efficacy of adalimumab and upadacitinib compared to their respective placebos, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is testing the effectiveness of fremanezumab and placebo in treating migraine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium and olodaterol in improving lung function and exercise capacity. The eligibility criteria include having a diagnosis of COPD, being a current or ex-smoker with a smoking history of more than 10 pack years, and having certain spirometric criteria.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the efficacy of ertugliflozin and other drugs in combination with metformin for glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of seasonal allergic rhinitis, testing the effectiveness of drugs such as gsp 301 ns, olopatadine hcl ns, mometasone furoate ns, and gsp 301 placebo ns, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer. The trial will test the effectiveness of mirvetuximab soravtansine, paclitaxel, pegylated liposomal doxorubicin, and topotecan as treatment options. The eligibility criteria include having folate receptor alpha positive tumor expression, platinum-resistant ovarian cancer, and measurable disease. Exclusion criteria include clear cell or low-grade ovarian cancer, primary platinum-refractory disease, and prior treatment with mirvetuximab soravtansine.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs alk3831, olanzapine, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, testing the efficacy of ezetimibe and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pain, testing the effectiveness of buprenorphine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of moderate-to-severe chronic plaque psoriasis using fumaric acid esters, methotrexate, and ixekizumab, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis, testing the efficacy of \"dfd06 cream\" and \"vehicle cream\" on subjects with moderate to severe plaque-type psoriasis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus (HCV) genotype 4, 5, or 6 infection using the drug abt-493/abt-530, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of nocturia in adult males with benign prostatic hyperplasia, using the drugs fedovapagon 2 mg and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of itca 650 osmotic mini pump, metformin, and liraglutide in combination with stable diet and exercise regimens, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hepatitis C virus infection, testing the drugs sof/vel/vox and sof/vel, with specific eligibility criteria including prior treatment experience and HCV RNA levels.",
    "This sample is a phase 3 clinical trial for patients with chronic genotype 3 hepatitis C virus infection and cirrhosis, testing the efficacy of the drugs sof/vel/vox and sof/vel in treating the disease. The eligibility criteria include HCV RNA \u2265 10^4 IU/mL, treatment-naive or treatment-experienced with interferon-based regimen, and the use of specified contraception methods.",
    "This sample is a phase 3 clinical trial for the treatment of urinary tract infection, testing the effectiveness of drugs such as canephron\u00ae n and fosfomycin trometamol, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 2/phase 3 trial for fibromyalgia, testing the drug pregabalin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of ABT-493/ABT-530, sofosbuvir, and daclatasvir in treating chronic hepatitis C caused by genotype 3 hepatitis C virus, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for the treatment of palmoplantar pustulosis, a skin condition, using the drugs guselkumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection, chronic hepatitis C, and compensated cirrhosis using the drug ABT-493/ABT-530, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of spi-2012, pegfilgrastim, docetaxel, and cyclophosphamide in combination with adjuvant or neo-adjuvant TC chemotherapy for patients with early-stage breast cancer, who meet specific eligibility criteria, while excluding those with concurrent malignancy, known sensitivity to certain products, or previous exposure to certain drugs.",
    "This sample is a phase 3 clinical trial for diabetes, specifically type 2 diabetes, testing the drugs semaglutide and dulaglutide in combination with metformin, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart and biphasic insulin aspart in combination with fasting during Ramadan. The inclusion criteria include being diagnosed with type 2 diabetes, being on insulin treatment for at least 90 days, and having an HbA1c level between 7.0% and 10.0%. The exclusion criteria include contraindications for fasting and recent severe hypoglycemia or ketoacidosis.",
    "This phase 3 trial aims to evaluate the effectiveness of neutrolin and heparin in preventing catheter-related infections in patients with chronic kidney failure, who undergo chronic hemodialysis and have a HD catheter implanted in a jugular or subclavian vein.",
    "This sample is a phase 3 trial for the treatment of opioid use disorders, testing the effectiveness of drugs such as cam2038 sc injection and sl bpn/nx tabs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of anemia in patients with chronic kidney disease, testing the drugs fg-4592 and epoetin alfa, with specific eligibility criteria including age, kidney disease status, stable doses of epoetin alfa, and specific laboratory values.",
    "This phase 3 trial is testing the efficacy of the drug fg-4592, compared to a placebo, in treating anemia in patients with chronic kidney disease who are not receiving dialysis, and meet specific eligibility criteria.",
    "This phase 3 trial is investigating the effectiveness of elagolix and estradiol/norethindrone acetate in treating uterine fibroids and heavy menstrual bleeding in premenopausal females, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to investigate the effectiveness of liraglutide in treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in patients with a body mass index (BMI) greater than 27.5 kg/m2 and a waist circumference greater than 90 cm (male) or 80 cm (female). The study includes specific inclusion and exclusion criteria, such as the absence of certain medications, pregnancy, cardiovascular or respiratory disease, and renal impairment.",
    "This sample is a phase 3 clinical trial for patients with advanced ovarian cancer, testing the effectiveness of the drug niraparib compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is investigating the effectiveness of a placebo in treating urinary incontinence caused by neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis, with key inclusion criteria including inadequate response to oral medications and routine clean intermittent catheterization.",
    "This phase 3 trial is investigating the effectiveness of a placebo in treating urinary incontinence caused by neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis, with key inclusion criteria including inadequate response to oral medications and routine clean intermittent catheterization.",
    "This sample is a phase 3 clinical trial for patients with human immunodeficiency virus (HIV) and chronic hepatitis C. The trial aims to evaluate the effectiveness of the drugs e/c/f/taf and ledipasvir-sofosbuvir in treating the diseases, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is investigating the effectiveness of atorvastatin, a lipid-lowering drug, in males and females with type 2 diabetes and stable diabetes therapy, who have specific LDL-C levels, to determine its impact on hyperlipidemia and mixed dyslipidemia.",
    "This sample is a phase 3 clinical trial for patients with stage III colon cancer, testing the efficacy of regorafenib compared to a placebo, with specific eligibility criteria including prior surgery, completion of adjuvant chemotherapy, and various medical test results.",
    "This sample is a phase 3 trial for the treatment of acute migraine or probable migraine using the drug bupivacaine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the drug etc-1002 and placebo in patients with hypercholesterolemia and atherosclerotic cardiovascular diseases, who have high cardiovascular risk and are on maximally tolerated lipid-modifying therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of benign prostatic hyperplasia (BPH) using drugs such as hcp1303 capsule and hgp1201, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs crenezumab and placebo, with eligibility criteria including specific weight range, caregiver availability, language fluency, abnormal memory function, and meeting diagnostic criteria for probable AD dementia or prodromal AD.",
    "This sample is a phase 3 trial for bipolar disorder and depression, testing the effectiveness of cariprazine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for bipolar disorder and depression, testing the effectiveness of cariprazine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the efficacy of faster-acting insulin aspart, insulin aspart, and insulin degludec in reducing HbA1c levels.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drug sof/vel. The study includes patients with chronic HCV infection, regardless of genotype, who are treatment-naive or treatment-experienced. The inclusion criteria require patients to have a documented history of HCV infection and a HCV RNA level of at least 10^4 IU/mL. The exclusion criteria include patients with clinically-significant illnesses, gastrointestinal disorders, hepatic decompensation, or non-HCV related chronic liver disease. Pregnant or nursing females and patients with hepatitis B virus or human immunodeficiency virus infections are also excluded.",
    "This sample is a phase 3 trial for individuals with opioid use disorder, testing the effectiveness of the drug CAM2038 in treating the disorder. The eligibility criteria include being 18-65 years old, having a current diagnosis of moderate or severe opioid use disorder, and being a good candidate for BPN treatment. The exclusion criteria include having a current diagnosis of AIDS, chronic pain requiring opioids, or a current diagnosis of substance use disorder other than opioids.",
    "This phase 3 trial aims to investigate the effectiveness of anakinra and sodium chloride 0.9% in treating hypogonadism, metabolic syndrome x, and obesity in men aged 18 to 75 years with a BMI >30 kg/m2 and at least one manifestation of the metabolic syndrome, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis using the drug risankizumab, with eligibility criteria including a diagnosis of chronic plaque psoriasis, involvement of at least 10% body surface area, and a Psoriasis Area and Severity Index (PASI) score of at least 12.",
    "This sample is a phase 3 clinical trial for the treatment of open-angle glaucoma and ocular hypertension, testing the effectiveness of three ophthalmic solutions (pg324, netarsudil, and latanoprost) in reducing intraocular pressure, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the drugs placebo and upadacitinib, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for the treatment of metastatic hormone sensitive prostate cancer, testing the efficacy of enzalutamide compared to placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of community acquired bacterial pneumonia (CABP) using the drugs delafloxacin, moxifloxacin, and linezolid, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial aims to investigate the efficacy of ferric maltol and ferric carboxy maltose in treating iron deficiency anemia in patients with inflammatory bowel disease, including Crohn's disease, who meet specific eligibility criteria.",
    "This phase 3 trial aims to evaluate the efficacy of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus and inadequate glycaemic control, who are on stable metformin therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of zx008 (fenfluramine hydrochloride) and a matching placebo in reducing convulsive seizures in children with Dravet syndrome, a type of seizure disorder that is not controlled by current antiepileptic drugs.",
    "This phase 3 trial is testing the efficacy of lyophilized albiglutide dcc pen injector and albiglutide liquid auto-injector, both GLP-1 analogues, in patients with type 2 diabetes mellitus who have inadequate glycemic control on their current regimen of diet and exercise or metformin.",
    "This sample is a phase 3 clinical trial for patients with advanced or metastatic renal cell cancer, testing the effectiveness of a combination of avelumab, axitinib, and sunitinib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with chronic plaque psoriasis, testing the efficacy of risankizumab and ustekinumab compared to placebo, with eligibility criteria including a diagnosis of psoriasis for at least 6 months, moderate to severe psoriasis symptoms, and being a candidate for treatment with ustekinumab.",
    "This sample is a phase 3 trial for patients with chronic plaque psoriasis, testing the effectiveness of risankizumab and ustekinumab as treatments, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for constipation predominant irritable bowel syndrome, testing the effectiveness of the drug tenapanor compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with osteoarthritis, specifically osteoarthritis of the knee. The study aims to evaluate the effectiveness of diacerein, celecoxib, and placebo in reducing knee pain and improving function. The eligibility criteria include age, specific OA criteria, joint space width, pain levels, and exclusion criteria related to individual characteristics, comorbidities, and medication use.",
    "This sample is a phase 3 trial for the treatment of keratoconjunctivitis sicca (dry eye syndrome) using cyclosporine and a vehicle of otx-101, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial called ReBIC-1, which aims to enroll heart failure outpatients who meet specific eligibility criteria, including age, functional class, ejection fraction, previous hospitalization, and stable furosemide treatment. The study will test the efficacy of placebo and furosemide in these patients.",
    "This phase 3 trial is investigating the effectiveness of elagolix and estradiol/norethindrone acetate in treating uterine fibroids and heavy menstrual bleeding in premenopausal females, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis C who have received a liver or kidney transplant, testing the effectiveness of glecaprevir/pibrentasvir in non-cirrhotic patients on stable immunosuppression regimens.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of semaglutide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs alks 3831 and olanzapine, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with chronic plaque psoriasis, testing the efficacy of risankizumab compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for participants with iron deficiency anemia, testing the effectiveness of ferumoxytol and fcm drugs as IV iron treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for chronic idiopathic constipation, testing the effectiveness of lubiprostone and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of ixekizumab, adalimumab, and placebo in treating radiographic axial spondyloarthritis in participants who have had an inadequate response to non-steroidal anti-inflammatory drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of ixekizumab and placebo in treating radiographic axial spondyloarthritis (rad-xSpA) patients who have had an inadequate response to TNF inhibitors and NSAIDs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of gastroenteritis using the drugs domperidone and placebo, with inclusion criteria including symptoms of vomiting, diarrhea, and dehydration, and exclusion criteria including severe dehydration, chronic severe diarrhea, and upper respiratory symptoms.",
    "This sample is a phase 3 clinical trial for acute pain, testing the drugs diclofenac, capsaicin, and placebo, with specific inclusion and exclusion criteria for patients with back or neck pain.",
    "This sample is a phase 2/phase 3 trial for dry eye, testing the effectiveness of pregabalin and placebo in patients undergoing LASIK, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for hepatocellular carcinoma (HCC) patients who have failed or are intolerant to sorafenib treatment, and it aims to evaluate the efficacy and safety of pembrolizumab (Keytruda) compared to placebo.",
    "This sample is a phase 3 clinical trial for cervical cancer patients with specific eligibility criteria, including biopsy-proven carcinoma, certain clinical stages, normal organ function, and signed informed consent. The trial involves concurrent or adjuvant chemotherapy with cisplatin, docetaxel, or both.",
    "This sample is a phase 3 trial for rheumatoid arthritis patients who have been treated with bDMARD therapy and are still exhibiting active RA or had to discontinue due to intolerability or toxicity. The study will test the efficacy of upadacitinib compared to a placebo in reducing swollen and tender joints, with inclusion criteria including a diagnosis of RA for at least 3 months, a certain number of swollen and tender joints, and a specific level of hsCRP. Exclusion criteria include prior exposure to any Janus kinase (JAK) inhibitor and a history of arthritis onset before age 17 or current diagnosis of inflammatory joint disease other than RA.",
    "This phase 3 trial is investigating the efficacy of upadacitinib, methotrexate, and placebo in treating rheumatoid arthritis patients who meet specific inclusion criteria, such as having a duration of symptoms consistent with RA for at least 6 weeks and fulfilling the 2010 ACR/EULAR classification criteria for RA.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the effectiveness of methotrexate, upadacitinib, and placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with HIV, testing the effectiveness of ibalizumab and an optimized background regimen in treating patients with documented HIV-1 infection and resistance to antiretroviral medications.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C virus using the drugs abt-493/abt-530 and obv/ptv/r, with eligibility criteria including postmenopausal females, HCV single genotype infection, and absence of hepatocellular carcinoma.",
    "This sample is a phase 3 clinical trial for the treatment of osteoarthritis in the hip and knee using the drugs tanezumab and placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis, testing the drugs gsp 301 ns, gsp 301 placebo ns ph 3.7, and gsp 301 placebo ns ph 7.0, with inclusion criteria including age \u226512 years, a documented clinical history of PAR, and a positive skin prick test to at least 1 allergen known to induce PAR.",
    "This phase 3 trial aims to evaluate the efficacy of bupivacaine liposome injectable suspension compared to placebo in providing pain relief after primary unilateral total knee arthroplasty (TKA), with inclusion and exclusion criteria specified for eligible participants.",
    "This sample is a phase 3 trial for pain management in patients undergoing shoulder surgery, testing the efficacy of bupivacaine liposome injectable suspension compared to a placebo, with eligibility criteria including age, specific surgical requirements, and exclusion criteria such as pregnancy, hypersensitivity to certain medications, and history of impaired kidney or liver function.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using paliperidone palmitate 3 month formulation (pp3m), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of irritable bowel syndrome, using ileocolonic release peppermint oil and placebo as drugs, with eligibility criteria including age between 18 and 75 years, diagnosis of IBS according to Rome IV criteria, and exclusion criteria such as previous use of peppermint oil capsules in the last 3 months and known allergic reaction to peppermint.",
    "This phase 3 trial aims to evaluate the efficacy of Chronocort\u00ae and standard glucocorticoid therapy in treating congenital adrenal hyperplasia (CAH) patients who have been on stable glucocorticoid therapy for at least 6 months, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia who have failed to respond to previous antipsychotic treatments. The study will test the efficacy of risperidone, olanzapine, lu af35700, and lu af35700 as potential treatment options.",
    "This sample is a phase 3 trial for patients with nonproliferative diabetic retinopathy, testing the efficacy of intravitreal aflibercept injection and sham treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal cancer, testing the effectiveness of carboplatin, paclitaxel, avelumab, and avelumab in combination with platinum-based chemotherapy as a first-line treatment option.",
    "This sample is a phase 3 clinical trial for the treatment of genital psoriasis and psoriasis using the drugs ixekizumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for rheumatoid arthritis, testing the drugs placebo and upadacitinib, with eligibility criteria including a diagnosis of RA for at least 3 months and fulfillment of the ACR/EULAR classification criteria.",
    "This sample is a phase 3 clinical trial for axial psoriatic arthritis, testing the effectiveness of secukinumab and placebo in patients who have had an inadequate response to non-steroidal anti-inflammatory drugs.",
    "This sample is a phase 3 clinical trial for chronic pain, testing the effectiveness of gabapentin and tramadol in children aged 3 months to less than 18 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drug sof/vel, with specific inclusion and exclusion criteria.",
    "In this phase 3 trial, the drug dexamethasone and placebo will be tested on patients with asthma, who have a history of at least two prior episodes of wheezing treated with inhaled beta agonists, while excluding pregnant patients and those with severe chronic cardiac, respiratory, neurological or neuromuscular disease, complete resolution of symptoms after one treatment of beta agonists, and severe asthma symptoms defined by a Pulmonary Index Score of 12 or greater.",
    "This sample is a phase 3 trial for patients with pulmonary arterial hypertension (PAH) who have received at least one PAH specific therapy for at least 3 months, and it will test the effectiveness of inhaled nitric oxide and placebo in improving their condition.",
    "This sample is a phase 3 trial for constipation predominant irritable bowel syndrome, testing the drug tenapanor, with specific inclusion and exclusion criteria for subjects.",
    "This phase 3 trial is testing the efficacy of squalamine lactate ophthalmic solution, 0.2%, placebo ophthalmic solution, and ranibizumab in treating age-related macular degeneration, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for patients with multiple sclerosis, testing the drugs bcd-033 (interferon beta 1a), rebif (interferon beta 1a), and placebo, with inclusion and exclusion criteria specified.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using a combination of drugs (ff/umec/vi, ff/vi, umec, placebo, albuterol/salbutamol), with specific eligibility criteria including age, gender, COPD diagnosis, smoking history, severity of symptoms, existing maintenance treatment, history of exacerbations, and exclusion criteria such as pregnancy, asthma, alpha 1-antitrypsin deficiency, and other respiratory disorders.",
    "This sample is a phase 3 clinical trial for constipation, testing the effectiveness of the drug lubiprostone compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for attention-deficit hyperactivity disorder (ADHD) using the drug dasotraline 4mg, and the eligibility criteria include being 6-12 years old, meeting DSM-5 criteria for ADHD, and currently being on a treatment regimen of a methylphenidate formulation.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) who have an ALK rearrangement, and it is testing the effectiveness of the drugs brigatinib and crizotinib in treating the disease. The eligibility criteria include having stage IIIB or stage IV NSCLC, sufficient tumor tissue for analysis, and meeting certain organ function and performance status requirements. There are also exclusion criteria, such as previous use of investigational antineoplastic agents or tyrosine kinase inhibitors, recent chemotherapy or radiation therapy, and certain medical conditions that may compromise participant safety.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection and human immunodeficiency virus infection using the drug abt-493 coformulated with abt-530, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drugs ldv/sof, sof, and rbv. The eligibility criteria include being chronically infected with genotype 2 HCV, being treatment naive or experienced, and having Child-Pugh-A compensated cirrhosis.",
    "This sample is a phase 3 trial for patients with uncontrolled essential hypertension, testing the effectiveness of telmisartan/amlodipine+hydrochlorothiazide and telmisartan/amlodipine compared to a placebo for hydrochlorothiazide, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is investigating the efficacy of sitagliptin, metformin, and insulin glargine in treating type 2 diabetes mellitus patients who meet specific inclusion criteria, while excluding those with certain medical histories or who have been treated with other anti-hyperglycemic agents within the past 12 weeks.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, mixed dyslipidemia, and type 2 diabetes, testing the effectiveness of evolocumab compared to a placebo in reducing LDL-C and Non-HDL-C levels. The inclusion criteria include being \u2265 18 years old, having type 2 diabetes, and being on a maximally tolerated dose of statin. The exclusion criteria include moderate to severe renal dysfunction, uncontrolled hypertension, and recent cardiovascular events.",
    "This sample is a phase 3 clinical trial for hypercholesterolemia, testing the effectiveness of ezetimibe and rosuvastatin drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for cystic fibrosis patients with specific CFTR gating mutations, testing the efficacy of ivacaftor and placebo drugs, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with Clostridium difficile infection, testing the effectiveness of fidaxomicin and vancomycin as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of methotrexate and placebo drugs, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2/phase 3 trial for the treatment of acute migraine using the drugs zp-zolmitriptan and placebo, with eligibility criteria including a history of episodic migraine, specific headache characteristics, and no significant ECG findings.",
    "This sample is a phase 3 clinical trial for patients with hypercholesterolemia, testing the effectiveness of rosuvastatin and ezetimibe in reducing cholesterol levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial testing the effectiveness of cholecalciferol (vitamin D) versus placebo in treating vitamin D deficiency, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of sleep initiation and maintenance disorders in patients with Alzheimer's disease using the drug suvorexant compared to a placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for patients with melanoma, testing the effectiveness of pembrolizumab + epacadostat and pembrolizumab + placebo as treatments. The eligibility criteria include having confirmed melanoma, unresectable Stage III or Stage IV melanoma, and a minimum of 1 measurable lesion.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glargine/lixisenatide, insulin glargine u100, and metformin in combination with stable basal insulin and oral anti-diabetic drugs. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2/phase 3 clinical trial for type 2 diabetes, testing the efficacy of the drug \"yh1 group\" compared to a placebo group, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic or recurrent non-squamous non-small cell lung cancer, testing the effectiveness of bevacizumab, sb8, carboplatin, and paclitaxel as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with relapsed/refractory multiple myeloma, testing the efficacy of placebo, bortezomib, dexamethasone, and venetoclax as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of atopic dermatitis using the drug dupilumab, with eligibility criteria including specific disease severity scores, prior treatment history, and exclusion criteria such as prior participation in a dupilumab study and recent use of certain medications.",
    "This phase 3 trial is testing the effectiveness of ixekizumab and placebo in treating nonradiographic axial spondyloarthritis, a type of back pain, in patients who have not responded to non-steroidal anti-inflammatory drugs (NSAIDs) and have objective signs of inflammation.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart and biphasic insulin aspart in combination with metformin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of methotrexate and folic acid as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is testing the effectiveness of atezolizumab, carboplatin, etoposide, and placebo in treating small cell lung carcinoma patients who have not received prior systemic treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with recurrent squamous cell lung carcinoma or stage IV squamous cell lung carcinoma, testing the drug docetaxel, and includes eligibility criteria such as no prior exposure to immunotherapy, no history of primary immunodeficiency, and no active or prior autoimmune or inflammatory disease within 3 years.",
    "This sample is a phase 3 clinical trial for the drug lubiprostone, which is being tested for the treatment of functional constipation in children aged 6 to 18 years. The inclusion criteria include a medically-confirmed diagnosis of functional constipation and the exclusion criteria include any gastrointestinal condition affecting GI motility or defecation.",
    "This sample is a phase 3 clinical trial for subjects diagnosed with type 2 diabetes mellitus, testing the effectiveness of insulin degludec/liraglutide and insulin glargine in combination with SGLT2i in monotherapy or in combination with metformin \u00b1 DPP4i \u00b1 pioglitazone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for hepatocellular carcinoma (HCC) patients, testing the effectiveness of sorafenib and folfox protocol drugs, with specific eligibility criteria including tumor measurement, performance status, laboratory parameters, and exclusion criteria such as hepatic decompensation and known allergies to investigational agents.",
    "This phase 3 trial is testing the drugs docetaxel and erlotinib in patients with non-small cell lung carcinoma who have evidence of disease progression after one platinum-containing regimen, and meet specific eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of paclitaxel, nab-paclitaxel, carboplatin, and a saline placebo for pembrolizumab in treating stage IV squamous non-small cell lung cancer, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the effectiveness of dolutegravir, tenofovir disoproxil fumarate/lamivudine, and efavirenz as antiretroviral therapy. The eligibility criteria include being HIV-1 infected, age \u2265 18 years, and having not received more than 7 days of prior antiretroviral therapy.",
    "This sample is a phase 2/phase 3 trial for attention deficit disorder with hyperactivity, testing the drugs nfc-1 and placebo, with eligibility criteria including specific diagnostic criteria, intelligence quotient requirements, and the presence of disruptive mutations in genes within the glutamate receptor metabotropic network.",
    "This sample is a phase 3 trial for patients with migraine disorders, testing the drug prochlorperazine, and includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs lanabecestat and placebo, with inclusion criteria including meeting NIA-AA criteria for probable AD dementia and having evidence of amyloid pathology, and exclusion criteria including significant neurological diseases other than AD and history of malignant cancer within the last 5 years.",
    "This sample is a phase 3 clinical trial for the treatment of insomnia, focusing on elderly males and postmenopausal females, with specific inclusion and exclusion criteria, and the use of drugs such as lemborexant and zolpidem tartrate.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C and HIV using the drugs grazoprevir/elbasvir and ribavirin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) who are eligible for therapy with either decitabine or azacitidine. The study aims to determine the efficacy of the drugs 33a, placebo, azacitidine, and decitabine in treating AML patients with intermediate or adverse cytogenetic risk. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2/phase 3 trial for patients with recurrent squamous cell lung carcinoma, testing the effectiveness of the drugs docetaxel and palbociclib in combination, with specific eligibility criteria and requirements for patients to participate in the study.",
    "This sample is a phase 3 clinical trial for the treatment of interstitial cystitis using the drugs mirabegron and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the efficacy of various GLP-1 receptor agonists in combination with metformin and other oral anti-diabetic drugs. The trial will evaluate the safety and effectiveness of drugs such as insulin glargine/lixisenatide fixed ratio combination, liraglutide, exenatide, albiglutide, and dulaglutide in managing diabetes.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer, testing the effectiveness of atezolizumab, cobimetinib, and regorafenib as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with diabetic foot ulcers, testing the effectiveness of chitosan, isosorbide dinitrate, and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of sitagliptin, metformin ir, and placebo as treatment options, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for relapsing multiple sclerosis, testing the effectiveness of ofatumumab subcutaneous injection and teriflunomide capsule compared to their respective placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for relapsing multiple sclerosis, testing the effectiveness of ofatumumab subcutaneous injection and teriflunomide capsule compared to their respective placebos, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of abp 798, rituximab (us), and rituximab (eu) in treating rheumatoid arthritis patients who meet specific inclusion criteria, such as having active RA and being on a stable dose of methotrexate for a certain period of time.",
    "This sample is a phase 3 clinical trial for post-surgical ocular inflammation and pain, testing the efficacy of kpi-121 1% ophthalmic suspension and its vehicle in routine cataract surgery patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes mellitus, testing the efficacy of ipragliflozin l-proline and metformin compared to a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of various drugs including aclidinium bromide, formoterol fumarate, and tiotropium, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of cystic fibrosis using the drug lum/iva, targeting subjects who weigh \u22658 kg, have a confirmed diagnosis of CF, and are homozygous for the F508del-CFTR mutation.",
    "This sample is a phase 3 clinical trial for patients with primary open angle glaucoma or ocular hypertension, testing the effectiveness of the drugs Pro-067 and GAAP Ofteno\u00ae (latanoprost 0.005%) in controlling the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for idiopathic pulmonary fibrosis (IPF) patients, testing the efficacy of nintedanib, placebo, and sildenafil as potential treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with prostate adenocarcinoma undergoing radiotherapy, where the focus is on the occurrence of overactive bladder (OAB) symptoms and the effectiveness of succinate of solifenacin compared to a placebo in treating OAB symptoms during and after radiotherapy.",
    "This sample is a phase 3 trial studying the effectiveness of aerosolized plus intravenous colistin and intravenous colistin in treating neonates with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii. The inclusion criteria include neonates admitted to the neonatal intensive care unit at Hat Yai Hospital during the study period, while the exclusion criteria include neonates with major anomalies or chromosomal abnormalities, those who received colistin prior to the study, and those with significant renal dysfunction.",
    "This sample is a phase 3 trial for children with seasonal allergic rhinitis, testing the effectiveness of bifidobacteria and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for chronic constipation, testing the drugs linaclotide and placebo, with eligibility criteria including SBM frequency, related symptoms, absence of loose stools, and exclusion criteria such as IBS, surgical resection, inflammatory bowel disease, and concurrent diseases.",
    "This sample is a phase 3 clinical trial for the treatment of dry eye syndromes and keratoconjunctivitis sicca using kpi-121 0.25% ophthalmic suspension and its vehicle, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of benralizumab and seasonal influenza virus vaccine in treating asthma in patients aged 12 to 21 years, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy and safety of oliceridine, placebo, and morphine in patients who have undergone bunionectomy surgery and are experiencing moderate to severe acute pain.",
    "This sample is a phase 3 trial testing the effectiveness of a contraceptive drug (15 mg e4/3 mg drsp) in heterosexually active females at risk for pregnancy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of a contraceptive drug (15 mg e4/3 mg drsp) in heterosexually active females at risk for pregnancy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of dry eye syndromes and keratoconjunctivitis sicca using kpi-121 0.25% ophthalmic suspension and its vehicle, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for acute pain, testing the drugs oliceridine, placebo, and morphine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for primary open angle glaucoma or ocular hypertension, testing the drugs de-117 ophthalmic solution and latanoprost ophthalmic solution 0.005%, with inclusion criteria including patients with the mentioned diseases and exclusion criteria including patients at risk of progression of visual field loss and severe visual field defect.",
    "This phase 3 trial is investigating the use of faster-acting insulin aspart and insulin aspart in patients with type 1 diabetes mellitus who are using a Medtronic pump in a basal-bolus regimen, and have a HbA1c level between 7.0-9.0%.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of semaglutide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV-infected adults, testing the efficacy of a dual regimen of dolutegravir, lamivudine, and tenofovir disoproxil fumarate/emtricitabine in reducing plasma HIV 1 RNA levels, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for HIV-infected adults, testing the efficacy of a dual regimen of dolutegravir, lamivudine, and tenofovir disoproxil fumarate/emtricitabine in reducing plasma HIV 1 RNA levels, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with peripheral arterial occlusive disease, testing the effectiveness of sildenafil 100mg single oral dose and placebo in improving walking ability, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for individuals with type 2 diabetes mellitus and inadequate glycemic control, testing the effectiveness of the drug bexagliflozin compared to a placebo, with specific inclusion and exclusion criteria related to diabetes diagnosis, renal impairment, and pregnancy/nursing status.",
    "This sample is a phase 3 trial for pre-exposure prophylaxis of HIV-1 infection, testing the drugs f/taf, f/tdf, f/taf placebo, and f/tdf placebo, with key inclusion criteria including being at high risk of sexual acquisition of HIV and having adequate renal, liver, and hematologic function, and key exclusion criteria including unexplained or unmanageable proteinuria or glycosuria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of semaglutide and sitagliptin in combination with other anti-diabetic drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the drugs lt-02 and lt-02 placebo, with key inclusion criteria including an established diagnosis of UC, active disease confirmed by endoscopy, and mesalamine refractory, and exclusion criteria including Crohn's disease, toxic megacolon, and prior colon resection.",
    "This sample is a phase 3 clinical trial for patients with renal cell carcinoma, testing the effectiveness of the drugs axitinib and sunitinib, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of aqx-1125 and placebo in treating interstitial cystitis, bladder pain syndrome, and painful bladder syndrome, with specific eligibility criteria for participants, including age range, duration of symptoms, and recent cystoscopy.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of semaglutide and empagliflozin in combination with metformin, with specific eligibility and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of semaglutide and liraglutide compared to a placebo, with eligibility criteria including a diagnosis of diabetes for at least 90 days, specific HbA1c levels, and stable use of metformin or a SGLT-2 inhibitor.",
    "This sample is a phase 3 clinical trial for previously untreated chronic lymphocytic leukemia (CLL) patients, testing the efficacy of ibrutinib compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of short bowel syndrome using the drugs ntra-9620 and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for patients with atrial fibrillation who have undergone successful PCI with stenting, and it aims to assess the efficacy of edoxaban, clopidogrel, prasugrel, ticagrelor, and vitamin K antagonist in preventing major bleeding complications.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis (SAR) using drugs such as gsp 301 ns, gom-ns, gmm-2 ns, and gsp 301 placebo ns, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for HIV and STI prevention using the drug TDF/FTC, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients undergoing TA chemotherapy, testing the efficacy of drug f-627 compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of migraine, with or without aura, using the drugs ubrogepant, placebo-matching ubrogepant, and usual care, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of dexlansoprazole and placebo in treating heartburn and gastroesophageal reflux disease (GERD) in participants with a history of symptomatic GERD, with specific inclusion and exclusion criteria provided.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis (RA) patients who have had an inadequate response or intolerance to biologic disease modifying antirheumatic drugs (bDMARDs). The study aims to evaluate the efficacy of filgotinib, a janus kinase (JAK) inhibitor, in combination with csDMARDs compared to placebo in reducing the signs and symptoms of RA.",
    "This sample is a phase 3 clinical trial for the treatment of hyperkalemia using sodium zirconium cyclosilicate (ZS) and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the efficacy of low dose and high dose asenapine maleate transdermal patches compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial testing the drugs omadacycline and linezolid for the treatment of bacterial infections and skin structures and soft tissue infections, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with congestive heart failure and left-sided heart failure, testing the drug albuterol. The inclusion criteria include heart failure with preserved ejection fraction and elevated left ventricular filling pressures, while the exclusion criteria include prior albuterol therapy, current long-acting inhaled beta agonist use, and various other conditions.",
    "This sample is a phase 3 trial for the treatment of plaque psoriasis, testing the effectiveness of tazarotene cream 0.05% and tazorac\u00ae cream 0.05% compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis (RA) patients who have limited or no prior treatment with methotrexate (MTX). The study will test the efficacy of filgotinib, a janus kinase (JAK) inhibitor, in combination with MTX compared to a placebo, in reducing the number of swollen and tender joints in RA patients.",
    "This sample is a phase 3 clinical trial for smoking cessation in patients with chronic obstructive pulmonary disease (COPD) in New Zealand, using varenicline as the drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with stable coronary artery disease and diabetes, testing the effectiveness of ticagrelor and clopidogrel in preventing adverse cardiovascular events.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the efficacy of filgotinib, adalimumab, and methotrexate in patients who meet specific inclusion criteria, while excluding those who have previously been treated with any janus kinase (JAK) inhibitor.",
    "This sample is a phase 3 trial for subjects with essential hypertension, testing the drugs cs-3150 and eplerenone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with mild asthma, testing the efficacy of qmf149 150/80 \u03bcg and mf 200 \u03bcg drugs in improving symptoms and lung function, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with ankylosing spondyloarthritis, testing the effectiveness of secukinumab and placebo in treating the disease, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to evaluate the effectiveness of mycophenolate mofetil compared to placebo in treating systemic sclerosis patients with interstitial lung disease, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with HER2-positive metastatic breast cancer, testing the efficacy of docetaxel, pertuzumab, and trastuzumab in combination with placebo, with specific eligibility and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of ipragliflozin, a drug used to treat type 2 diabetes, in patients with type 1 diabetes mellitus who are already receiving insulin therapy. The study will assess the impact of ipragliflozin on HbA1c levels, fasting blood C-peptide levels, and body mass index (BMI) within specific ranges, while excluding patients with type 2 diabetes, previous participation in similar studies, and various other medical conditions.",
    "This sample is a phase 3 clinical trial for the treatment of chronic rhinosinusitis phenotype with nasal polyps (CRSwNP) using the drugs dupilumab sar231893 (regn668), placebo, and mometasone furoate nasal spray, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial aims to investigate the effectiveness of intranasal oxytocin spray in treating alcoholism and substance-related disorders, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 3 clinical trial for psoriasis, testing the drugs guselkumab and placebo, with inclusion criteria including negative pregnancy test, specific age requirements, and certain disease severity levels, and exclusion criteria including unstable cardiovascular disease and recent use of anti-TNF-alpha biologic therapy.",
    "This sample is a phase 3 trial for ventilator-associated pneumonia (VAP) caused by Gram-negative MDR bacteria resistant to all \u03b2-lactams and fluoroquinolones. The study will test the efficacy of intravenous colimycin and nebulized colimycin as treatments for VAP.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of semaglutide compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Japanese subjects with type 2 diabetes mellitus (T2DM) who have been on stable daily insulin doses for at least 60 days prior to screening. The trial aims to evaluate the efficacy and safety of insulin degludec/liraglutide and insulin degludec in combination with metformin and other oral anti-diabetic drugs (OADs) in controlling blood glucose levels. The inclusion criteria include HbA1c levels between 7.5-11.0%, BMI equal to or above 23 kg/m^2, and a diagnosis of T2DM for at least 6 months. The exclusion criteria include recent use of investigational medicinal products, certain anti-diabetic drugs, GLP-1 receptor agonists, and DPP-4 inhibitors, as well as impaired liver function, renal impairment, and history of pancreatitis or medullary thyroid carcinoma.",
    "This sample is a phase 3 clinical trial for the treatment of chronic rhinosinusitis phenotype with nasal polyps (CRSwNP) using the drugs dupilumab sar231893 (regn668), placebo, and mometasone furoate 50 micrograms, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the use of dabigatran etexilate and warfarin as oral anticoagulants for the treatment of thromboembolism, specifically cerebral venous or dural sinus thrombosis, with certain inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with open angle glaucoma or ocular hypertension, testing the drug travoprost, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug azeliragon 5mg, and includes eligibility criteria such as successful completion of a previous study, informed consent, reliable caregiver/informant, and ability to ingest oral medications.",
    "This sample is a phase 3 clinical trial for patients with hypertension, testing the drugs hcp1401 and hcp0605. The inclusion criteria include specific blood pressure ranges and whether the patient takes antihypertensive drugs, while the exclusion criteria include factors such as the number of antihypertensive drugs taken and blood pressure differences.",
    "This sample is a phase 3 clinical trial for the treatment of metastatic pancreatic cancer using the drug folfox, with specific eligibility criteria including measurable disease, prior chemotherapy completion, and no history of certain medical conditions.",
    "This sample is a phase 3 clinical trial for asthma patients, testing various drugs including ff/umec/vi and fluticasone/salmeterol, with eligibility criteria including age, diagnosis of asthma, inadequately controlled asthma, and specific spirometry measurements.",
    "This sample is a phase 3 trial for the treatment of Dravet syndrome, a rare form of epilepsy, using the drug zx008 at different doses, along with a placebo, and the eligibility criteria include age, previous medication history, and exclusion criteria such as hypersensitivity to fenfluramine or any cardiovascular or cerebrovascular disease.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of sotagliflozin (sar439954) in combination with metformin compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic high grade soft tissue sarcoma, testing the efficacy of trabectedin as a second-line treatment option after doxorubicin chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of rapastinel and placebo in treating major depressive disorder (MDD) in patients who have not responded well to other antidepressant treatments.",
    "This sample is a phase 3 trial testing the use of liposomal bupivicaine, a local anesthetic, for patients undergoing ambulatory hand surgery for various conditions such as CMC arthritis and hand fractures.",
    "This sample is a phase 3 trial for the treatment of low back pain using the drug sirdalud\u00ae 2 mg tablets, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for HIV infections, testing the efficacy of drugs such as cabotegravir and rilpivirine, with eligibility criteria including being HIV-1 infected, ART-naive, and meeting certain reproductive potential conditions for female participants.",
    "This sample is a phase 3 trial testing the drugs iron isomaltoside/ferric derisomaltose and iron sucrose for the treatment of iron deficiency anemia in patients with chronic kidney disease, with specific eligibility criteria including low hemoglobin levels, renal impairment, and abnormal urine composition.",
    "This sample is a phase 3 trial for the treatment of iron deficiency anemia, testing the effectiveness of iron isomaltoside/ferric derisomaltose and iron sucrose in patients with specific eligibility criteria, including low hemoglobin levels and transferrin saturation.",
    "This sample is a phase 3 trial for postpartum depression, testing the drugs placebo, sage-547 60 \u03bcg/kg/h, and sage-547 90 \u03bcg/kg/h, with key inclusion criteria including participants who have ceased lactating, have a major depressive episode, and have a HAM-D total score of \u226526, while key exclusion criteria include active psychosis and a history of bipolar disorders, schizophrenia, and/or schizoaffective disorder.",
    "This sample is a phase 3 trial for postpartum depression, testing the drugs placebo and sage-547 90 \u03bcg/kg/h, with key inclusion criteria including having a major depressive episode in the third trimester or within 4 weeks after delivery, and a HAM-D total score of \u226520 and \u226425.",
    "This sample is a phase 3 trial for patients with atrial fibrillation, testing the effectiveness of edoxaban and a vka-based regimen in reducing the risk of stroke and systemic embolism, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is testing the effectiveness of rapastinel and placebo in treating major depressive disorder (MDD) in patients who have not responded well to other antidepressant treatments.",
    "This phase 3 trial is testing the effectiveness of rapastinel and placebo in treating major depressive disorder (MDD) in patients who have not responded well to other antidepressant treatments.",
    "This sample is a phase 3 clinical trial for the treatment of episodic cluster headache using the drugs fremanezumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic lower back pain and chronic pain. The trial aims to evaluate the effectiveness of buprenorphine in treating moderate to severe chronic lower back pain.",
    "This sample is a phase 3 clinical trial for the treatment of influenza, testing the effectiveness of baloxavir marboxil and oseltamivir compared to their respective placebos, with eligibility criteria including confirmed diagnosis of influenza, specific symptoms, and high-risk factors for complications.",
    "This sample is a phase 3 clinical trial for the treatment of HIV infections using cabotegravir and rilpivirine, along with other antiretroviral drugs, in patients who have been on a stable regimen for at least 6 months. The eligibility criteria include age, viral load, previous treatment history, and contraception requirements for female participants. The exclusion criteria include certain medical conditions, drug resistance, and pregnancy.",
    "This sample is a phase 3 clinical trial for the treatment of insomnia disorder using the drugs lemborexant and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with early-stage breast cancer, testing the efficacy of the drugs spi-2012, pegfilgrastim, docetaxel, and cyclophosphamide in combination with adjuvant or neo-adjuvant TC chemotherapy. The eligibility criteria include specific disease diagnosis, certain blood counts, kidney function, liver function, and exclusion of concurrent malignancy or previous exposure to certain drugs.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the drugs tacrolimus and vedolizumab, with eligibility criteria including confirmed diagnosis of UC, disease extent beyond 15 cm, and moderate to severe UC.",
    "This sample is a phase 3 clinical trial for the treatment of influenza, testing the efficacy of baloxavir marboxil and oseltamivir compared to their respective placebos, with eligibility criteria including confirmed diagnosis of influenza, specific symptoms, and age range.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs elenbecestat and placebo. The study includes participants with mild cognitive impairment or mild AD dementia, confirmed by cognitive tests and positive biomarkers for brain amyloid pathology. The study has various exclusion criteria, including pregnancy, history of seizures or stroke, psychiatric diagnosis or symptoms, and contraindications to MRI scanning.",
    "This sample is a phase 3 clinical trial for glucose transporter type 1 deficiency syndrome (Glut1 DS) patients, testing the efficacy of the drug \"ux007\" compared to a placebo in reducing paroxysmal movement disorder events, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to evaluate the efficacy of liraglutide 3.0 mg, a drug used for type 2 diabetes, compared to a placebo in patients with obesity and metabolism and nutrition disorders, who are also diagnosed with type 2 diabetes mellitus and are currently on stable treatment with basal insulin.",
    "This sample is a phase 3 trial for the treatment of obesity, using the drug liraglutide, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of liraglutide compared to a placebo, with specific inclusion and exclusion criteria, such as HbA1c levels and previous medication usage.",
    "This sample is a phase 3 clinical trial for chronic cluster headache, testing the effectiveness of fremanezumab and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial investigating the efficacy of docetaxel and an FGFR inhibitor called AZD4547 in patients with squamous cell lung carcinoma, who have specific genetic mutations or amplifications, and have progressed on docetaxel treatment. The eligibility criteria include various medical and laboratory requirements, as well as restrictions on concomitant medications and prior exposure to FGFR inhibitors.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of pimavanserin and placebo as adjunctive treatment options for those who have had a partial but inadequate response to antipsychotic treatment. The inclusion criteria include a clinical diagnosis of schizophrenia, a minimum duration of 1 year, and a history of response to antipsychotic treatment other than clozapine. Exclusion criteria include having a psychiatric disorder other than schizophrenia, a history of resistance to antipsychotic treatment, and current evidence of certain medical disorders.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of acalabrutinib, rituximab, idelalisib, and bendamustine in treating chronic lymphocytic leukemia patients who have received prior systemic therapies, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for the treatment of chronic HCV infection using the drug elbasvir/grazoprevir fixed dose combination, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with HER2 positive metastatic breast cancer, testing the efficacy of pyrotinib, placebo, and capecitabine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for dry eye syndrome, testing the effectiveness of the drug rgn-259 compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for postpartum depression, testing the drugs sage-217 and placebo, with key inclusion criteria including having a Major Depressive Episode in the third trimester or within 4 weeks after delivery, and being \u2264 six months postpartum.",
    "This sample is a phase 3 trial for hypertension, testing the effectiveness of a combination of amlodipine besylate and celecoxib in treating hypertension in adults aged 40 to 75 years who are already on pharmacological therapy for hypertension.",
    "This sample is a phase 3 trial for chronic hepatitis B, testing the efficacy of TAF and TDF drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with macular edema and retinal vein occlusion, testing the effectiveness of suprachoroidal cls-ta and ivt aflibercept in reducing central subfield thickness and improving visual acuity.",
    "This sample is a phase 3 clinical trial for the drug KHK4827 in patients with axial spondyloarthritis, who have not responded adequately to non-steroidal anti-inflammatory drugs (NSAIDs). The study aims to evaluate the efficacy and safety of KHK4827 compared to placebo in reducing back pain.",
    "This sample is a phase 3 clinical trial for metastatic castration-resistant prostate cancer, testing the drugs olaparib, enzalutamide, and abiraterone acetate, with eligibility criteria including confirmed diagnosis, evidence of mCRPC, progression on prior hormonal agents, and a qualifying HRR mutation.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, atherosclerotic cardiovascular disease, and statin adverse reactions, testing the drug bempedoic acid as a lipid-modifying therapy for primary or secondary prevention of cardiovascular disease in statin-intolerant patients with high LDL-C levels.",
    "This sample is a phase 3 clinical trial for patients with septic shock, testing the effectiveness of the drug midodrine in increasing mean arterial pressure (MAP) to above 65 mmHg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of bempedoic acid and placebo in patients with hypercholesterolemia and atherosclerotic cardiovascular disease, who have high cardiovascular risk and are on maximally tolerated lipid-modifying therapy.",
    "This sample is a phase 3 clinical trial for patients with advanced pancreatic ductal adenocarcinoma (PDAC) that is metastatic. The trial will test the effectiveness of nab-paclitaxel with gemcitabine therapy in combination with napabucasin, a drug for treating PDAC. The eligibility criteria include having a confirmed diagnosis of metastatic PDAC, not having received previous chemotherapy or investigational agents for PDAC, and having an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drugs sof/vel and rbv, with key inclusion criteria including being a chronic HCV-infected individual, treatment-naive or treatment-experienced, and having a Child-Pugh-Turcotte Score of 7-12 at screening.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have progressed following prior therapy with an EGFR-TKI agent. The study will test the drug azd9291 dosing to evaluate its effectiveness in treating the disease.",
    "This sample is a phase 3 clinical trial for patients with progressive fibrosing interstitial lung disease (PF-ILD) who have not responded to approved medications, and it will test the effectiveness of nintedanib and placebo in treating the disease.",
    "This sample is a phase 3 clinical trial for patients with hypercholesterolemia, atherosclerosis, and statin adverse reactions, testing the effectiveness of bempedoic acid and ezetimibe in reducing LDL-cholesterol levels, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 clinical trial for patients with acute back pain or neck pain, testing the efficacy of ibuprofen, caffeine, and placebo as potential treatments. The eligibility criteria include having a signed informed consent, being 18 years or older, and having a pain score of at least 5 on the Numerical Rating Scale.",
    "This sample is a phase 3 trial for the treatment of hepatitis C, using the drugs daclatasvir, asunaprevir, and ribavirin, with specific eligibility criteria including HCV genotype 1b, liver disease status, HCV infection duration, age, and pregnancy status.",
    "This sample is a phase 3 clinical trial for patients with episodic migraine headaches, testing the effectiveness of the drug \"dfn-15 active\" in reducing migraine attacks, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with episodic migraine headaches, testing the effectiveness of the drug \"dfn-15 active\" in reducing migraine attacks, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to evaluate the efficacy of scrt and placebos in treating perennial allergic rhinitis, with inclusion criteria including age 18-60 years, presence of nasal symptoms for more than 2 consecutive years, and positive reaction to perennial allergen in skin prick test, while exclusion criteria include recent use of certain medications, presence of rhinosinusitis, hypertension, abnormal liver or renal function, neoplasm or severe systemic inflammation, history of drug allergy or anaphylaxis, pregnancy or lactation, and recent participation in other clinical studies.",
    "This sample is a phase 2/phase 3 trial for the treatment of social anxiety disorder and performance anxiety using the drugs bhv-0223 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes, testing the drugs semaglutide, placebo, and liraglutide, with eligibility criteria including a diagnosis of type 2 diabetes mellitus and specific HbA1c levels.",
    "This sample is a phase 3 clinical trial for chronic hepatitis C, testing the efficacy of danoprevir, ritonavir, peginterferon alfa-2a, and rbv in patients who have never received prior treatment for HCV with interferon, RBV, or other direct-acting or host-targeting antivirals for HCV. The inclusion criteria include chronic HCV infection, serum HCV RNA of \u2265 1 \u00d7 104 IU/mL, and non-cirrhosis patients with specific fibroscan or liver biopsy results. The exclusion criteria include liver cirrhosis, presence or history of non-hepatitis C chronic liver disease, history of liver cell cancer or suspected hepatocellular carcinoma, positive hepatitis A antibody, positive hepatitis B surface antigen, HIV antibody, presence or history of nervous system diseases and/or mental illness, obvious cardiovascular dysfunction, pregnancy or nursing, and others as specified in the detailed protocol.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the drug semaglutide against a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of caffeine in treating migraine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) using the drugs cenicriviroc and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial that aims to evaluate the effectiveness of cefiderocol, meropenem, and linezolid in treating healthcare-associated pneumonia, hospital-acquired pneumonia, and ventilator-associated pneumonia, with specific inclusion and exclusion criteria for eligible subjects.",
    "This phase 3 trial is testing the efficacy of rovalpituzumab tesirine and dexamethasone in patients with extensive-stage small cell lung cancer who have shown clinical benefit after first-line platinum-based therapy, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for the treatment of neovascular age-related macular degeneration and wet macular degeneration using the drug dorzolamide-timolol, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the use of esketamine, a drug used for major depressive disorder, in participants with suicidal ideation and a Montgomery Asberg Depression Rating Scale (MADRS) score greater than 28. Participants must meet specific inclusion criteria and not have certain exclusion criteria, such as a diagnosis of bipolar disorder or substance use disorder.",
    "This sample is a phase 3 clinical trial for the drug Apatinib in patients with gastric cancer or gastric adenocarcinoma who have failed prior chemotherapies, and it includes detailed inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of osteoarthritis of the knee using the drug fx006 32 mg, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of heavy menstrual bleeding associated with uterine fibroids, using drugs such as relugolix and estradiol/norethindrone acetate, with eligibility criteria including premenopausal females aged 18 to 50 years old who have a diagnosis of uterine fibroids and experience heavy menstrual bleeding.",
    "This sample is a phase 3 clinical trial for patients with idiopathic Parkinson's disease, testing the drug tozadenant, and includes eligibility criteria such as a minimum of 3 years since diagnosis, good response to levodopa, and stable regimen of anti-PD medications.",
    "This sample is a phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) using the drug sel. The eligibility criteria include specific liver biopsy results, laboratory parameters, and exclusion of certain liver diseases.",
    "This sample is a phase 3 trial for the treatment of nonalcoholic steatohepatitis (NASH) using the drug sel. The eligibility criteria include specific liver biopsy results, laboratory parameters, and exclusion of certain liver diseases and conditions.",
    "This sample is a phase 3 clinical trial for the treatment of bronchiolitis in pediatric subjects using nitric oxide, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of moderate-to-severe atopic dermatitis using the drug dupilumab, with specific eligibility criteria for participants.",
    "This phase 3 trial is testing the efficacy of rovalpituzumab tesirine, topotecan, and dexamethasone in treating small cell lung cancer patients with high Delta-like protein 3 (DLL3) expression, who have experienced disease progression after front-line platinum-based systemic regimen.",
    "This sample is a phase 2/phase 3 trial for patients with coronary artery disease and poor metabolism of clopidogrel, testing the effectiveness of clopidogrel and ticagrelor in preventing platelet aggregation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis using secukinumab, a biologic drug targeting IL-17, and placebo, with eligibility criteria including a minimum duration of psoriasis, specific severity scores, and previous inadequate control with topical, phototherapy, or systemic treatments.",
    "This sample is a phase 2/phase 3 trial for amyotrophic lateral sclerosis (ALS) patients, testing the effectiveness of the drugs acthar and placebo. The inclusion criteria include age between 18-75, ALS symptom onset within 2 years, and forced vital capacity (FVC) no higher than 60%. Exclusion criteria include tracheostomy, diaphragm pacing, recent medication use, diabetes mellitus, infection history, recent use of edaravone or steroids, and stem cell replacement therapy.",
    "This sample is a phase 3 clinical trial for the treatment of moderate-to-severe plaque psoriasis using the drugs ixekizumab, placebo, and etanercept, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C virus infection using the drug sof/vel, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of insulin degludec and insulin glargine in treating type 2 diabetes patients who have experienced hypoglycemic episodes, have moderate chronic renal failure, hypoglycemic symptom unawareness, or have been treated with insulin for more than 5 years.",
    "This sample is a phase 3 trial for infertility, testing the drugs nolasiban 900mg and placebo, with key inclusion criteria including being indicated for IVF/ICSI and following a specific protocol, and key exclusion criteria including frozen-thawed embryo transfer and having more than 20 oocytes in the current cycle.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of semaglutide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using amphetamine extended-release oral suspension and placebo as drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis, testing the drugs guselkumab and secukinumab, with eligibility criteria including a diagnosis of plaque-type psoriasis for at least 6 months and exclusion criteria such as a history of lymphoproliferative disease or previous use of guselkumab or secukinumab.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of glucagon in reducing insulin dosage, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hepatitis C (HCV) using glecaprevir/pibrentasvir and ribavirin, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for relapsing remitting multiple sclerosis (RRMS) patients, testing the drugs alks 8700 and dimethyl fumarate, with key inclusion criteria including confirmed diagnosis of RRMS and neurologically stability, and key exclusion criteria including progressive forms of MS, history of significant medical conditions, and prior use of dimethyl fumarate.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and low peak inspiratory flow rate (PIFR). The study will test the effectiveness of revefenacin and placebo for revefenacin and spiriva handihaler\u00ae in treating COPD. The inclusion criteria include being 40 years or older with a diagnosis of COPD and a smoking history of at least 10 pack-years. Exclusion criteria include hypersensitivity to inhaled anticholinergics and medical conditions that would preclude the use of inhaled anticholinergics.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of esketamine and placebo in reducing suicidal ideation and improving depressive symptoms in hospitalized patients with a MADRS score greater than 28.",
    "This sample is a phase 3 clinical trial for chronic idiopathic constipation, testing the effectiveness of the drugs lubiprostone and placebo, with inclusion criteria including a confirmed diagnosis of chronic constipation and stable use of a fiber supplement or blood pressure medication.",
    "This sample is a phase 3 trial for patients with chemotherapy-induced neutropenia, testing the drugs plinabulin and pegfilgrastim, and includes eligibility criteria such as age, performance status, disease types, prior treatments, laboratory results, and exclusion criteria such as prior chemotherapy, concurrent anticancer therapies, and significant cardiovascular history.",
    "This sample is a phase 3 clinical trial for the treatment of heavy menstrual bleeding associated with uterine fibroids, using drugs such as relugolix and estradiol/norethindrone acetate. The eligibility criteria include being a premenopausal female aged 18 to 50 years old with a diagnosis of uterine fibroids and heavy menstrual bleeding.",
    "This sample is a phase 3 clinical trial for the treatment of binge eating disorder, testing the efficacy of dasotraline 4mg and 6mg compared to a placebo, with eligibility criteria including meeting DSM-5 criteria for BED, having a history of at least 2 binge eating days a week for at least 6 months, and having a BE-CGI-S score \u2265 4, among other criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of syl1001 ophthalmic solution and vehicle ophthalmic solution in treating dry eye disease, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the drug eslicarbazepine acetate in the treatment of epilepsy, specifically partial onset seizures, in children aged 4 to <18 years. The inclusion criteria include confirmed diagnosis of epilepsy, documented EEG and MRI results, and a minimum seizure frequency of 6 seizures per month. The exclusion criteria include prior exposure to eslicarbazepine acetate, history of allergic reactions to certain medications, certain seizure types, and significant medical illnesses.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of drugs such as b/f/taf, f/taf, and dtg, with eligibility criteria including documented plasma HIV-1 RNA < 50 copies/mL and no resistance to integrase strand transfer inhibitors (INSTIs) or confirmed virologic failure.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs crenezumab and placebo, with eligibility criteria including specific weight range, caregiver availability, language fluency, abnormal memory function, and meeting diagnostic criteria for probable AD dementia or prodromal AD.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of bexagliflozin, sitagliptin, and their respective placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, testing the drug glecaprevir/pibrentasvir in HCV treatment-na\u00efve patients with specific eligibility criteria, including HCV RNA plasma \u2265 10,000 IU/ml, HCV genotype 1-6, and stage F0-3 liver disease.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the efficacy of dolutegravir, tenofovir alafenamide, truvada, and atripla in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug apremilast, targeting patients with moderate to severe plaque psoriasis, and the eligibility criteria include age, diagnosis, health status, and contraceptive use for females of childbearing potential.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of semaglutide, canagliflozin, and placebos in combination with metformin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial skin and skin structure infections (ABSSSI) using ceftobiprole medocaril and vancomycin+aztreonam, with detailed inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of acute myeloid leukemia (AML) using the drugs pracinostat, placebos, and azacitidine, with eligibility criteria including age, co-morbidities, and organ function.",
    "This phase 3 trial is investigating the efficacy of dexamethasone, daratumumab, and carfilzomib in treating relapsed or refractory multiple myeloma patients who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for acute schizophrenia patients, testing the efficacy of risperidone ism and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and aims to evaluate the efficacy of glycopyrronium/formoterol fumarate and umeclidinium/vilanterol as maintenance therapies. The inclusion criteria include age, smoking history, COPD diagnosis, severity, and COPD Assessment Test score, while the exclusion criteria include other respiratory diseases, recent exacerbations, pneumonia, and significant comorbidities.",
    "This sample is a phase 3 clinical trial for patients with non-squamous non-small cell lung cancer, testing the effectiveness of the drugs ql1101, avastin\u00ae, paclitaxel, and carboplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with active rheumatoid arthritis, testing the effectiveness of adalimumab, methotrexate, folic acid, and prednisolone as a treatment regimen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients diagnosed with acute or chronic gastritis, testing the effectiveness of drugs dwc20155, dwc20156, and their placebos, in reducing erosions found by gastroscopy.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C, testing the drug Zepatier oral product, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of semaglutide and liraglutide in combination with other anti-diabetic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial investigating the use of d-chiro-inositol and myoinositol in treating polycystic ovarian syndrome and infertility in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug e2007, testing its effectiveness in treating partial onset seizures in participants with epilepsy who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 1 diabetes mellitus, testing the effectiveness of ly900014, insulin lispro, insulin glargine, and insulin degludec in managing blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of various drugs including ly900014, insulin lispro, insulin glargine, insulin degludec, metformin, and sglt2 inhibitor, along with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for functional dyspepsia, testing the drugs ui05msp015ct and gasmotin, with inclusion criteria including age >19 years, diagnosis of functional dyspepsia meeting Rome III criteria, and at least three moderate or severe symptoms included in the Symptom Score, and exclusion criteria including history of dyspepsia unrelated to functional dyspepsia or diseases, history of gastrointestinal surgery, history of malignancy in the previous 5 years, psychiatric disorders, liver cirrhosis or abnormal liver laboratory findings, advanced chronic kidney disease, uncontrolled hypertension or diabetes, pregnancy and lactation, and recent history of taking medication affecting the gastrointestinal system.",
    "This sample is a phase 3 clinical trial for the treatment of migraines, testing the efficacy of the drug rimegepant compared to a placebo, with specific eligibility criteria for patients to be included in the study.",
    "This phase 3 trial is testing the effectiveness of htx-011, bupivacaine hcl, and saline placebo in providing analgesia for patients undergoing unilateral open inguinal herniorrhaphy with mesh under general anesthesia.",
    "This phase 3 trial aims to evaluate the efficacy of rimegepant, a drug used for the treatment of migraines, compared to a placebo, in patients with a history of migraines and specific inclusion criteria, while excluding patients with certain medical conditions or substance abuse history.",
    "This sample is a phase 3 clinical trial for infertility, specifically targeting anovulation, and is testing the effectiveness of letrozole and clomiphene citrate plus n acetyl cystine as potential treatments. The eligibility criteria include excluding male factor infertility, tubal factor, endocrineopathy, hypothyroidism, morbid obesity, underweight, and patients with previous surgery or resistance to ovulation with clomiphene citrate.",
    "This phase 3 clinical trial aims to evaluate the efficacy of sotagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease stage 4, who have an estimated glomerular filtration rate (eGFR) between \u226515 and <30 mL/min/1.73 m2, and are not currently on an SGLT2 inhibitor.",
    "This sample is a phase 3 clinical trial for contraception, testing the drug \"amphora\" in healthy women who are sexually active and at risk of pregnancy, with specific eligibility criteria including age range, negative pregnancy test, normal menstrual cycles, and willingness to use the study drug as the only method of contraception.",
    "This sample is a phase 3 trial for pregnant women with untreated HIV infection in late pregnancy, testing the efficacy of dolutegravir and standard of care (efv + 2 nrti backbone) in reducing mother-to-child transmission of HIV.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar depression using the drug lumateperone, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for patients with myocardial infarction, testing the drugs ticagrelor 90 mg and ticagrelor 60 mg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with acromegaly, testing the effectiveness of octreotide capsules and a matching placebo in controlling the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the use of ethanol-lock as a treatment for infection, catheter-related and central line-associated bloodstream infection (clabsi) in pediatric surgery patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of tardive dyskinesia using propranolol hydrochloride and placebo oral tablet, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of gabapentin, metamizol, and tramadol in treating chronic pain due to trauma and spinal cord injuries, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for HIV infections, where eligible participants must have HIV-1 infection, be on current therapy for at least 4 months, have specific drug regimens, and meet various health criteria. Exclusion criteria include HIV-2 infection, chronic viral hepatitis, and certain concomitant treatments.",
    "This sample is a phase 3 clinical trial for the treatment of primary open angle glaucoma and ocular hypertension, using the drugs pro-122 and krytantek ofteno\u00ae, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar I disorder with acute manic episodes using the drugs brexpiprazole and placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar I disorder with acute manic episodes using the drugs brexpiprazole and placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the efficacy of leuprolide mesylate, an androgen ablation therapy, in males with histologically confirmed carcinoma of the prostate, who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for Still's disease, testing the efficacy of a placebo drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of faster-acting insulin aspart, insulin aspart, insulin degludec, and metformin in combination with a basal-bolus insulin regimen. The inclusion criteria include being diagnosed with type 2 diabetes for 10 years or longer, being treated with a basal-bolus insulin regimen for at least 1 year, and having an HbA1c level between 7.0% and 10.0%. The exclusion criteria include recent cardiovascular events, NYHA Class IV classification, planned revascularization procedures, recent use of GLP-1 receptor agonists, and anticipated initiation or change in certain concomitant medications.",
    "This sample is a phase 3 clinical trial for patients with advanced brafv600 wild-type melanoma, testing the effectiveness of cobimetinib, atezolizumab, and pembrolizumab as a systemic anti-cancer therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with acute ischemic stroke, testing the effectiveness of sonothrombolysis using the drugs sonovue and sodium chloride, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pain management after bunionectomy surgery, testing the effectiveness of tramadol as a parenteral analgesia drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 clinical trial for dry eye disease, testing the effectiveness of cyclasol topical ocular eye drops and vehicle topical ocular eye drops in patients with a history of DED in both eyes who are currently using over-the-counter or artificial tears for dry eye symptoms. The inclusion and exclusion criteria include factors such as signed informed consent, absence of pregnancy or plans for pregnancy, absence of ocular malignancy or herpetic keratitis, absence of ocular or systemic infection, and absence of uncontrolled systemic diseases or known allergies to the study drug or its components.",
    "This phase 3 trial is testing the efficacy of htx-011, a drug for analgesia, compared to a saline placebo and bupivacaine hcl, in patients scheduled for a primary unilateral, distal, first metatarsal bunionectomy with osteotomy and internal fixation under regional anesthesia.",
    "This sample is a phase 3 clinical trial for HIV infections, testing the effectiveness of cabotegravir and rilpivirine tablets and injectable suspension, with specific eligibility criteria for participants, including age, reproductive potential, and prior HIV treatment.",
    "This sample is a phase 3 clinical trial for patients with colorectal adenocarcinoma, testing the effectiveness of oxaliplatin, leucovorin calcium, fluorouracil, and capecitabine as a maintenance therapy after prior chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hyperkalemia in patients receiving hemodialysis, testing the efficacy of sodium zirconium cyclosilicate (zs) compared to placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is investigating the efficacy of astx727 and dacogen in treating myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia, with specific eligibility criteria including age, organ function, and previous treatments.",
    "This sample is a phase 3 clinical trial for psoriasis vulgaris, testing the efficacy of mc2-01 cream, cal/bdp combination, and cream vehicle as topical treatments, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial is investigating the effectiveness of fremanezumab and placebo in the prevention of migraines in participants with a diagnosis of migraine with onset at \u226450 years of age, and who have a history of migraine for \u226512 months prior to screening.",
    "This sample is a phase 3 clinical trial for cervical cancer patients, testing the effectiveness of cisplatin in combination with pelvic radiation therapy, with eligibility criteria including biopsy-proven primary, untreated, histologically confirmed invasive squamous and aden-squamous cell carcinoma of the uterine cervix, and exclusion criteria including prior invasive malignancy other than cervical cancer within the past 24 months.",
    "This sample is a phase 3 clinical trial for the treatment of atopic dermatitis using the drugs baricitinib and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of atopic dermatitis using the drugs baricitinib and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of dermatitis, atopic using the drug dupilumab, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using paliperidone palmitate, with specific inclusion and exclusion criteria, and the presence of an identified reliable caregiver.",
    "This sample is a phase 3 clinical trial for the drug pf-04965842 in patients with moderate to severe atopic dermatitis, who have had an inadequate response to topical treatments or require systemic treatments for disease control. The study aims to evaluate the efficacy and safety of the drug compared to placebo.",
    "This sample is a phase 3 clinical trial for patients with refractory peripheral T-cell lymphoma and relapsed T-cell lymphoma, testing the drug pralatrexate, with specific eligibility criteria including documented progressive disease after prior treatment and certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with gastrointestinal stromal tumors who have progressed on previous treatments, and it is testing the efficacy of the drug dcc-2618 compared to a placebo oral tablet. The eligibility criteria include having a histologic diagnosis of GIST, having a certain ECOG performance status, and meeting specific laboratory assessments.",
    "This sample is a phase 3 trial for the treatment of seasonal allergic rhinitis using the drugs omalizumab and placebo, with eligibility criteria including a clinical history of Japanese cedar pollinosis, inadequately controlled symptoms, specific IgE levels, and developing symptoms during the cedar pollen season.",
    "This sample is a phase 3 trial for the drugs dasiglucagon, glucagen, and placebo in patients with hypoglycemia and diabetes mellitus type 1, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of inclisiran, a drug, in treating heterozygous familial hypercholesterolemia and elevated cholesterol, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy of inclisiran sodium, a drug used to lower LDL cholesterol, compared to a placebo in participants with a history of ASCVD and elevated cholesterol levels, who are either on statins or have documented intolerance to statins.",
    "This sample is a phase 3 clinical trial for the treatment of homozygous familial hypercholesterolemia using the drugs evinacumab and placebo, with specific eligibility criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy of inclisiran sodium, a drug used to lower LDL cholesterol levels, compared to a placebo in participants with a history of ASCVD and elevated cholesterol levels, who are either on statins or have documented intolerance to statins.",
    "This sample is a phase 3 clinical trial for patients with acute ischemic stroke, testing the effectiveness of simvastatin 10 mg and simvastatin 40 mg in reducing the risk of stroke. The eligibility criteria include patients with symptom onset less than 24 hours, aged 18 to 85, and without certain indications or medical conditions.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of drugs such as fosnetupitant/palonosetron, netupitant/palonosetron, and dexamethasone in combination with an AC chemotherapy regimen. The eligibility criteria include being a female patient of at least 8 years of age with histologically or cytologically confirmed breast cancer, and having a negative urine pregnancy test.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the use of peg-filgrastim as a prophylactic treatment during chemotherapy cycles, with specific eligibility criteria including age, disease stage, organ function, and negative pregnancy test.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the drug b/f/taf, and includes key inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of pneumonia caused by Pseudomonas aeruginosa, using the drugs murepavadin and two anti-pseudomonal antibiotics, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for participants with Type 1 or Type 2 diabetes, testing the effectiveness of glucagon nasal powder and glucagon hydrochloride solution in managing diabetes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of the drugs ly900014 and insulin lispro in combination with an insulin pump and continuous glucose monitoring, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the effectiveness of insulin glargine/lixisenatide and other background therapies in controlling uncontrolled diabetes.",
    "This sample is a phase 3 trial for patients with melanoma, testing the drugs temozolomide plus cisplatin and high-dose ifn-a2b, with eligibility criteria including age over 18, confirmed diagnosis of mucosal melanoma, completely resected primary tumor, and no evidence of distant metastatic disease.",
    "This sample is a phase 3 trial for the treatment of severe hypoglycemia in patients with type 1 diabetes mellitus, using the drugs g-pen and lilly glucagon, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for HIV infections, testing the efficacy of the drugs dtg + 3tc and taf based regimen (tbr) in patients who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for cystic fibrosis patients who are heterozygous for F508del and an MF mutation, with key inclusion criteria including a FEV1 value between 40% and 90% of predicted mean, and key exclusion criteria including clinically significant cirrhosis, lung infection with certain organisms, and solid organ or hematological transplantation. The drugs being tested are vx-659/tez/iva, iva, and placebo.",
    "This sample is a phase 3 trial for cystic fibrosis patients who are homozygous for the F508del mutation, with key inclusion criteria including a specific range for forced expiratory volume in 1 second (FEV1) value, and key exclusion criteria including cirrhosis, lung infection, and organ or hematological transplantation. The study will test the efficacy of vx-659/tez/iva, tez/iva, iva, and placebo drugs.",
    "This sample is a phase 3 clinical trial for the treatment of migraines, testing the effectiveness of the drug rimegepant compared to a placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis (SAR) in children aged 6 to 12 years, using the drugs gsp 301 ns and gsp 301 placebo ns. The inclusion criteria include a clinical history of SAR, demonstrated sensitivity to a seasonal allergen, and a high rTNSS value. Exclusion criteria include pregnancy, travel outside the pollen area, and certain medical conditions.",
    "This phase 3 trial aims to evaluate the effectiveness of the drug bp101 and placebo in treating hypoactive sexual desire disorder (HSDD) in women aged 21 to 50 years old, with specific inclusion and exclusion criteria, and the use of adequate contraception throughout the study.",
    "This sample is a phase 3 trial testing the use of tranexamic acid in patients with hemorrhagic shock or trauma injury, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of overactive bladder using the drugs vibegron and tolterodine tartrate er, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the efficacy of the drugs Genvoya and Dolutegravir in combination with antiretroviral therapy, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for cystic fibrosis, testing the drugs vx-445/tez/iva, iva, and placebo, with key inclusion criteria including being heterozygous for the F508del mutation and having a forced expiratory volume in 1 second (FEV1) value between 40% and 90% of predicted mean for age, sex, and height.",
    "This sample is a phase 3 trial for cystic fibrosis patients who are homozygous for the F508del mutation, with key inclusion criteria including a specific range of forced expiratory volume and key exclusion criteria including cirrhosis and lung infection. The study will test the efficacy of vx-445/tez/iva, tez/iva, iva, and placebo drugs.",
    "This phase 3 trial aims to evaluate the efficacy of nemonoxacin and tavanic, along with placebos, in the treatment of moderate to severe community-acquired pneumonia, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for cystic fibrosis patients, testing the drugs tez/iva, iva, and placebos, with specific eligibility criteria including genetic mutations, lung function, and ability to swallow tablets.",
    "This sample is a phase 3 clinical trial for the treatment of migraine, testing the effectiveness of galcanezumab, a CGRP antibody, compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of irritable bowel syndrome characterized by constipation, using the drugs linaclotide and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the effectiveness of uritos\u00ae and urotol\u00ae in treating overactive bladder, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the drug pf-04965842 in patients with moderate to severe atopic dermatitis, who have had an inadequate response to topical treatments or require systemic treatments for control. The study aims to evaluate the efficacy and safety of the drug compared to placebo.",
    "This sample is a phase 3 trial for pneumonia, testing the drugs murepavadin and one anti-pseudomonal antibiotic, with eligibility criteria including mechanical ventilation for at least 48 hours or specific signs/symptoms, specific APACHE score, presence of new or progressive infiltrate on chest X-ray, clinical criteria consistent with pneumonia, and strong clinical suspicion of pneumonia due to P. aeruginosa. Exclusion criteria include certain types of pneumonia, hypersensitivity to certain drugs, severe liver or renal impairment, expected survival less than 72 hours, evidence of co-infection with certain resistant pathogens, and pregnancy or nursing.",
    "This sample is a phase 3 trial for the treatment of influenza, testing the drugs baloxavir marboxil and oseltamivir, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of Duchenne muscular dystrophy using the drug deflazacort, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for alcohol dependence, testing the drugs Odelepan and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for hypoglycemia, testing the drugs dasiglucagon, placebo, and glucagen hypokit, with eligibility criteria including signed informed consent, T1DM diagnosis, age between 6 and 18, and body weight \u226520 kg.",
    "This sample is a phase 3 clinical trial testing the efficacy of dasiglucagon, a drug used in the rescue treatment of hypoglycemia, in patients with type 1 diabetes mellitus. The trial includes eligibility criteria such as a minimum duration of T1DM, stable insulin treatment, and a maximum hemoglobin A1c level. Exclusion criteria include previous participation in the trial or known allergies to the trial drug.",
    "This sample is a phase 3 clinical trial for acute pain, testing the effectiveness of different drugs such as tramadol/diclofenac and tramadol in participants requiring extraction of impacted lower third molars, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial that focuses on patients undergoing mastectomy with possible immediate breast reconstruction, and it investigates the use of nitroglycerin paste in combination with other treatments for perfusion complications.",
    "This sample is a phase 3 clinical trial for the treatment of moderate to severe atopic dermatitis, testing the efficacy of baricitinib, topical corticosteroid, and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for patients with Duchenne muscular dystrophy (DMD) who have a documented mutation in the Dystrophin gene associated with DMD that is amenable to exon 51 skipping. The study will test the efficacy of wve-210201 (suvodirsen) compared to placebo in improving pulmonary and cardiac function in ambulatory males with stable corticosteroid therapy.",
    "This sample is a phase 3 trial for the drug ustekinumab in patients with systemic lupus erythematosus, with specific inclusion and exclusion criteria, and the trial aims to assess the drug's efficacy in treating lupus symptoms.",
    "This sample is a phase 3 trial for the treatment of coronavirus infection using hydroxychloroquine sulfate, azithromycin, and chloroquine sulfate, with specific inclusion and exclusion criteria for participants."
]